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Abstract
Neuroimaging has enabled the observation of damage to the white matter that occurs
frequently in elderly population and is depicted as hyperintensities in specific magnetic
resonance images. Since the pathophysiology underlying the existence of these signal
abnormalities and the association with clinical risk factors and outcome is still inves-
tigated, a robust and accurate quantification and characterisation of these observations
is necessary. In this thesis, I developed a data-driven split and merge model selection
framework that results in the joint modelling of normal appearing and outlier observa-
tions in a hierarchical Gaussian mixture model. The resulting model can then be used to
segment white matter hyperintensities (WMH) in a post-processing step. The validity
of the method in terms of robustness to data quality, acquisition protocol and prepro-
cessing and its comparison to the state of the art is evaluated in both simulated and
clinical settings. To further characterise the lesions, a subject-specific coordinate frame
that divides the WM region according to the relative distance between the ventricular
surface and the cortical sheet and to the lobar location is introduced. This coordinate
frame is used for the comparison of lesion distributions in a population of twin pairs and
for the prediction and standardisation of visual rating scales. Lastly the cross-sectional
method is extended into a longitudinal framework, in which a Gaussian Mixture model
built on an average image is used to constrain the representation of the individual time
points. The method is validated through a purpose-build longitudinal lesion simulator
and applied to the investigation of the relationship between APOE genetic status and
lesion load progression.
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Chapter 1
Introduction
Medical imaging has been developed to enable the visualisation of hidden reality and
investigate, describe and assess otherwise inaccessible reality of the human body. Sub-
sequent image analysis comes naturally as a way of robustly and objectively charac-
terising, summarising, describing and quantifying the information embedded in the ob-
tained images. Such process is however put in place to answer clinical needs, biological
questions and more globally health issues. As the title of this thesis emphasises, most
of the contribution of this work can be classified at the end of the process in the attempt
to robustly quantify information coming from medical images. Apart from the inherent
intellectual challenge, this would however seem less meaningful without being driven
by a clinical need. The rationale behind medical image analysis in this case holds
behind the following questions: assuming that the observations in medical images are
representative of a biological process, is it possible to provide one or different solutions
to robustly quantify these observations so as to answer a clinical question? Can these
objective descriptions be proven relevant and participate in a better understanding of
the complex underpinning clinical reality?
This introduction tries to reflect the strong link between the three aspects of patho-
physiological clinical observation, imaging and image analysis. The synergy between
this three themes in the context of white matter hyperintensities (WMH) is made
stronger by the fact that clinical questions and theories have only risen when neu-
roimaging has enabled the depiction of such abnormal observations. Besides, the de-
nomination itself is directly derived from an imaging perspective. First, the biological
situation and the needed clinical context of age-related white matter hyperintensities are
detailed in Section 1.1 before addressing in Section 1.2 the importance of neuroimag-
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ing and reporting the existing solutions for the visualisation of this specific condition.
The challenges of quantification, particularly in terms of delineation of the investigated
WMH, and the wide range of available methods (that will be more detailed in Chapter
2) are broadly mentioned in Section 1.3 before finally outlining the rationale and main
components of this thesis in Section 1.4.
1.1 Brain, white matter and pathology
To describe the brain, different scales and perspectives can be adopted: cellular compo-
nents, structural tissue types, anatomical regions of interest or functional connections
are some of the ways the brain can be investigated. Neurons, cells that carry the electri-
cal information across complex networks are at the core of the brain processing. They
may be considered as composed of three parts: the cell body, the dendrites and the
axonal extension. To interact together, most neurons use both electrical and chemical
information transfer pathways. Information under the form of electrical impulses will
be conveyed along the axon of the neuron until reaching its end. To "communicate" the
so far electrical information, a chemical encoding is performed and the neurotransmit-
ters released as a cellular answer to the electrical message will reach the dendrites of
the second neuron via the synaptic cleft. Upon chemical reception, this second neuron
may in turn proceed with the firing of a further electrical impulse. In the brain, neurons
are usually well organised and the cell bodies with the dendrites packed together into
what is defined as the grey matter (GM). Clinical research has so far largely focused
its attention on grey matter since the cortical GM is more directly accessed and links
between brain grey matter lesion and clinical outcome are naturally observed. In the
popular language, grey matter as even been used as a metonymy for the whole brain
with for example Agatha Christie’s hero referring proudly to his "little grey cells". The
reality of the brain is however much more complicated and the billions of neuronal cells
could not perform appropriately without the adequate support of other brain cells called
glial cells. One of the crucial aspects in the functioning of the brain lies for instance
in the need for neurons to be appropriately supplied in energy via nutrients and oxygen
while being simultaneously protected from any potentially dangerous compound. This
complex system of protection and supply is named the blood-brain barrier (BBB).
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1.1.1 Defining white matter
As defined by Malloy et al. [1], the white matter (WM), located under the cortical rib-
bon, represents 40 to 50% of the brain volume of a young healthy adult. It is composed
by the neuronal axons and their supportive glia. Among these supportive elements, the
astrocytes, cells that enact the blood brain barrier process, control the delivery of nu-
trients and restrict the incoming of damaging elements. In turn, another type of cells,
the oligodendrocytes, are key elements to produce and maintain the myelin sheaths that
coat the axons. To that aim, they develop membrane processes that encircle the axons
forming multi-lammelar structures. The myelin, composed of lipids at 80%, acts as an
insulator and allows for the saltatory electrical conduction along the axons, from one
point of discontinuity (called node of Ranvier) to another, thereby increasing the speed
of neuronal signal transmission [2]. Responsible for the connection of the different
regions of the brain, white matter is therefore crucial to the transfer of information.
The myelin-coated fibres of the white matter gathered in bundles or tracts can be
separated in three main subgroups according to their end-points [1]:
Projection tracts : These long tracts connect the cortex with the spinal cord, as well
as the diencephalic and mesencephalic regions of the brain. The ascending tracts
connect the thalamus and basal ganglia to the cortex.
Commissural tracts : These tracts serve to the lateral connection between hemi-
spheres.
Association tracts : The cortical association tracts within an hemisphere are sub-
classified into two groups. The short U fibres connect adjacent gyri and are rarely
affected by white matter disease. The long association tracts however are more
disparate and susceptible to suffer from cerebral small vessel disease (CSVD).
These tracts are likely to traverse periventricular regions and deep white matter.
The longest among these association tracts are related to the frontal lobes that are
a place of predilection for white matter disease.
Damages to the white matter either affecting the myelin and/or leading to axonal
loss affect deeply the signal transmission and may in turn be associated with cogni-
tive impairment. The pathophysiological explanations for such damages range from
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genetic disorders (leukodystrophies) to inflammatory diseases (lupus) going through
toxic or traumatic events, infectious diseases (HIV), demyelinative disorders (multiple
sclerosis), or vascular pathologies [3].
1.1.2 Ageing and white matter disease
The definition of white matter disease in ageing population is difficult due to incon-
sistencies in the terminology [4]. In general, the term white matter disease (WMD) is
used as a generic term to refer to pathological observations in the white matter with a
presumed ischaemic origin as opposed to multiple sclerosis or leukodystrophies [5].
1.1.2.1 Other lesions than WMH
White matter lesions associated with cerebral small vessel disease have been classified
by Wardlaw et al. [4] as small subcortical infarcts, lacunes, enlarged perivascular spaces
(EPVS), cerebral microbleeds (CMB) and leukoaraiosis (LA). The latter, defined and
introduced based on neuroimaging findings [6], has also been naturally named white
matter hyperintensity (WMH) and will be described in a neuroimaging perspective in
Section 1.2.4. Lacunes are older small infarcts that have cavitated and are fluid-filled.
Enlarged perivascular spaces also known as enlarged Virchow-Robin spaces consist in
the abnormal extension of the fluid space around the vessels and run along them at the
interface between vessel walls and glia limitans. Normally microscopic and invisible,
they can expand with age. Used for interstitial clearance towards the ventricles, and
as inflammatory response pathways, their enlargement is associated with some fluid
entrappement and is observed in ageing population and in multiple sclerosis patients.
According to their location in the brain, pathophysiology may be different: hyperten-
sive arteriopathy affects principally the deep (brainstem, basal ganglia and deep white
matter) arterioles while cerebral amyloid angiopathy effects are mostly observed on
cortical and leptomeningeal vessels [7]. Those enlarged PVS may also be a marker of
BBB impairment in small vessel disease [8]. Lastly, cerebral microbleeds are believed
to relate to vascular leakage of blood cells in the perivascular space.
1.1.2.2 Leukoaraiosis/WMH
Leukoaraiosis, is a term introduced in 1986 [6] to account for the non-specific changes
observed in the white matter in the ageing population. Its greek roots leuko that refers
to the colour white and here white matter and ario that means loose and rare, com-
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bined with the action transforming suffix -osis was conceived to mean "rarefaction of
the white matter". Reflecting the neuroimaging observations that are associated to it
and will be further developed in Section 1.2.4, the term white matter hyperintensities
(WMH) is indifferently used in its place. The description as white matter changes
(WMC) has also been proposed.
To account for these tissue changes occurring in ageing [9], various biological
explanations have been proposed such as the degradation of the myelin, the increase
in extracellular water, the desaturation of the myelin lipid contributing to its instability,
the damaging action of free radicals or the effects of inflammation with a reactive astro-
cytosis [10]. On an histological perspective, white matter changes can present a partial
loss of myelin, axons and oligodendrocytes, a slight increase in the number of other
glial cells, a stenosis of the arterioles as well as the presence of macrophages [11]. In
the ageing process, the myelin degradation has been associated with myelin pallor, the
loss of myelinated fibres and the deformation of myelin sheaths [9].
Historically, WMH have commonly been considered as a consequence of the par-
tial ischaemia of the tissue. Unable to obtain their required survival components, neu-
rons and oligodendrocytes progressively decay leading to the degradation of the myelin
sheath [12]. In general, damage to the blood vessels through wall thickening, lumen
narrowing and vessel stiffness may impair the tissue perfusion therefore preventing its
metabolic needs from being answered in a timely and appropriate manner. Higher bi-
ological markers of hypoxia (lack of oxygen) have been reported in WMH [13] and
arteriolosclerosis has been observed as the most important pathological finding [14].
Increasing evidence shows the relationship between an impaired vascular endothe-
lium and the occurrence of WMH [15] and markers of increased BBB permeability, that
not only control the tissue supplies but also protects the brain against toxic attacks have
been reported [3]. Indeed, depending on the location, impairment of the endothelium
can lead to an accumulation of plasma protein in the vessel walls, damaging the struc-
ture of the vessels at the smooth muscle cells level or by the deposition of fibrin. These
alterations may directly affect blood flow auto-regulation with subsequent inappropri-
ate tissue perfusion especially when evolving at later stage to vessel stiffness and lumen
narrowing. Alternatively, if leakage of plasmatic compounds in the perivascular space
occurs, for example at the level of the capillaries for which no smooth muscle layer
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exists, the toxicity of the leaked compound through vasogenic edema is potentially
threatening to the surrounding tissue. Additionnaly, if red blood cells are extravasated
from the vessels, alterations in the iron metabolism can induce oxidative stress thereby
promoting the damage [12]. Implications of the iron metabolism are further backed
up by the recent discovery of the independent association of the gene for hemochro-
matosis with severe white matter changes [16]. Further impairment at the venule level
especially around the ventricles has been observed with venous collagenesis [13].
The blood-brain barrier is known to be more permeable with increasing age which
is in line with the fact that age is a major risk factor for the occurrence of WMH and
that markers of BBB dysfunction have been observed in WMH. Even in the absence
of risk factors, the potential for vasodilation reduces with age and the expression of
inflammatory compounds increases. However, the exact pathways leading to BBB dis-
ruption in normal ageing are still unclear [17]. In the case of WMH, feed-forward
loops of increasing damage may occur, explaining the exponential accrual of observed
lesions [15]. For instance, hypoxia is known to contribute to a higher BBB permeabil-
ity that, as mentioned before can lead to further vascular damage and inadequate tissue
perfusion. Further inflammatory mechanisms as a response to the presence of toxic
proteins or in response to ischaemia have also been observed to disrupt the structure of
tight junctions at the BBB level [17].
By choice, the terms leukoaraiosis and WMH are indefinite enough to encom-
pass the large variety in appearance, spatial distribution and potential histopathologi-
cal explanations. With respect to location, varied hypothetical pathways have actually
been suggested but obtaining robust and reproducible characterisations of such loca-
tion properties is in itself a challenging task. Lesions are classically separated between
those that are located continuously to the ventricular surface (periventricular WMH or
PVWMH) and those that are not (deep WMH or DWMH).
DWMH are generally associated with the ischaemic explanation for leukoaraio-
sis [18] while the PVWMH can be substratified according to their appearance, with
different pathophysiological explanations. In the milder cases of periventricular (PV)
caps around the frontal horns evolving to a thin pencil line around the lateral ventri-
cles lining toward smooth halos [16], the observed areas of hyperintensities appear to
be due to some discontinuity in the ependymal lining delimiting the ventricles or to a
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loosening of the fine fibre tracts. These changes contribute to the increase in extracel-
lular space and thus to the water content of the region [11,18,19] not affecting directly
the signal transmission through myelin deterioration. Therefore, in periventricular re-
gions, the observed hyperintensities are not discriminative for myelin degradation or
increased water content due to BBB disruption and should not be completely associ-
ated with myelin pathology [20]. The leakage of cerebrospinal fluid (CSF) in the brain
parenchyma causing this increase in water content may not be corrected if the blood-
brain-barrier is altered and the reabsorption process hindered. Irregular PVWMH are
in turn mostly explained by a chronic hemodynamic insufficiency and a fibrohyalonic
process.
Characterising the lesion spatial distribution is made more difficult by the fact that
the damage to the white matter evolves in time. This may for instance lead to the
coalescence of periventricular damage and deep white matter lesions. As underlined
by Yoshita et al. [21], the problem is thus not only volumetric: a fourth dimension,
time, must also be included. In the study of pathologies, the question of longitudinal
evolution is crucial to clarify potential causal relationships.
In the evolution of white matter disease, a partially consistent pattern has been
described. Hyperintensities seem to first appear at the horns of the lateral ventricles,
then all around them before occurring in the deep white matter and the basal ganglia [1].
Maillard et al. [22] showed the trend of the lesions to extend from existing damage in
vulnerable neighbouring regions. Moreover, the rate of appearance of new white matter
signal change is associated with the initial volume of lesions such that more severe
cases will develop more rapidly [23, 24].
1.1.3 White matter changes, risk factor and clinical correlates
On a clinical perspective, in addition to age, some risk factors, such as diabetes mellitus,
hypertension or smoking, have been associated to the presence of white matter changes
(WMC) [1, 15, 25, 26]. Although thought to affect mostly the arterial part of the vascu-
lature, with emphasis on the deleterious effect of hypertension and other vascular risk
factors such as diabetes mellitus and smoking, WMH have also been observed in pop-
ulations free of vascular risk factors [15]. Attempting to map locally WMH and risk
factors, Rostrup et al. [27] demonstrated a clearer association of hypertension in the
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DWM regions while age was strongly associated to the most common areas of WMH
that is the periventricular horns and lateral bands.
Although at first considered as clinically silent and benign, evidence is now point-
ing to a relationship between WMH and deleterious clinical outcomes. With respect
to cerebrovascular damage, WMH have been shown to increase the risk of stroke in
the general population [28]. In terms of cognitive abilities, the preexistence of WMH
appeared to negatively affect cognitive results one year after a stroke [29]. Further-
more, WMD can be linked to cognitive decline especially with respect to processing
speed disorders [30]. This observation strengthens the hypothesis that the clinically
relevant WMH are those in which myelin deterioration and in turn tract disruption is
involved [20, 31]. Most of the complaints were related to the executive functions with
decreased processing speed, erroneous goal formation, planning or organisation [16],
motor disturbances with gait disorders, problems in postural control or urinary conti-
nence [16, 32]. Due to the high concentration of white matter fibres in the frontal re-
gions related to these functions, the probability of these regions to be affected in white
matter degradation could indeed be higher and therefore explain this observation [10].
To a lesser extent, some memory deficits, and recognition difficulties have also been
reported [16] as well as mood disorders such as depression [18].
Using the above mentioned distinction between PVWMH and DWMH, PVWMH
have been more easily associated to executive function and processing speed defi-
ciencies while DWMH have been mostly highlighted in relationship to mood disor-
ders [18, 26, 33–35]. The association of mood disorders to DWMH is explained by
potential disruptions to the tracts in the frontostriatal circuits, known to be related to
mood regulation [11]. Such a distinction is still controversial [36] and the reviewing
studies about the location of the WMH show a high heterogeneity in methods, includ-
ing the definition of the WMH, the choice of the used neuroimaging technique, the
method of WMH quantification and of neurocognitive assessment [35]. When look-
ing at the link to the risk of developing dementia, the role of WMH location remains
unclear [37]. However, in most of the studies, the total WMH burden has been asso-
ciated with a higher risk of developing Alzheimer’s disease (AD) and other dementia
types for the general population but has not been found significant when predicting the
transition from Mild Cognitive Impairment (MCI) to AD [37]. Associated with cortical
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GM atrophy in the normal ageing population [38], two complementary hypotheses can
be advanced with respect to the occurrence of white matter changes [18]. On one hand,
the destruction of grey matter (GM) cells could lead, by Wallerian degeneration, to the
decay of the associated fibres. On the other hand, disruptions at the axon level could
propagate towards the GM by a retrograde deafferentiation process.
Studying more specifically the possible relationship between AD and the presence
of white matter damage, various hypotheses have been presented to explain a potential
link between the expression of both pathologies. It appears that in AD cases, white mat-
ter abnormalities are more prominent in posterior than anterior regions [1], compared
to normal controls, thus inferring that a different mechanism is induced by AD in poste-
rior regions. However, Radanovic et al. [25] conclude that WMH occur independently
from the AD pathology but that the risk of cognitive decline in association with WMH
is increased when amyloid deposition is observed, and they consider the presence of
WMH as a sign of increased vulnerability to cognitive decline. This conclusion can in
some ways be linked with the controversial hypothesis of the existence of a threshold
above which silent white matter damages become symptomatic [1, 37]. Ertens-Lyons
et al. [14] found an association between a higher WMH load and AD and three expla-
nations were proposed for this finding: first the Wallerian degeneration induced by the
loss of cortical grey matter driven by the AD process was causing white matter dis-
ruption; second an ischaemic cause to axonal injury may lead to tangle formation and
eventually to neuronal degeneration; third a common mechanism could lead to both,
ischaemia causing both white matter damage and neurodegeneration. Additionally, as
amyloid increases the permeability of the BBB, white matter changes linked to BBB
disruption might be further explained in AD pathology [15]. In the case of cerebral
amyloid angiopathy (CAA), when amyloid plaques are deposited on the vessel walls
and often observed in AD, WMH are more prominent [39].
Longitudinally, a larger increase in lesion burden is further associated with a
higher brain volume loss [40], while smoking appears to accelerate the progression
[41]. In terms of links with cognitive outcome, a larger WMH increase seems to be
related to the absence of remission in depression [42].
All these hypotheses, theories and clinical associations with respect to WMH rely
however on the observation and quantification of the lesion burden. Such relationships
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would have been impossible to draw without the development of relevant neuroimaging
solutions.
1.2 Medical imaging and WMH
1.2.1 Medical imaging and pathology
In order to understand, evaluate and ascertain pathological processes happening in the
body, different strategies have been applied. The most invasive one, consists in putting
outside what is inside. Drawing samples from tissues or fluid (blood or CSF) is possible
in vivo but provides only a partial and limited knowledge about the reality. Moreover,
these useful snapshots of a biological situation do not inform on the relative organisa-
tion of tissues. In the special case of biopsies, the randomness of the draw, may actually
even mislead the diagnosis. Even in most extreme cases when the analysis is performed
post-mortem, at which stage a dissection of the relevant tissues is possible, the changes
in physiology may modify the structures and the applied mechanical constrains further
affect the tissue organisation. Although in some cases, partial information on a patho-
logical situation can be acquired without the sense of sight, using the sense of touch
to assess swollen ganglia, abnormal tumour growth or broken bones for instance, the
brain, encased in the solid skull remains inaccessible.
Medical imaging, in making visible what naturally would remain hidden to sight
has allowed new and crucial insight in understanding the organisational structure and
functioning of this organ as well as the potential abnormal situations that can be encoun-
tered. Abnormalities as a whole in terms of imaging, can refer to structural presentation
such as shrinkage of the hippocampus or enlarged ventricles, but also unexpected in-
tensity signals as observed in tumour masses, necrosis or WML. With respect to abnor-
malities, the natural assumption is that these observations are linked to a pathological
process affecting the functioning of the organ and contributing to detrimental clinical
outcomes. However, it must be underlined that drawing causality relationships is ex-
tremely difficult and most of the conclusions are merely associations and correlations
that in time prove useful and relevant clinically.
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1.2.2 Imaging the brain
For the brain, medical imaging in its different modalities relies on the differential prop-
erties of the present tissues that either respond differently to a stimulus (X-ray, mag-
netic field) or behave differently with respect to a source of stimulus (Positron emis-
sion tomography radiotracers). Magnetic Resonance Imaging (MRI) has been proven
as a modality of choice to image differences between the soft tissues that compose the
brain. In brief, it consists in analysing how tissues answer in time to different types
of magnetic excitations. During an MR acquisition, a main magnetic field is applied
continuously and the spins of the protons naturally align to it. Upon excitation by
transient magnetic pulse oriented in a perpendicular plane, spins will align to this new
field and rotate in phase at a given resonance frequency. Once the excitation pulse
has subsided, spins will naturally tend to go back to their original state, governed by
two main tissue properties. The T1 relaxation property also known as spin-lattice re-
laxation reflects the level of energy released by interactions between the protons and
the surrounding molecules. The T1 relaxation time is then the time required for the
protons to reach back 63% of their initial energy. In turn, the T2 relaxation property
also known as spin-spin relaxation expresses how fast the excited spins dephase due to
magnetic interactions between protons. In particular it helps evaluating the density of
macromolecules in a tissue and the coherence of the proton organisation. With respect
to the T2 property, additional inhomogeneities in the main field such as those due to
susceptibility-related field distortions may strengthen the magnetic interactions. Such
distortions are in particular due to the presence of blood or iron in a tissue. The associ-
ation of both causes of magnetic interactions is summarised as the T2* characteristic.
According to the way the magnetic pulse sequences are designed, different contrasts
can be achieved exposing the varied and complementary tissue properties. With T1-
weighted images (also denoted T1w or T1), thought to provide good structural contrast
between tissues, the T1 relaxation properties are favoured compared to the T2 charac-
teristics, thus emphasising the different levels of energy interactions between protons
and surrounding molecules. Highly organised with large molecules, fat tissues present
a short T1 relaxation time. In T1-weighted images, these tissues will then appear with
a higher signal than tissue in which energetic interaction with surrounding molecules
is lower, as in the CSF, that appears dark. The high proportion of lipid in the com-
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position of the white matter therefore contributes to its higher signal on T1-weighted
(T1) images, aligned with its autopsy derived original denomination. In the case of T2-
weighted (T2w or T2) pulse sequences, the emphasis is put on the property of magnetic
interactions between protons while in PD-weighted images also referred to as interme-
diate weighted image, the proportions of protons in the tissues are imaged. In turn T2*
weighted and susceptibility weighted (SW) images convey also the information of the
internal sources of magnetic distortion. More recently, Fluid Attenuated Inversion Re-
covery (FLAIR) pulse sequences have been developed to provide T2-weighted contrast
while nulling the signal of free water.
1.2.3 Imaging white matter disease
White matter lesions (WML), globally defined as any type of signal abnormalities ob-
served in the white matter appear in a wide range of pathologies as mentioned in Sec-
tion 1.1. Due to the high variability of their appearances, their systematic study is
extremely challenging, all the more so that neuroimaging findings often do not allow
for the discrimination between pathological explanations [3, 9, 26]. To differentiate
multiple sclerosis (MS) and age-related WMH, due to the similarities in appearance,
Fazekas et al. [43] developed new criteria based on location pattern, size and evolution
to distinguish between the two pathologies.
Ischaemia related injuries on the white matter can present themselves along vari-
ous patterns among which the most common are the leukoaraiosis and the lacunes [1,4].
Standardised descriptions and the respective image acquisition modalities of choice
have been described by Wardlaw et al. [4] to help discriminating between ischaemic
neuroimaging findings related to cerebral small vessel disease (CSVD).
Small subcortical infarcts The modality of choice for the detection of recent small
subcortical infarcts is diffusion weighted imaging (DWI). With a diameter in-
ferior to 20 mm, they appear afterwards with a decreased intensity on T1 and
increased in T2 and FLAIR in the region of a perforating arteriole.
Lacunes They are round or ovoid in shape, usually fluid filled, thus with a signal sim-
ilar to the CSF and their diameter range from 3 to 15 mm. On FLAIR images,
lacunes usually appear as an hypointense centre surrounded by a rim of hyper-
intensity. When it is not completely fluid filled, such lesion can appear totally
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hyperintense on a FLAIR image. Usually, the old lesions appear smaller than the
recent ones because of an ex vacuo effect in the old lesions and a tendency to
swelling in the new ones.
Enlarged perivascular spaces When enlarged, they resemble lacunes in much of their
appearance since they are also seen as fluid-filled cavities with CSF like signal
on all sequences. They differ however in their shape since they usually follow the
course of a vessel whereas lacunes appear ovoid in shape and are usually larger
than 3 mm in diameter [4]. They are mostly prominent in the lower basal ganglia.
Cerebral microbleed A cerebral microbleed appears generally hypointense on T2*
image with a round or oval shape in small areas with a maximum diameter of
10 mm. Their dark appearance is due to the accumulation of hemosiderin-laden
macrophages at these locations.
1.2.4 Imaging white matter hyperintensities
1.2.4.1 Impact on structural images signal
White matter hyperintensities, as their denomination indicates, are observed as bright
on certain MRI pulse sequences. These abnormalities have actually been described
when noticed in medical images and were underlined as potential focus of research
thanks to the advances in neuroimaging. This terminology may however be slightly
misleading since other lesion types (e.g subcortical infarcts) may also be reported with
hyperintensities. Historically such bright spots seen on brain images of T2-weighted or
PD-weighted images were denoted as UBO (undefined bright objects). In age-related
cases of white matter damage, deterioration of the myelin sheath, increase of water in
the extracellular volume near the ventricles contribute both to the change in the ratio
between fat and water in the tissue and so between densely packed molecules and free
protons. In periventricular regions, the inability of structural images to distinguish be-
tween those origins has been substantiated by histological studies suggesting that the
hyperintense signal observed do not only correspond to the myelin deterioration [20,24]
but also to a higher water content. The change in water/fat ratio [1] in turn directly af-
fects the T1 and T2 relaxation time and the tissue properties appear to move towards the
properties of the CSF. This is the reason why, in cases of T2-weighted contrast, such
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T1 T2 FLAIR
Figure 1.1: Example of leukoaraiosis on T1, T2 and FLAIR MR images.
damage is observed as brighter than the healthy tissue. However, if the water proportion
increases in such lesion, it is usually not completely fluid filled which justifies why it
is still observed as bright on FLAIR images except in most severe cases. T2-weighted,
PD-weighted and FLAIR sequences, all sensitive to the damage to the white matter
have therefore been particularly used for the visualisation and assessment of WMH.
Figure 1.1 illustrates the presence of leukoaraiosis on T1, T2 and FLAIR images.
Trying to study WMH in a normal elderly population in order to avoid finding
dementia confounders to WM deterioration, Murray et al. observed that a high FLAIR
signal was related to a higher vacuolation linked both to myelin loss and decrease in
small vessel density [44]. The vacuolation enables indeed the accumulation of intersti-
tial fluid that contributes to increase the FLAIR and T2 signal.
As mentioned in Section 1.1.1, it appears that the pathology often starts from the
ventricular lining. Separating between CSF and lesions in T2 and PD-weighted im-
ages can therefore become quite challenging since both present a high signal. The
main strength of the FLAIR sequence relies in its ability to null the CSF signal while
preserving a bright signal for the hyperintensities. In contrast, these regions of hyper-
intense signal in T2 and FLAIR usually present iso to slightly hypointense signal in T1
depending on the severity of the damage and even though used by Leritz et al. [45], T1-
weighted images are usually not well suited for the quantification of leukoaraiosis [46].
Very hypo-intense regions in T1 would correspond to regions of complete degrada-
tion of the tissue as with a complete infarct. In the definition of leukoaraoiosis itself,
some have even considered that the corresponding T1 intensities should be isointense
to the healthy white matter [47]. Nonetheless, with the evolution of the disease and the
increasing damage to the tissue the distinction may be sometimes difficult to draw.
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1.2.4.2 Focus on FLAIR sequence
FLAIR sequences, although becoming the structural modality of choice for the as-
sessment of WMH thanks to its ability to clearly differentiate lesions from ventricles,
suffers from various drawbacks. The rationale behind the use of medical images is,
as mentioned earlier for the general field of medical imaging, its assumed reflection
of an existing damage to the brain tissues. Links between histopathological findings
and imaging observations on FLAIR pulse sequences have however demonstrated that
FLAIR images tend generally to overestimate the extent of lesions [48–50]. Besides,
the intensity observed on FLAIR scans cannot be directly related to the severity level
of the lesion [51,52] contrarily to T1 or T2 acquisition sequences. Moreover, it must be
underlined that the imaging hyperintense signals are non discriminative with respect to
the underlying pathological process. Therefore, in different diseases, the presentation
of lesions may be strongly similar as can be the case for MS lesions and age-related
WMH.
When relying on FLAIR images to observe WMH, one must be aware of possible
normal hyperintense confounders and artefacts that may affect their depiction. Regard-
ing artefacts, those are more prominent at 3T than at 1.5T due to increased field inho-
mogeneities and magnetohydrodynamics [53]. They include pulsatile CSF flow within
the ventricular system or at subarachnoidal spaces, magnetic susceptibility at the floor
of the frontal lobe due to air and bone structure, spatial misregistration of the anterior
cerebral artery or problem in the nulling of the CSF due to the presence of metallic
foreign objects. An increased incidence of pulsatile flow artefacts has been observed
for expanded ventricular system [54], thus being more problematic when studying an
ageing population potentially presenting enlarged ventricles. The effect increases at
places with fast pulsatile flow such as the Sylvan aqueduct or the fourth ventricle. Be-
sides, those artefacts are not limited to ventricular system and may overlay adjacent
structures. The fine delineation of lesion may be further hindered by shine through
effects, present as increased signal intensity at the border between parenchyma and
ventricles or between cortical ribbon and external CSF. All these artefacts observed in
2D acquired FLAIR images are luckily mostly resolved by the use of 3D FLAIR im-
ages [53, 55] but such acquisitions are still not widely performed in clinical settings.
At the time of the development of FLAIR pulse sequences, studies have moreover
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reported the potential lower sensitivity to lesions in the infratentorial region of the brain
while other tissues than damaged white matter may present similar MR properties and
result in similar intensity signal. Additionally, normal findings in FLAIR images such
as a bright septum pellucidum [56,57] may further hinder the definition of the WMH to
assess and encourage to an increased caution in its definition [23,46,58]. As of yet, very
few directives have however been given on how to delineate and distinguish normal and
abnormal hyperintense findings appropriately [59]. This question of border delineation
is further thwarted by the continuity observed in the damage severity between normal
appearing and hyperintense tissue. This continuity is further highlighted by the obser-
vation of a progressive degradation of the normal appearing tissue neighbouring the
lesions [22].
1.2.4.3 Alternative choices of pulse sequences
Other MR pulse sequences initially developed for other applications than the study of
age-related white matter changes may bring further information relative to the charac-
teristic of white matter damage. Magnetic transfer imaging (MTI), that measures the
ratio between mobile and bound water is for instance highly sensitive to demyelina-
tion and used for multiple sclerosis (MS) to evaluate damage severity. Diffusion tensor
imaging (DTI), that provides measures of the ability of the water to diffuse freely in the
tissue can also be used to assess how water is bounded through anisotropy evaluation
and consequently reflect white matter integrity [24]. It suffers however from image dis-
tortion, high sensitivity to movement, low resolution and the difficulty to register it to
high resolution structural images [1]. Its true link to white matter integrity remains con-
troversial [9] but it has been used to study the normal appearing white matter (NAWM),
shown to be more vulnerable at the neighbourhood of existing lesions [23,60]. A com-
bination of modalities even only structural may bring a more accurate information on
what to consider as WMH [49, 61] and might further help distinguishing lesion sub-
types.
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1.3 WMH and quantitative image analysis
1.3.1 Need for quantitative assessment - visual grading and volume
Whatever the clinical hypotheses tested or the associations that are being drawn be-
tween white matter damage in any type of pathological presentation, a quantitative
assessment must be used to ascertain the extent of the damage. Two main options are
available for that purpose: visual grading scales and volumetric measurements. In the
case of age-related WMH, grading scales have been designed to provide a quantifica-
tion of the severity of the damage over the whole brain. Although those visual gradings
are fast to obtain, they suffer from grade non linearity, their lack of sensitivity to small
changes and their susceptibility to ceiling and flooring effects [18,62]. In fact, they con-
vert continuous data into categorical elements. Moreover, the training to apply them
properly is strenuous [1] and inter- and intrarater variability that varies according to le-
sion load [63] adds to the uncertainty. The heterogeneity of the designed scales in terms
of location separation, grading methods, lesion characterisation or modality on which
they are applied, has been put forward as the reason for discrepancies in clinical asso-
ciation results [64]. Others find however that some of those scales correlate well with
each other and the correspondences allow for a partial translation between scales [65].
These opposite findings regarding the influence of the choice of visual scales can be
explained by the improvement in image acquisition that make the lesion burden easier
to assess. Nonetheless, it has been reported that the finer grading scales, defined on a
more local level appear to be more relevant when looking at the correlations between
WMC and cognition [62, 66].
Generally those scales correlate well but not linearly with the volumetric measure-
ments of the white matter damage [1, 62]. The Fazekas scale has even been shown to
give almost equivalent estimates of the WMH burden [58]. The main discrepancies in
the correlations are either due to the misdetection of subtle hyperintensities as lesion
or the disproportionate importance acknowledged in grading scales by the presence of
small subcortical lesions compared to the induced relative lesion volume change. For
longitudinal analysis however, volumetric measurements appear to be more reliable
than classical visual scales [67]. Scales designed for the purpose of longitudinal as-
sessment were shown to perform better when compared to cross-sectional scales [66].
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Furthermore volumetric measurements of the white matter hyperintensities appear to
enable the assessment of more subtle cognition changes than visual scales [62].
If those observations support the use of volume measurement compared to visual
scales, the non-linear correlation with volume measurement could also be related to
the hypothesis that additional lesion descriptions could further refine the information
brought by the overall volume lesion load [61]. Linking different types of lesion char-
acterisation with the rationale of the used visual scales would further help to better
define the most important features of the lesions and thus make their analysis more
clinically meaningful.
1.3.2 Importance for lesion segmentation - need for automation
Quantitative measurements based on the delineation of tissues such as volumetric es-
timations need to be robust and accurate to ascertain subtle and valid clinical associa-
tions. As far as lesions are concerned, the importance of their accurate segmentation
is doubled. Not only can the information coming from their delineation be invaluable
in terms of clinical association, but this delineation can impact greatly the accuracy of
other quantitative measurements based on tissue delineation. It has been reported for
different pathologies (MS, AD), that not accounting for the existence of lesion could
affect healthy tissue volume measurement such as grey or white matter [68–70]. More-
over, obviating the presence of lesions may also have a deleterious effect on other
image analysis processes such as image registration [69]. Manual segmentation of
lesions, a time consuming and cumbersome task, suffers from inter and intrarater vari-
ability [71, 72] and is therefore hard and costly to implement in large clinical studies.
Even though decreasing the time required [71], semi-automated methods of WMH seg-
mentation remain highly dependent on the operator with still a strong time constraint.
These techniques may involve observer [73] or automatic [74] thresholding, contour
evolution [75] or texture analysis [76] from an initial rough drawing and may poten-
tially be followed by a manual editing refinement stage [77]. With the advances in MR
imaging, 3D images are now more commonly available to assess lesions. Reported
to more accurately depict white matter damage such images contribute however to an
increase in time expense for operator-based lesion segmentation methods. Thus, and
even more so in the perspective of large population studies, the development of reli-
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able, robust and reproducible automated white matter lesion segmentation techniques
has become crucial.
1.3.3 Automated WMH segmentation: goals and strategies
The arduous task of WMH segmentation reflects the need to obtain as reliably and
objectively as possible a satisfying delineation of WMH. Ideally, the solution would
allow to find all lesions (sensitivity) but no more (specificity), while being consistent in
the definition of their borders across varied conditions of resolution, noise and artefacts.
As underlined in Section 1.2.4, WMH are areas of bright signal present in the
white matter. This description in itself provides strong constraints on the task at hand in
terms of signal and spatial criteria. Focusing for a moment on the word hyperintensity,
the prefix hyper meaning over, beyond or in excess, refers to a comparison and therefore
to the potential inclusion of a certain degree of subjectivity in the definition of the
described lesion. Among others, the question of the definition of the level of outlierness
arises along with the reference to the normality. These issues need to be addressed
somehow consistently when trying to automate them. Among the reported challenges
to detect WMH, the fact they can occur everywhere with a high variability in shape
and location is not the least. Furthermore, the intensity signature of such lesions can
be confused with healthy grey matter especially at the border of the lesions thereby
leading to misclassifications. These observations of mixed intensities are due to the
presence in a single voxel of both normal and damaged tissue. This problem, related to
the image resolution, is called partial volume effect (PVE).
As will be detailed in Chapter 2, numerous techniques have been developed for the
automated segmentation of white matter hyperintensities in various pathological situ-
ations, mostly MS and age-related WMH. Their grouping is made challenging by the
variability in the number of steps considered and in the relative importance of detec-
tion and potential refinement stages described in each method. Indeed, if one considers
with great care the question of an appropriate detection that would require only (if any)
minor corrections [78–82], others develop with more emphasis means of refining the
segmentation to avoid false positives ( [83,84]) or consider both these stages with equal
importance [85–88]. Such distinction makes blurrier the border between the core of the
method and what could/should be considered as postprocessing. The classical grouping
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between supervised and unsupervised methods is also blurred and does not correspond
to the same definition according to reviews. In the review by Lladó et al. [50] for in-
stance, any method including knowledge from examples of a population is classified
as a supervised method. Therefore, methods using statistical atlases, that are maps of
tissue probabilities obtained from an average of population segmentations, are consid-
ered as supervised. The degree of supervision could also be subject to discussion since,
even if not using explicitly a database of manual segmentations, knowledge and com-
parison with existing examples may influence methods designs and parameters choices.
In complement, data-based tuning of methods parameters [89, 90] could be argued to
belong to supervised methods.
A possible, although artificial, line of demarcation between methods can be drawn
between discriminative methods that derive a criteria to distinguish lesions from other
tissues and those developing generative models of the data accounting for lesions.
Methods are classified as belonging to the generative group if they attempt to model
how all observations are distributed even if these involve a secondary non-generative
step. In the first group, the discriminant factor may be a single intensity threshold, or
derived from the study of more complex feature vectors with respect to a manual le-
sion segmentation database and appropriate classifiers. Such methods differ in the type
of features and classifiers. In turn, generative methods that are robust to the presence
of lesions describe strategies that model the outlierness of given observations with re-
spect to healthy tissues. They may either adopt non-parametric strategies that consider
the full data sample or model the data parametrically through classes described by a
limited number of characteristics. Many options have been developed to that respect,
either modelling lesion classes explicitly or excluding outliers from the representation
of healthy observations.
Apart from the definition of intensity abnormality level, inclusion of anatomical
knowledge either within the chosen method or as a postprocessing step is essential to
limit the amount of false positive detection. A popular way of including such infor-
mation both in discriminative [85, 91–95] and generative [78, 79, 96–100] methods is
through the use of healthy tissue atlases obtained from the averaging of tissue seg-
mentations of an healthy population and aligned to the cases of interest. With respect
to postprocessing and final refinement of lesion segmentation, some strategies do take
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pride into the fact that all risks for false positives are accounted for [78, 101]. Such a
step may affect considerably the segmentation results.
However, WMH rarely stand alone and are often combined to other pathological
observations. For instance, the reported clinical importance of measures of atrophy in
both ageing and MS and the observed impact of lesions in such measurements high-
lights the need for a joint robust segmentation of healthy tissues [102]. In both ageing
and MS, the picture of the pathology is not complete if only taking into account WMH
since other lesion subtypes also contribute towards the pathological description. Thus,
apart from the technical differences between the existing strategies, other aspects in the
statement of the problem, such as the need for high-throughput in the processing, the
type (binary or fuzzy) of segmentation, the need for complementary outputs (segmen-
tation of healthy tissues, of other lesion subtypes) or generalisation potential impact the
initial methodological choices.
Such choices relate in particular to the availability and need for specific pulse se-
quences. At one end of the spectrum, monospectral strategies generally consider the
FLAIR image as their modality of choice. Indeed, compared to the T2w and PDw im-
ages on which WMH also appear bright, the main advantage of the FLAIR sequence is
the nulling of the CSF signal which enables for a good separation between lesions and
CSF, important to delineate periventricular lesions. The promoters of the monospec-
tral strategies [103–107] argue that it allows for results free of registration error since
no alignment between images is required. Additionally, it is less costly in terms of
scanning and usually computationally less demanding. However, FLAIR images suffer
from some drawbacks such as the presence of flow artefacts, a tendency to overes-
timate the lesions and a low sensitivity in the infratentorial regions as mentioned in
Section 1.2.4.2. With the increase in computational power weakening the processing
speed argument, multispectral signal is nonetheless often considered as more capable
of correctly determining the lesion extent and is often used to avoid or correct for false
positives.
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1.4 Motivation of the work
1.4.1 Rationale
Rarely is a methodological automated solution developed to answer a single condition
scenario problem. In itself, the word automated connotes an idea of large applica-
bility and strong generalisation potential. More intricate and subtle clinical questions
requiring larger study populations warrant such methods in the case of WMH quan-
tification. In any automatic technique, learning, tuning and rules are biased by the
knowledge introduced to answer a specific question. This issue is especially sensitive
for discriminative classifiers relying on databases of specific segmentation examples
but exists also for methods that incorporate heuristic rules. Strategies that decouple
the robust modelling of the data from the expected output have therefore the advantage
of being transferable. Although discriminative methods based on segmentation exam-
ples may enable a perfect reproduction of manual delineations, intrinsic human errors
may simultaneously be learned and reproduced. With respect to generative techniques,
those that model lesions explicitly or integrate their description in their data explana-
tion may overlook the existence of other types of outliers or lesions while those that
consider unexpected observations as a whole may overconstrain their data represen-
tation and miss finer descriptions. Decoupling the complete data modelling from the
application process may thus overcome these potential limitations. Neither the com-
plete (inlier+outlier) data joint modelling nor the subsequent application tuned solution
should however be considered as an end-result. Considering finer representations, par-
allel applications in the perspective of the clinical needs should indeed further allow
for a deepening of the understanding of the underlying pathologies.
1.4.2 Thesis Overview
This thesis presents a generic model selection framework, named BaMoS (Bayesian
Model Selection), which models multimodal images with abnormal intensities using a
hierarchical Gaussian mixture model (GMM). The end-result of this model selection
process is further applied to automatically segment and characterise white matter hy-
perintensities. Chapter 3 will introduce the theoretical background of GMM and their
optimisation in the Expectation-Maximisation (EM) algorithm. Previously developed
improvements to the GMM are then described, namely the correction for intensity inho-
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mogeneities, the introduction and relaxation of a priori anatomical knowledge through
statistical atlases and the addition of neighbourhood context constraints via a Markov
Random Field. To these commonly applied variations, a further constraint on the co-
variance matrices is developed. This chapter ends with a short review on model selec-
tion in GMM with a focus on split and merge strategies. Chapter 4 first explains the
development process that led to the model selection framework in Section 4.1 before
detailing the final hierarchical model (Section 4.2) and explaining how the variations
detailed in Section 3.2 can be adapted to this framework (Section 4.2.2). The imple-
mentation details are then presented in Section 4.3. Chapter 5 focuses on applying the
framework to the study of white matter hyperintensities. How the final GMM obtained
through BaMoS can be used to provide the white matter lesion segmentation is detailed
in Section 5.1. Before validating BaMoS within the context of lesion segmentation, the
assessment measures based on a gold standard reference are described and discussed
in Section 5.2. An internal validation is first carried out in Section 5.4 before compar-
ing the developed algorithm to other available lesion segmentation methods in Section
5.5 using both simulated and clinical data. As noted in Section 1.3.1, lesion volumes
may not gather the full extent of the information and specific biological questions may
require finer descriptions (cf Section 1.1.2.2) related in particular to the location and
spatial distribution. Chapter 6 is thus devoted to the development and applications
of a systematic patient specific location scheme enabling the description local lesion
characteristics, then applied in different contexts and at both population and individ-
ual levels. If the location information can bring further insight into the understanding
of WMH pathology at a specific time, longitudinal changes are crucial to the estab-
lishment of causality relationships especially if associated to specific lesion patterns.In
that perspective, Chapter 7 is dedicated to the longitudinal extension of BaMoS then
validated on a purpose-built lesion simulator (Section 7.3) and on clinical data (Section
7.4). Finally, Chapter 8 attempts to summarise the work presented in this thesis and
presents avenues of further investigation.
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As evoked in Section 1.2.4, different pathologies can result in similar abnormal intensi-
ties on MR images. This is the case for the unexpected hyperintense white matter signal
observed both in age-related leukoaraiosis and in multiple sclerosis (MS). Compared to
MS cases, healthy tissues in ageing are less contrasted and WMH present smoother bor-
ders. These differences have been highlighted as the reason why a technique developed
for one pathology is difficult to transfer to the other [49]. Some methods have however
been successfully validated in both situations [89, 100] or marginally adapted as with
the method developed by Schmidt et al. [90] and revalidated by Maldjan et al. [108].
Reviews on WMH segmentation imaged through MRI have been recently published fo-
cusing either on the MS problem [50,109,110] or on the elderly case [111]. Therefore,
methods developed both in the context of an elderly population (e.g. [49, 81]) or MS
subjects (e.g. [78, 79, 88, 112]) will be mentioned in this chapter.
Across the many different algorithms developed to automatically segment white
matter hyperintensities, one important commonality lies in the need to preprocess the
data before analysis. Section 2.1 is therefore devoted to this aspect of the segmenta-
tion pipelines. The other end of the process, that tackles the refinement of preselected
potential lesions and the correction for misclassifications, is expanded in Section 2.4.
Following the demarcation line described in Section 1.3.3, methods are divided
between purely discriminative and partially generative strategies. Among the discrimi-
native techniques that attempt to draw a line between what should or not be considered
as WMH, methods are classified according to the choice of features used to obtain the
lesion discrimination. The decision criterion can be based on a single intensity thresh-
old [94, 103, 113] possibly combined with image enhancement techniques [95, 114],
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include spatial [80,82,91] or texture based [115] information or be built from the com-
parison between patches [112, 116].
Since this work develops a generative model of data in presence of outliers with
application to WMH segmentation, emphasis is given in this review to methods that
model the image globally trying to account for the presence of lesions, or more gener-
ally of outliers. Lesions can either be explicitly (Sections 2.3.1 and 2.3.2.1) or implic-
itly (Section 2.3.2.2) modelled using class centroids [78] or established probabilistic
distributions such as Gaussians [86] to parametrise the data. Alternatively partially
non-parametric solutions can be developed to model the data in presence of abnormal
observations [117].
Lastly, for all the techniques developed in the perspective of an application to
WMH segmentation, the question of validation and evaluation with respect to criteria
of generalisability, robustness, specificity, sensitivity and clinical relevance and their
comparison to existing solutions is crucial. Guidelines for validation have been de-
tailed by García-Lorenzo et al. [110] and the different strategies encountered are briefly
evoked in Section 2.5.
2.1 Preprocessing
Preprocessing of the data is an inherent part to the lesion segmentation process. Such a
step may include skull-stripping, correction for intensity inhomogeneity, images align-
ment or intensity normalisation [92, 112, 118]. In some cases, the segmentation of
other tissues using available brain segmentation tools such as SPM or Freesurfer is
also considered as a preprocessing step [119–121]. Although the impact of changes
in the parameters of the preprocessing steps is rarely assessed, Zijdenbos et al. [122]
underlined its strong standardisation as a factor of major importance for the generalis-
ability of proposed techniques. Since normalisation is needed when intensity features
are compared across images, Steenwijk et al. [118] compared different normalisation
strategies and showed that this choice impacted both the optimal parameter and the
measures of overlap with manual segmentations in the case of their k-nearest neigh-
bour procedure. Skull-stripping and fat removal are usually performed to improve the
intensity normalisation, limit the computational cost [80] and reduce the risk of in-
cluding tissues whose intensity distributions are close to the investigated WMH [123].
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This is especially important for FLAIR images [124] in which artefacts around the eyes
may appear [125]. Although some strategies use in-house methods for skull-stripping
[99,104,117,117,126,127] or base it on thresholding applying the Otsu technique that
minimise the within class variance between background and brain tissues [114, 124],
available algorithms such as BET [128], SPECTRE [129] or MBRASE [130] are also
commonly applied. Despite its influence on normalisation, no analysis is available to
evaluate the influence of these skull-stripping strategies on the subsequent lesion seg-
mentation.
Another source of problems, often taken care of in a preprocessing step, is the
presence of smooth variations in intensity across the image. This artefact, known as
intensity inhomogeneity (IIH), bias field (BF) or gain field [131] is mostly due to imag-
ing instrumentation and the nonuniformity of the applied magnetic fields. The most
accepted way of representing image intensity affected by such an effect in the presence
of noise is y = αx+ ξ where ξ refers to the noise, x to the true intensity and α to the
bias field effect. Correcting for this artefact has been shown by Johnston et al. [132]
to improve the lesion segmentation. When included in generative models, linear com-
binations of basis functions (trigonometric or polynomial) are often used to model the
smooth variations [78, 79, 133]. Otherwise, a very large proportion of the methods de-
scribed in this review, tend to use the N3 method developed by Sled et al. [134] in the
preprocessing of their data. It consists in deconvolving the histogram and finding an
intensity shift to which a smooth function is fitted to minimize the signal entropy.
Additionally, enhancement and denoising of the images may be applied in strate-
gies that usually do not include a parametric modelling of the data at hand. Enhance-
ment techniques may however lead to an increase in the level of noise as noticed by
Boudraa et al. [135] when using histogram equalisation techniques. Furthermore, when
the contrast varies across the image, local solutions should be used. One of the most
common enhancement techniques is the application of an anisotropic diffusion filter
that has the property of smoothing homogeneous regions while enhancing the edges.
Such a filter has initially been introduced by Perona and Malik [136] for 2D images
and its 3D implementation is available in the ITK library, an open source C++ library
dedicated to medical imaging research (www://http.itk.org), which contributes
to its popularity. Its iterative effect on the image I, with λ a user-defined parameter is
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expressed as
∂ I
∂ t
= div(g(‖ ∇I ‖)∇I)
with g(x) =
1
1+
x2
λ 2
or g(x) = exp
(
− x
2
2λ 2
)
If the use of such enhancement procedure is quite common in the case of MS
pathology, Dyrby et al. [81] have underlined its possible limitations in the case of age-
related lesions for which lesion edges are smoother.
Alignment between images, known as registration, can also be required as a pre-
processing step in three main situations. First an intra-subject alignment or coregis-
tration of the images is often required when multiple pulse sequences are used for a
single subject. Indeed, even if acquired during the same scan session, the subject may
have moved, or the resolution be different between pulse sequences. The reference
space chosen varies across methods; this choice may depend on the further processing
but the resolution may also play a role. Additionally, the choice of reference space for
the registration has to be taken into account when further evaluating the accuracy of the
methods. Second, a general knowledge built over a population in a specific space, often
referred to as template space, has sometimes to be transferred to the individual case.
Such generic knowledge may for instance take the form of tissue statistical atlases, that
are maps giving an a priori probability for each voxel to belong to a certain tissue.
An alignment transformation between template and individual space is then needed to
propagate the information. Lastly, some methods require for all subjects in a population
to be spatially comparable resulting in an inter-subject alignment into a common space.
Very commonly, the MNI (Montreal Neurological Institute) population template [137]
is chosen as space of reference [112, 118, 138–140].
In all situations, registration implies the resampling of interpolated intensities for
the modified images. Apart from the occasional registration error leading to inconsis-
tent intensity pairing, the resampling may in particular blur tissue edges. In the reg-
istration problem, one tries to estimate the transformation that enables the best match
between the images. Depending on the allowed degrees of freedom and type of mod-
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ifications, two main families can be distinguished. On one hand, the linear registra-
tions can be expressed as a matrix multiplication transformation applied globally to
the image with a maximum of 12 degrees of freedom in tridimensional cases: rotation,
translation, scaling and shearing in each of the directions. On the other hand, non-rigid
or elastic transformations allow for local image modifications and can be associated
to many more degrees of freedom. When dealing with images bearing lesions, linear
registration is commonly favoured over non rigid solutions due to the effect of lesions
on registration as evoked by Guizard et al. [112] and reported by Skika et al. [141]. The
non-linear solution applied by Tomas-Fernandez et al. is claimed not to be affected by
the presence of pathology [87].
2.2 Discriminative methods
2.2.1 Unidimensional feature: intensity thresholding
Based on the denomination of such lesions, the most natural solution to separate WMH
from healthy tissues appears to be the determination of a threshold above which all
voxels of a FLAIR image should be evaluated as potential candidates. In the method
of Jack et al. [103], an histogram is drawn for each slice of the skull-stripped, bias
field corrected, anisotropic filtered FLAIR image, and the characteristics of the central
peak of the distribution are derived. Based on a dataset of manual segmentations, these
characteristics are used in a linear regression to determine the appropriate threshold for
WMH. A database of manual segmentations is also used by Gaonkar et al. [125] to
obtain a global optimal threshold this time and correction for false positives is based
on a probabilistic map. Ong et al. [94] also consider a threshold on the full FLAIR
histogram but do not use a database to derive the optimal threshold to apply. The
lesions are selected from a 1.5 standard deviation from the third quartile of the assumed
normal tissue distribution and corrected for false positives with a WM mask derived
from the T1 based tissue segmentation. It is also the search for an optimal threshold
that warranted the work by Yoo et al. [105]. Using the parenchymal histogram from the
result of the SPM8 segmentation, and modelling the variation of the z-score threshold
with respect to the volume of WMH, a database of manual segmentations is used to
estimate the parameters. False positive correction is realised based on a WM mask
template registered to the image.
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Using only the GM histogram of the FLAIR image obtained after segmentation
of the T1 image, works from Roura et al. [120] and de Boer et al. [113] bear a lot of
similarities. After thresholding, only lesion clusters with a high enough proportion of
neighbours segmented as healthy WM are retained. In both cases the various thresh-
old parameters (histogram and neighbourhood proportion) are tuned based on a set of
manual segmentations. The most important difference between both methods lies in
the way the initial tissue segmentation is obtained; Roura et al. use the outcome of the
SPM5 segmentation while De Boer et al. implement an atlas-based k-nearest neigh-
bours (kNN) stategy.
2.2.2 Image transformation and region growing
The previously described methods focus on how to obtain an optimal threshold for the
WMH discrimination on the FLAIR histogram. Others have dedicated their efforts to
the image enhancement in order to increase the contrast and allow for an easier WMH
discrimination.
Samaille et al. [95] process the FLAIR image through serial steps of anisotropic
diffusion filtering and watershed segmentation in order to delineate homogeneous in-
tensity regions. Lesion regions are then selected based on a thresholding of the initial
FLAIR histogram while the result of the T1 segmentation is used to correct for false
positives.
In the work of Zhong et al. [104] a conservative threshold is first applied to the
FLAIR WM histogram. In order to remove elements from the GM, a high pass filter is
applied to the image. The remaining lesion seeds are finally used to initialise a region
growing algorithm.
In a similar perspective, Pattino-Correa et al. [114] also select seeds to initialise a
region growing framework. Such seeds are obtained from the image, smoothed with a
mean filter and enhanced with gamma correction and removal of the background mean.
2.2.3 Multi-dimensional features and classifiers
Classification techniques use features extracted from a set of labelled examples to train
a tool (the classifier) that will then decide under which label a newly presented data
point should be categorised. Techniques vary widely both in the extracted features
and in the training and classification method. In order for comparable features to be
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extracted from the images, normalisation steps are necessary both for intensity and
spatial information. Normalisation of the spatial information is for instance realised by
aligning all images to a common space.
Sweeney et al. [142] concluded from their comparison between the impact of fea-
tures and classifier choice that the feature design impacted more the segmentation result
than the choice of classifier. Popular classification techniques in WMH segmentation
range mainly among k-nearest neighbours (kNN) [80, 92, 118, 125]), support vector
machine (SVM) [82, 140], random forests [91, 115] and neural networks [81, 143]. In
the kNN technique, a distance metric is chosen and the k samples of the training set
that are the closest to the sample to classify are selected; the average of their labels is
attributed to the sample of interest. With the SVM, it is the hyperplane separating with
the highest margin positive and negative findings that is looked for. The label of an in-
coming sample is obtained according to the side of the hyperplane on which it will lie.
In the case of the random forest, decision trees are built for which at each node a binary
feature based decision is defined so as to maximise a given criterion representing the
consistency of the data in each subclass. Building many such trees based on slightly
different training samples and/or feature sets leads to a random forest. For a given new
sample, the label decision is then the average over all results given by the decision trees.
Finally, with neural networks, the association between features and labelling is the re-
sult of an activation function on the combination of functions of the weighted features.
Such a combination is learnt so as to minimise an objective cost function.
As for the feature vectors, they can be based only on intensity [92], or encompass
also voxel spatial location [80], texture characteristics [115] or derive further informa-
tion from statistical priors [91, 118]. With the recent increase in computational power,
patch-based methods are lately gaining in popularity.
2.2.3.1 Voxel-wise features
Zijdenbos et al. [143] propose an artificial neural network to segment healthy tissues
and WMH based on T1, PD and T2 images but since the classifier is trained from
samples selected by an operator for each image, this can only be considered as a semi-
automated method. In the k-nearest neighbours algorithm derived by Anbeek et al.
[80], all modalities are registered to the FLAIR image and all tissue intensities are
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gathered into the feature vector. In order to account for the spatial location of the
lesions, coordinates of the studied voxel are added as features. Improving on this initial
method, Steenwijk et al. [118] incorporated in the feature vector statistical probabilities
of tissue label and normalised the spatial information to the MNI space. In parallel,
Wu et al. [92] also considered a kNN algorithm to separate various tissues and lesion
subtypes instead of giving a binary answer. The output of the kNN was then corrected
through the application of a template derived segmentation. Introducing anatomical
spatial information through atlases appeared to consistently improve the segmentation
as mentioned in the comparative study led by Kamber et al. [93]. Dyrby et al. [81]
studied the impact of feature vectors used in a neural network classifier developed for
a multi centre study. The comparison between feature vectors underlined the relevance
of complementary intensity information from modalities other than FLAIR especially
in the case of low lesion load.
2.2.3.2 Explicit context enriched features
In a random forest framework, Geremia et al. [91] use as a basis the feature vector
proposed by Steenwijk. et al. [118] transformed by mean filtering to account for noise.
Context features are included as the difference between the local feature value and the
mean over a large distant patch or the mean over a region symmetrical with respect to
the mid-sagittal plane. In the solution of Cabezas et al. [85], the features considered
include, in addition to the intensities and a priori atlas tissue probabilities described
by Steenwijk et al. [118], the probabilistic values of an outlier map. They complement
the vector with meta-features similar to those proposed by Geremia et al. [91] obtained
as the difference of the feature value and the mean of other features over large distant
regions. Sweeney et al. [139] obtain context enriched features thanks to the smoothing
of the images at multiple window scales for all modalities. With a different weight
given to each feature, the logistic regression used for classification allow for a relative
weighting of the modalities. Using coregistered T1 and FLAIR images, Ithapu et al.
[115] include explicit texture features from a patch surrounding each voxel of interest
and investigated the performance of support vector machine (SVM) and random forest
(RF) classifiers on such feature vectors.
2.2. Discriminative methods 61
2.2.4 Patch-based approaches
With the increase in computational power, patch-based techniques applied to lesion
detection have recently been more widely investigated. In those techniques, the infor-
mation attributed to one voxel comes from a patch over its neighbourhood.
After image smoothing via a Gaussian kernel, Lao et al [82] use a SVM on feature
vectors that do not contain any direct spatial information but in which all the intensities
in the neighbourhood of a given voxel are concatenated. A similar feature vector is used
by Damangir et al [140] where, in order to avoid the imbalance between sample sizes in
the healthy and lesion class, an active sampling is applied in a series of cascading SVM
that aim at pruning the non lesion samples from the sample pool. In the approach of
Jog et al. [138], a regression tree is learnt over the patch intensities and meta-features
close to those described by Cabezas et al. [85]. A lesion membership is calculated as
the average of the labels per voxel of each patch in the resulting leaf node, that is then
thresholded and corrected for false positives with a WM mask derived from the T1
segmentation.
Similarity measures between patches can also be used in the classification process.
Introduced initially for denoising purposes, the non local mean (NLM) includes such
similarity evaluation. With the voxels j belonging to the neighbourhood Ω of voxel i,
the NLM xˆ(i) is expressed as
xˆ(i) =
∑ j∈Ωwi jx( j)
∑ j∈Ωwi j
with wi j = exp
(‖ P(x(i))−P(x( j)) ‖22
h2
)
where wi j is a measure of the similarity between the patches centred in i and j and h is
a smoothing parameter.
After alignment to a common space, Guizard et al. [112] first select in their
database the most similar subjects to the case of interest. For each voxel i, a weighted
label is obtained from a variant of the NLM applied using patches of neighbouring vox-
els coming from all selected subjects. Optimal results are realised when combining T2
and FLAIR modalities and including mirrored images to the database. In turn, Mechrez
et al. [116] use for each studied patch the NLM weighting to the selection via kNN of
the k most similar patches of their database. Spatial information is further introduced
by the estimation of the labelling distance between patches.
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In the work of Deshpande et al. [144], a sparse dictionary learning technique is
applied on the patches to learn the characteristic of a healthy and a lesion class and each
tested patch is then classified globally as healthy or abnormal. Majority voting over all
overlapping patches at one voxel gives the final lesion classification. The dictionary
learning patch-based procedure developed by Roy et al. [145] performs the learning
using a different set of patches selected with a kd-tree for each new presented patch.
The lesion membership of the patch central voxel is the weighted sum of the labels of
training patches.
2.3 Generative models
Generative models for lesion segmentation vary greatly in their presented strategies and
different classification criteria can be highlighted to differentiate them. A great source
of variability lies for instance in the way pulse sequences are considered in a pipeline
ranging from the monospectral approaches [124] to the fully multispectral ones [79]
going through those that incorporate the information progressively [135]. In the meth-
ods described here, the robust generative model that takes outliers into account is often
not the only step in the pipeline resulting in the lesion segmentation. When present,
additional steps may rely on thresholding [101], gradient based elastic evolution [86],
fuzzy connectivity [117] or graph-cuts [87].
As the denomination suggests, parametric methods are based on the estimation of
parameters needed to explain the distribution of the observed data while non-parametric
solutions consider the full-sample distribution. For lesion segmentation, some paramet-
ric methods may attempt to explicitly model both normal and abnormal observations
while others may keep the modelling of outliers implicit. Alternatively, non-parametric
models may be used to ascertain the presence of unexpected intensities. Parametric
methods gather models based for instance on Fuzzy C-Means (FCM) clustering or
Gaussian Mixture Models (GMM).
2.3.1 Explicit modelling with fuzzy-C Means clustering
In the fuzzy-C Means clustering, classes are parametrised based on their intensity cen-
troids. The soft segmentation is based on the minimisation of an energy function ac-
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counting for the distance between sample and centroids features with the form
E =
N
∑
n=1
J
∑
j=1
wmn j ‖ yn− c j ‖2,
where wmn j is the membership of voxel n to class j, c j the centroid feature (usually
intensity) of class j and yn the intensity at voxel n. The fuzziness parameter m describes
how fuzzy the segmentation will be, with the limit of crisp delineation when m tends
towards 1. The weight expression is obtained as
wmn j =
1
∑Jk=1
(‖ yn− c j ‖
‖ yn− ck ‖
) 2
m−1
.
Boudraa et al. [135] apply a 3 class FCM on PD images enhanced by histogram
equalisation and power law and use the corresponding T2 intensities to select potential
lesion and CSF classes. Reiterated on the selected elements, a second FCM provides a
more accurate selection that is then corrected for false positives based on minimum size
and adjacency to brain border. Admiraal-Behloul et al. [49], use FCM in parallel on
T2, PD and FLAIR images with different numbers of clustering classes and the resul-
tant information is then combined through a fuzzy inference system based on intensity
linguistic rules. Template prior atlases, used to initialise the centroids of the FCM, are
also further employed to improve the false positive correction.
One of the difficulties in fuzzy-clustering is the incorporation of spatial consis-
tency in order to avoid misclassification errors due to the presence of noise in the data.
In the strategy of Anitha et al. [146], information on the spatial variability is included
to the FCM framework and shown to improve the lesion segmentation applied on an
elderly population for which FLAIR images contrast is previously enhanced. The FCM
energy functions has also been adapted in order for instance to model the bias field as
in the method of Gao et al. [133]. Additionally, in this work, spatial consistency is
introduced in the energy function through the application of a non-local mean regu-
lariser over the distance to the corrected centroids. In the method developed by Shiee
et al. [78], the energy function includes the bias field modelling and both statistical
and topological atlases are incorporated to ensure spatial consistency. Local modality
64 Chapter 2. State of the art in WMH segmentation
weighting, minimum size rules and distance constraints are added to the model so as to
account for potential false positive detection.
2.3.2 Lesion segmentation with Gaussian mixture models
Since the Rician noise observed in MR is classically modelled as close to Gaussian,
Gaussian mixture models (GMM) are a very common type of parametric models. They
consist in modelling the data as a weighted sum of Gaussian distributions, each of them
representative of a different tissue type. The distribution of the data Y is thus expressed
as
f (Y) =
K
∑
k=1
pikG (µk,Λk) ,
where K is the number of Gaussian components in the model, µk and Λk the parameters
of the normal probability distribution G of class k and pik the corresponding mixture
weight. To obtain a labelling of the image based on such a model, a common solu-
tion consists of introducing hidden labels and applying the expectation-maximisation
(EM) algorithm described by Dempster et al. [147]. The EM alternates between the
estimation of the posterior responsibilities of the labels given the current parameters
(expectation step) and the update of the Gaussian parameters (maximisation step) in
order to increase the log-likelihood of the complete data (intensities and labels). The
theoretical background of the EM algorithm is detailed later on in this thesis (Section
3.1).
The EM is however known to be sensitive to the presence of outliers [148]. So-
lutions either modelling explicitly the lesion distribution or robustly estimating the
healthy tissue parameters have thus to be adopted.
To establish the level of abnormality of a given observation with respect to a tissue
class, the Mahalanobis distance is often chosen [101]. In a multispectral view, the Ma-
halanobis distance for a sample yn to the mean of a Gaussian distribution of parameters
(µ ,Λ) is expressed as
dMahal(yn,µ ,Λ) =
√
(yn−µ )Λ−1 (yn−µ )T .
In order to ensure spatial consistency in the labelling and limit the effects of noise,
as explained by Zhang et al. [149] and further detailed in Section 3.2.3, Markov Ran-
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dom Fields (MRF) can be introduced to limit labelling variability by incorporating in-
formation from the neighbourhood classification in the probabilistic estimation of the
labels [79, 89, 107].
2.3.2.1 Explicit modelling with Gaussian mixture models
After skull-stripping and bias field correction, Simões et al. [89] model a FLAIR im-
age using a 3 component Gaussian mixture model with CSF, GM+WM and WMH
classes initialised based on the histogram analysis. The EM algorithm is associated to a
neighbourhood filter in order to enforce regularity in the segmentation and the resultant
WMH map is thresholded before false positive correction. The two extrinsic model
parameters (size of the neighbouring filter and probabilistic threshold for the binary
segmentation) are jointly tuned based on a dataset of segmented lesions. Khayati et
al [107], propose a solution based on the combination of an adaptive mixture model
(AMM) with an iterative Bayesian classifier that includes a Markov Random Field for
neighbourhood consistency. Incorporating sequentially the observations to the model,
a new Gaussian component is added each time the observed sample cannot be properly
modelled by the existing distributions. The Gaussian components are then grouped un-
der three umbrella classes whose parameters are iteratively optimised using the AMM
and an MRF to constrain the probabilities. A generalised extreme value distribution
(EVT) models the lesions in combination with a 2-component GMM for the healthy
tissues in the work of Wang et al. [123]. In this case, the hard segmentation between
EVT and GMM is iteratively used to progressively discard samples in the image and
recompute the healthy tissue parameters until convergence. The adaptation to a multi-
spectral case simply implies the use of a 3-component GMM.
Exploiting the different pulse sequences sequentially, Schmidt et al. [90] use the
segmentation performed on the T1-weighted image to create beliefs maps that are then
thresholded and used as seeds to initialise the lesion segmentation. The FLAIR image
is modelled with a 3-component GMM for the healthy tissues combined to a gamma
distribution for the lesion class. To ensure spatial consistency, only voxels neighbouring
lesion labels can be reclassified from healthy to damaged tissue in the optimisation
process. Wango et al. [121] also use the pulse sequences sequentially obtaining first
a T1 weighted segmentation. Similarly to Simões et al. [89], the FLAIR image is
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first modelled as a 3 component GMM and a discriminative threshold for WMH is
determined. After correction for false positives, the T1 segmentation is used to select
the WM +DGM volume and a 2 component GMM is optimised on the FLAIR image
after being initialised with the parameters of the first model. This step not only allows to
constrain the lesions to the WM but make the estimation of the lesion class more robust
due to its higher proportion in the data to model. Indeed, the argument of instability due
to the small available number of samples is classically underlined as a potential caveat
of methods modelling lesions as a distinct separate class with a defined distribution
function.
Among the multispectral techniques, Wei et al. [98], building on the method devel-
oped by Warfield et al. [150], consider T2 and PD sequences acquired in a dual-echo
sequence and apply an EM with 4 classes initialised with the statistical model of a
single subject. The initial GMM is postprocessed via morphological operations and ap-
plication of a template deformation performed with gradient analysis so as to consider
only lesion within the white matter. In the method developed by Forbes et al. [100],
that includes the use of an MRF and atlas tissue priors, a local informative weight is
attributed to each used modality (T1 T2 or PD or FLAIR). From the 3 class model
obtained after convergence of a variational Bayes EM, candidate lesion regions are de-
fined and used to initialise a 4-class model optimised in a similar way. The possibility
of the existence of other types of outliers in the data is however not considered.
Using more than 3 Gaussian components to model the healthy tissues has been
also proposed in the context of lesion segmentation with multispectral data. In the
solution designed by Freifeld et al. [86], many spatial Gaussian components are fit-
ted and classified into intensity tissue clusters. Spatially 1/20 of the voxels are used
as seeds for the spatially localised Gaussian distributions and the intensity parameters
are initialised based on a K-means algorithm. Each of the components contains indi-
vidual spatial information and relates to a global tissue intensity characteristic. The
parameters are optimised through an EM algorithm for all the Gaussian components.
Starting with three intensity clusters, heuristic intensity rules are used to reclassify after
convergence lesion components under a fourth intensity cluster. After this correction
procedure, the EM is processed again and the lesion segmentation is further improved
by the use of a curve evolution framework on the locally convex lesion regions. In con-
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trast, Harmouche et al. [151] challenge this idea of intensity stability across the brain
and consider that separate GMM including lesion Gaussian components should be op-
timised per homogeneous region of interest. In this case, the regions are predefined and
atlas priors are used to ascertain a good initialisation. Spatial consistency is enforced
via the application of an MRF. Instead of predefined regions, Galimzianova et al. [152]
developed a method defining the homogeneous regions and applied existing lesion seg-
mentation algorithms to the specified regions to obtain a stratified model. Such regional
separation can be put in parallel to methods that process the infratentorial region or the
deep grey matter separately [99, 126].
2.3.2.2 Implicit modelling in Gaussian mixture models
If some strategies do choose an explicit model distribution for the lesion intensities,
others may not impose such constraint. In order to avoid biasing the segmentation of
healthy tissues, robust solutions that limit the influence of the outliers on the estimation
of the healthy tissue parameters must then be applied [148].
For instance, the trimmed-likelihood estimator (TLE) only uses the fraction 1-h
(h user-defined threshold, known as trimming parameter) of the data best represented
by the model to estimate the parameters [96, 97, 101, 124, 153]. Aït-Ali et al. [97]
use healthy subject atlases to initialise the parameters of a 3-component GMM. After
convergence of the TLE, a Mahalanobis distance threshold is applied to select candidate
lesions, that are further refined based on intensity heuristic rules. In this case, the use
of multimodal data appeared to improve the final segmentation result. Bricq et al. [96]
augmented this solution with the introduction of context information through the use of
hidden Markov chains and statistical atlases. Wang et al. [124], determine the optimal
value for the trimming parameter h based on a database of manually segmented cases
and corrected the selected candidate lesion voxels by morphological operations.
Instead of considering all and only voxels excluded from the estimation of healthy
tissue parameters as potential lesion voxel candidates, the robust parameter estimation
and segmentation results may be used to characterise a secondary threshold for the
lesion segmentation [101, 127]. In order to avoid using atlases of healthy subjects to
initialise the parameters, García-Lorenzo et al. [101] implement a hierarchical initial-
isation based on the modes of the histograms that are combined with the TLE. The
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lesions are then segmented based on a Mahalanobis distance threshold and heuristic
rules of intensity, size and neighbouring tissues. An adaptive trimming obtained from
the Mahalanobis distance value is used by Dugas-Phocion et al. [127] to estimate ro-
bustly the healthy parameters. The lesion segmentation on the FLAIR image is obtained
by applying a Mahalanobis distance threshold based on the parameters estimated for the
normal tissues. Refined with the addition of partial volume classes [154], the scheme
has further been used by Souplet et al. [126] with a postprocessing pipeline that allows
after a generous selection of potential lesion locations for a refinement based on a WM
mask. In those last methods however, both outlier and some partial volume classes
may prove relevant to the final lesion segmentation. In order to limit the influence of
statistical atlases in regions where errors are likely to occur, Cabezas et al. [153] intro-
duce a similarity map summarising potential registration errors. Similarly to Bricq et
al. [96], a probabilistic threshold is used instead of the Mahalanobis distance to adapt
the fraction of trimmed voxels. The resulting robust GM FLAIR histogram was then
thresholded before final refinement. Compared to the thresholding methods relying on
preliminary segmentation described in Section 2.2.1 [95, 113, 120], the methods men-
tioned in this section insist on how to make their model more robust to the presence of
outliers rather than on how to select the relevant threshold. In a different perspective,
García-Lorenzo et al [88] used the output of the applied TLE combined with heuristic
intensity rules to initialise a graph-cut separating normal appearing tissues from lesions
so as to provide seeds of source and sink.
Rather than trimming samples from the likelihood estimation, Van Leemput et
al. [79] introduce a typicality weight to downweight the influence of outliers samples
towards the parameter estimation. The MRF used to promote spatial consistency across
the image is adapted in order to promote the association of lesion voxels with WM
and vessel voxels with CSF. Outlier samples that do not satisfy the heuristic intensity
criteria for being vessels or lesions are not downweighted. Segmentations of healthy
subjects are used in the approach proposed by Tomas-Fernandez et al. [87] to locally
inform if the segmented tissues are healthy or not and contribute to the downweight-
ing of the outliers in the model parameters estimation. After selecting the elements
that contribute the least to the model, a graph-cut algorithm is used to separate MS
lesions from other potential related source of outlierness such as cortical lesions, iron
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deposition in the basal ganglia or T1 hypointense lesions. Compared to the work from
García-Lorenzo et al. [88] for which the graph-cut procedure is applied on the full data,
it is here only executed on the selected lesion candidates.
2.3.3 Mixed parametric and non-parametric methods
Sajja et al. [117] propose a method combining parametric and non parametric methods
in order to segment not only lesions but also healthy tissues in the brain. At a first stage,
after skull stripping, bias field correction and contrast enhancement through anisotropic
diffusion filtering, 2-dimensional Parzen window non parametric technique is used on
T2 and FLAIR images in order to separate lesions, CSF and parenchyma. From a
set of N sample points of a given class, the density Parzen-Window estimate for the
observation x is expressed as
P(x) =
1
N
N
∑
n=1
1
hdN
K
(
x− xn
hN
)
where K is a density kernel, hN the window bandwidth and d the number of dimensions
used. The label attributed is the one corresponding to the highest obtained density
estimate. A threshold on the ratio between PD and T2 intensities is used in order to
remove potential false positives within the brain and too small clusters are excluded.
Using the T2 and PD images, GM and WM are segmented with an EM algorithm
incorporating spatial context information thanks to an MRF. Islands of GM within the
WM are then reclassified as lesion. The method is however considered semi-automated
as it depends strongly on the sample points chosen by an expert at the initial stage of the
Parzen window process. Closely to this work, Datta et al. [99] have also used a Parzen
classifier to separate CSF, lesions, and parenchyma based on T2 and FLAIR images.
Intensities are normalised across images in order to avoid having to choose for each
case a new feature set for the Parzen window training. The result of the non parametric
process is then used to initialise two EM algorithms including an MRF on T1 and
T2 images to separate GM and WM. One of the two EM is devoted to the separate
analysis of the cerebellum. Fuzzy connectivity rules are finally applied to refine the
lesion delineation. García-Lorenzo et al. [155], use the mean shift clustering to create
regions of homogeneous intensities. Once obtained, these regions are combined based
on the difference in mean intensity between neighbouring regions. Regions depicting
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lesions are finally selected according to an intensity threshold derived from the results
of a TLE applied to the multispectral data and their adjacency to WM.
Table 2.1 summarises the characteristics of the previously described generative
lesion segmentation strategies.
2.4 Postprocessing
As underlined in Section 1.2.4.2, in most cases, WMH coexist in the image with other
sources of hyperintensities that can therefore be mistaken for lesions. The CSF flow
artefacts at the border between GM and CSF or within the ventricles, remaining skin,
fat or bony structure, or elements of the choroid plexus are among the probable sus-
pects. Figure 2.1 gives examples of such hyperintensities confounders. Even though
spatial features or anatomical knowledge may be incorporated in the presented strate-
gies, many methods do require such a step to provide a relevant segmentation. The
detection of those elements is actually so important that for some methods the line be-
tween the core principle of the method and the postprocessing aspect becomes unclear
while others focus more on the ways of correcting for false labelling than on the detec-
tion itself [83, 84]. Theoretically, such a step is quite debatable: if it is needed, does
not it mean that the features used or the model developed are suboptimal? Practically,
consistent problems arise across datasets and common solutions are proposed. Due to
noise, isolated voxels may for instance be segmented as lesion. To correct for this effect
and select only biologically meaningful elements, a threshold over the minimum size
of the lesions is often applied either volumetrically [101, 107] or slice by slice [135].
Steenwijk et al. [118] explore this aspect of the lesion refinement in its impact on the
segmentation overlap but conclude that it leads to very small changes in the evaluation
measures. To correct for the segmentation as lesions of flow artefacts and non brain
tissues at the outer region of the brain, a common strategy is to eliminate all detected
a b c d
Figure 2.1: Examples of hyperintensities cofounders: a) Ventricular flow artefact; b) Outer
brain flow artefact (bright cortical ribbon) c) Choroid plexus d) Remaining outer
tissue after skull stripping.
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voxels within a certain distance to the mask border. Alternatively, morphological oper-
ations of erosion and dilation on the lesion maps are sometimes sufficient to get rid of
artefacts at the border of the cortical ribbon or within the ventricles [89,94,99,119,121].
Lastly, one of the stronger constraint is that they should belong to the WM and previous
segmentation of healthy tissues can contribute to the correction for false positives. Pro-
portions of neighbouring healthy tissues have for instance been proposed to ensure the
appropriate context of lesions [113, 120, 153]. Since healthy tissue segmentation can
be affected by the presence of lesions, this solution may however become a chicken
and egg problem. In fact, as mentioned in Section 1.2.4, WMH signal may sometimes
be confused with GM signal. Therefore, lesions may be segmented as islands of GM
within the WM. Morphological operations on WM masks such as hole filling have been
popularly used to avoid these false negative misclassifications [95, 98, 126].
2.5 Methodological validation
Once a method has been implemented, it needs to be validated according to criteria
of sensitivity, specificity, robustness to noise and artefacts, reproducibility and clinical
relevance.
2.5.1 Ground truth vs Gold standard
In the specific case of lesion segmentation, different aspects contribute to make the
evaluation of the results controversial and difficult. Validation usually requires the
availability of a ground truth against which to compare the obtained segmentation. Such
a ground truth is however a fleeting concept that is rarely available. More commonly,
a gold standard, defined as the result of expert manual lesion segmentations, is used
instead. The difficulty to obtain reliable manual segmentations of lesions naturally
limits the number of cases on which the method can be tested. The known inter- and
intrarater variability in manual segmentation combined with the fact that radiologists
may not agree in what to consider a lesion or not contributes further to the caution with
which such human dependent validation should be considered. Instead of the result
given by a unique expert, the combination of the segmentations realised by different
operators may increase the trust with which to consider a gold standard.
The use of synthetic data can partially alleviate the problems related to man-
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ually obtained gold standards. The Brainweb simulator (http://www.http://
brainweb.bic.mni.mcgill.ca/brainweb/) provides on the same synthetic
MR model the possibility to include MS lesions at mild, moderate and severe load.
Within the simulator, variations in noise level and bias field effect can also be incorpo-
rated and therefore enables the validation of the algorithm under different conditions.
Additionally, the availability of the simulator online enables for the comparison of the
results across methods [100, 101]. Such a simulator has however some drawbacks:
a single subject is represented thus bounding the statistical analysis, the images lack
realism and the range of loads is quite limited. Alternatively, synthetic data can be
created [103, 106, 156]. In those cases, masks of lesions are used to apply artificial
damage on lesion-free scans [103]. Instead, additional lesion voxels can also be in-
cluded in scans with existing lesions [156].
2.5.2 Measures of agreement
Numerous measures of agreement have been developed to assess the correspondences
between an obtained segmentation and a reference delineation. Since each of them
evaluates a specific characteristic of the segmentation quality, there is no one that stands
out and gathers all the relevant information. This is the reason why it has been strongly
suggested that such measurements should be combined and presented jointly when
validating a new segmentation algorithm [157]. Generally those measures assess in
different ways the relationships between the amount of true detection (true positives
TP), erroneous detections (false positives FP) and missing voxels (false negatives FN).
Due to the small amount of lesion voxels with respect to brain volumes some of the
measures of agreement widely used in most generic segmentation validation frame-
work are non optimal. Among the measures of agreement, Dice score coefficient (
DSC=2TP/(2TP+FP+FN) ), true positive rate or sensitivity (TPR=TP/(TP+FN)), false
positive rate (FPR=FP/(TN+FP)), positive predictive value (PPV=TP/(TP+FP)), speci-
ficity (Spec=TN/(FP+TN)), and accuracy (Acc=(TP+TN)/(TP+TN+FP+FN)) are com-
mon measures of interest. Such assessments can be considered either per voxel or per
lesion. Various other measures assessing for the difference in terms of shape based on
the average surface may also be used. Section 5.2 will further detail and analyse these
evaluation measures.
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2.5.3 Surrogate measures of relevance
In complement to local measures of agreement, relevance of a lesion segmentation out-
put can be assessed through the estimation of the correlation between obtained and
reference total lesion loads. This can carry relevant information in terms of the bias of
the evaluated algorithm with respect to the range of lesion load considered. Addition-
ally, in order to assess the proficiency of an algorithm on a large dataset, correlations
with clinical measures representative of the damage can be used as surrogate for rele-
vance. For instance, Maillard et al. [158] validate their method on a large dataset by
correlating the lesion load with the visual rating scores. A further way of validating a
new method or at least gathering some insight on its performance is to try and compare
it against existing previously validated methods. Comparisons on an in-house dataset
may prove difficult if the methods tested are not publicly available and need to be reim-
plemented. Furthermore such comparisons may be subject to bias if the solutions target
the specific cohort tested. To overcome these problems, in addition to simulator such
as Brainweb described above, publicly available datasets with training and testing sets
and gold standard manual segmentations, allow for a more direct comparison between
methods. For instance, the data used for the MICCAI challenge 2008 on lesion seg-
mentation [159] is nowadays widely used as part of the validation process.
Validation criteria are inherently dependent on the purpose of the lesion segmen-
tation and methods are often developed to answer specific needs and problems. For in-
stance, metrics related to the number of detected lesions will be more important in the
case of MS for which the cardinality of lesions is assessed as treatment effect whereas
it has been demonstrated not to be relevant in the case of age-related WMH [62]. Other
criteria such as the bias of the method towards high or low lesion load or its clinical
relevance are also characteristics that need to be assessed. Depending on the applica-
tion, the sensitivity may be more important than the specificity. In other situations, for
instance with elderly subjects that cannot lie still during scanning, robustness to noise
and artefact may be specially important.
A complementary way to assess the validity of a segmentation technique is the
evaluation of the results’ reproducibility mentioned by García-Lorenzo [110]. Apply-
ing the tested methods to scans acquired in a very short time interval may provide a
relevant measurement of potential bias. The lack of appropriate data make such a test
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difficult in practice and performed in very few studies [49, 98, 103].
2.6 Generalisability
Across all the methods presented in this review, the question of generalisability is a
major issue. In the case of methods using manual segmentation databases, this issue is
raised as a strong drawback. For instance, in the work by Guizard et al. [112], a large
part of the process success relies on the appropriate selection of subjects in the database
that are similar enough to the tested data. One must however bear in mind that bias may
appear in any design that attempts to tackle a specific problem. For instance, the tuning
of extrinsic model parameters may be strongly biased by the set of examples chosen for
comparison [89, 90, 120, 124]. In addition, initialisation frameworks, especially when
relying on pathological subjects, introduce also some bias [98, 99, 121].
Therefore, testing performance in various conditions of scanners, protocols, res-
olution, preprocessing, modalities, range of disease severity are many parameters that
require careful investigation. The question of the preprocessing is assessed by Steen-
wijk et al. [118] with respect to the intensity normalisation strategy, while many others
have studied the influence of the choice of modalities on their results [81,91,93,97,112].
Although monospectral solutions are generally faster, do not risk coregistration errors
and may be less demanding in term of MR protocol, multispectral information tend to
yield better performance. Admiraal-Behloul et al. [49] warn however against a dispro-
portionate amount of information that may potentially increase the results uncertainty.
This effect is shown by Guizard et al. [112] for which the performance with T2 and
FLAIR images is slightly higher than when including T1 modality to the feature space.
In many of the studies, the performance with respect to lesion load is evaluated,
separating the subjects in groups of lesion loads (mild, moderate and severe). In gen-
eral, the segmentation performance increases with the severity of WMH load. This is
due both to the sensitivity of the evaluation measures to the load, with the noticeable
case of the DSC, combined with the inherent difficulty of the detection at lower load
that often correspond to cases in which the lesions are also much less prominent in
term of signal. Yoo et al. [105] for instance found a positive correlation between lesion
load and mean lesion intensity. In all methods, the fact that lesions represent a very
small proportion of the total brain volume causes in fact problems in the balance of
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the volumes when learning from databases since the amount of training samples from
healthy tissues is much higher than the one from lesions. For instance, Deshpande et
al. [144] addressed this issue with respect to the size of the dictionaries to be learnt for
each of the classes. This is also the reason that leads Damangir et al. [140] to build a
cascade of SVM in their segmentation process. With generative solutions modelling
the lesions in a defined class, appearance variability and limited amount of samples
have been warned as potential limitations to the robustness of the algorithm. Wango
et al. [121] attempt to avoid the problem by limiting their space of interest for final
lesion detection to the mask of WM and DGM. In contrast, methods that discard the
lesions and other outliers based on trimming parameter may also lack in robustness for
the estimation of the healthy parameters if the trimming is too high as experimented by
García-Lorenzo [101]. In the work by Wang et al. [124], the trimming parameter, ob-
tained via optimisation with respect to a database of manual segmentations was actually
shown to be dependent on the lesion load and the performance differed accordingly. By
contrast, in extreme cases of WMH lesion loads, such trimming may actually lead to
an inverted segmentation between healthy and lesioned tissue.
A complementary subject of interest is the applicability of the method not only to
different pulse sequences [86, 97, 100, 101, 123, 153] but also to different resolutions
in case for instance of retrospective analysis. Schmidt et al. [90] performed such an
analysis by artificially thickening the slice thickness of their images. Indeed, with
thick slices, as may happen with FLAIR images, both partial volume and interpolation
induced blurring are stronger. It has also been observed that 3D acquired FLAIR images
were less affected by flow artefacts and tended to be more sensitive to lesions [160,161].
Chapter 3
Theoretical background
3.1 Gaussian mixture model and
Expectation-Maximisation algorithm
In this chapter, the underlying background behind the Gaussian Mixture Model
(GMM), the Expectation-Maximisation (EM) algorithm, initially introduced by Demp-
ster et al. [147], and the possible variations that have been designed in the field of
medical image segmentation will be described. The derivation of the EM algorithm
follows the work by McLachlan [162]. Denoting Y = {y1, · · · ,yN}, the set of log-
transformed normalised intensities indexed by n, with N the number of observations in
the image, each voxel based yn feature vector contains D intensity values, each of them
associated to the channel d used for the segmentation. In Gaussian mixture models
(GMM), the observed intensity is considered as originating in different mixing propor-
tions from K Gaussian density distribution functions. Indexed by k, these Gaussian
instances G (Y|θk), depend on the parameters θk = {µ k,Λk}, with µ k and Λk being
respectively the mean and covariance matrix of the kth component of the mixture, such
that
G (yn|θk) = 1
(2pi)D/2 |Λk|1/2
exp
(
−1
2
(yn−µ k)Λ−1k (yn−µ k)T
)
.
Given the set of parameters ΞK , the density for the mixed model in yn is expressed as
f (yn|ΞK) =
K
∑
k=1
ωkG (yn|θk) .
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Under the constraint that the mixing coefficients ωk of the mixture must be positive and
sum to 1, and denoting ωK = {ω1, · · · ,ωK}, the set of parameters ΞK = {ΘK,ω}where
ΘK = {θ1, · · · ,θK} are optimised in order to best model the intensity distributions of
the image and consequently provide an accurate labelling of the image.
The unknown labelling of the image, Z = {z1, · · · ,zN} is defined as hidden variables
where zn, supporting label `, is defined as the e` vector of the canonical basis, i.e.
the unity vector with component ` equal to 1 and all the others to 0. Introducing the
complete data X= {Y,Z}, the Expectation-Maximisation algorithm is used to optimise
the data modelling and the classification at each voxel. The goal is then to maximise
the marginal log-likelihood L (Y : ΞK) = log( f (Y|ΞK)). Since the distribution of
the complete data is unknown, the Expectation-Maximisation enables a progressive
increase of the marginal log-likelihood, by alternating between the estimation of the
expectation of the complete data conditioned on the parameters (E-step), followed by
its optimisation with respect to the parameters (M-step) using the decomposition
f (X | ΞK) = f (Y | ΞK) f (Z|Y,ΞK) .
At iteration t in the update of the parameters the marginal log-likelihood can be ex-
pressed as
log( f (Y|ΞK)) = EZ|Y,Ξ(t)K [log( f (Y|ΞK))]
= EZ|Y,Ξ(t)K
[
log
(
f (X|ΞK)
f (Z|Y,ΞK)
)]
= EZ|Y,Ξ(t)K
[log( f (X|ΞK))]−EZ|Y,Ξ(t)K [log( f (Z|Y,ΞK))]
=Q
(
ΞK
∣∣∣Ξ(t)K )−H (ΞK∣∣∣Ξ(t)K ) ,
where t represents the iteration number, E the expectation and
Q
(
ΞK
∣∣∣Ξ(t)K )= EZ|Y,Ξ(t)K [log( f (X|ΞK))]
H
(
ΞK
∣∣∣Ξ(t)K )= EZ|Y,Ξ(t)K [log( f (Z|Y,ΞK))] .
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The concave nature of the log function enables the use of the Jensen inequality so that
E [log(X)]6 log(E [X]) .
Focusing onH , it can be observed that:
H
(
ΞK
∣∣∣Ξ(t)K )−H (Ξ(t)K ∣∣∣Ξ(t)K )=EZ|Y,Ξ(t)K [log( f (Z|Y,ΞK))]
−E
Z|Y,Ξ(t)K
[
log
(
f
(
Z
∣∣∣Y,Ξ(t)K ))]
=E
Z|Y,Ξ(t)K
log
 f (Z|Y,ΞK)
f
(
Z
∣∣∣Y,Ξ(t)K )
 .
Then, applying the Jensen equality expressed earlier :
H
(
ΞK
∣∣∣Ξ(t)K )−H (Ξ(t)K ∣∣∣Ξ(t)K )6 log
E
Z|Y,Ξ(t)K
 f (Z|Y,ΞK)
f
(
Z
∣∣∣Y,Ξ(t)K )

= log
∫ f (Z|Y,ΞK)
f
(
Z
∣∣∣Y,Ξ(t)K ) f
(
Z
∣∣∣Y,Ξ(t)K )dZ
= 0.
Thus,
∀ ΞK ,H
(
ΞK
∣∣∣Ξ(t)K )6H (Ξ(t)K ∣∣∣Ξ(t)K ) .
This observation simplifies the Expectation-Maximisation algorithm since an increase
in the Q function increases the marginal log-likelihood. Thus, the iterative process
consists in alternating between:
Expectation step, in whichQ
(
ΞK
∣∣∣Ξ(t)K ) is estimated and
Maximisation step, which updates Ξ(t+1)K = argmaxΞKQ
(
ΞK
∣∣∣Ξ(t)K ).
Considering that the marginal log-likelihood is upper-bounded, the process will even-
tually converge.
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3.1.1 E-step
Using the chain rule, the log-likelihood of the complete data can be expressed as
log( f (Y,Z|ΞK)) = log( f (Y|Z,ΞK) · f (Z|ΞK))
= log( f (Y|Z,ΞK))+ log( f (Z|ΞK)) .
Assuming independence between the N observations, it can be written as
log( f (Y,Z|ΞK)) = log
(
∏
n
f (yn|zn,ΞK)
)
+ log
(
∏
n
f (zn|ΞK)
)
=
N
∑
n=1
log( f (yn|zn,ΞK))+
N
∑
n=1
log( f (zn|ΞK)) .
Introducing u(yn|ΞK) and s(yn|ΞK) two vectors whose kth components are respectively
uk (yn|ΞK) = log( f (yn|zn = ek,ΞK))
and
sk (yn|ΞK) = log( f (zn = ek|ΞK)) = log(ωk) ,
the expressions are simplified into
log( f (yn|zn,ΞK)) = zTn u(yn|ΞK)
log( f (zn|ΞK)) = zTn s(zn|ΞK) .
Replacing these inQ
(
ΞK
∣∣∣Ξ(t)K ) leads to the following:
Q
(
ΞK
∣∣∣Ξ(t)K )= EZ|Y,Ξ(t)K [log( f (X|ΞK))]
= EZ|Y,Ξ(t)K
[log( f (Y|Z,ΞK))]+EZ|Y,Ξ(t)K [log( f (Z|ΞK))]
= EZ|Y,Ξ(t)K
[
N
∑
n=1
log( f (yn|zn,ΞK))
]
+EZ|Y,Ξ(t)K
[
N
∑
n=1
log( f (zn|ΞK))
]
=
N
∑
n=1
Ezn|Y,Ξ(t)K
[log( f (yn|zn,ΞK))]+
N
∑
n=1
Ezn|Y,Ξ(t)K
[log( f (zn|ΞK))]
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=
N
∑
n=1
Ezn|yn,Ξ(t)K
[
zTn u(yn|ΞK)
]
+
N
∑
n=1
Ezn|yn,Ξ(t)K
[
zTn s(zn|ΞK)
]
=
N
∑
n=1
Ezn|yn,Ξ(t)K
[
zTn
]
u(yn|ΞK)+
N
∑
n=1
Ezn|yn,Ξ(t)K
[
zTn
]
s(zn|ΞK) .
The vector p(t+1)n = Ezn |yn ,Ξ(t)K
[
zTn
]
can be seen as the vector gathering the normalised
responsibilities
p(t+1)nk = f
(
zn = ek
∣∣∣yn,Ξ(t)K ) .
Applying the Bayes’ Rule then leads to
p(t+1)nk =
f
(
yn
∣∣∣zn = ek,Ξ(t)K ) f (zn = ek∣∣∣Ξ(t)K )
∑Kk′=1 f
(
yn
∣∣∣zn = ek′ ,Ξ(t)K ) f (zn = ek′∣∣∣Ξ(t)K ) .
3.1.2 M-step
Making use of the previously introduced notations, the Q function is optimised with
respect to the parameters by
Q
(
ΞK
∣∣∣Ξ(t)K )= N∑
n=1
K
∑
k=1
p(t+1)nk uk (yn|ΞK)+
N
∑
n=1
K
∑
k=1
p(t+1)nk sk (zn|ΞK)
=
N
∑
n=1
K
∑
k=1
p(t+1)nk log( f (yn|zn = ek,ΞK))+
N
∑
n=1
K
∑
k=1
p(t+1)nk log(ωk)
=
N
∑
n=1
K
∑
k=1
p(t+1)nk log
(
1
(2pi)D/2 |Λk|1/2
exp
(
−1
2
(yn−µ k)Λ−1k (yn−µ k)T
))
+
N
∑
n=1
K
∑
k=1
p(t+1)nk log(ωk) .
To facilitate the optimisation, a variant of the EM, called Expectation Conditional Max-
imisation (ECM) is used here. It consists in the separate and successive optimisation
of the parameters. Even though theQ function is not globally maximised, it increases
at each step in any case. The convergence properties of the algorithm are therefore
not affected. The independent updates of the Gaussian parameters are estimated as the
value of the critical points with respect to the corresponding variables, since it can be
shown that these critical points correspond to a maximum of the function. The update
of µ k is for instance obtained as the solution of
∂
∂µ k
Q
(
ΞK
∣∣∣Ξ(t)K )∣∣∣µ (t+1)k = 0
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∂
∂µ k
N
∑
n=1
p(t+1)nk log
 1
(2pi)D/2
∣∣∣Λ(t)k ∣∣∣1/2 exp
(
−1
2
(yn−µ k)Λ−1(t)k (yn−µ k)T
)
∣∣∣∣∣∣∣
µ (t+1)k
= 0
N
∑
n=1
p(t+1)nk (yn−µ k)Λ−1(t)k
∣∣∣∣∣
µ (t+1)k
= 0.
The update for µ k is then
µ (t+1)k =
∑Nn=1 p
(t+1)
nk yn
∑Nn=1 p
(t+1)
nk
.
Using the update obtained for µ k in the expectation conditional maximisation frame-
work, the update of the covariance matrix Λk is performed in a similar manner by
solving
∂
∂Λk
Q
(
· · · ,µ (t+1)k , · · · ,Λk, · · ·
∣∣∣Ξ(t)K )∣∣∣∣
Λ(t+1)k
= 0
∂
∂Λk
N
∑
n=1
p(t+1)nk log
(
1
(2pi)D/2 |Λk|1/2
exp
(
−1
2
(
yn−µ (t+1)k
)
Λ−1k
(
yn−µ (t+1)k
)T))∣∣∣∣∣
Λ(t+1)k
= 0
N
∑
n=1
p(t+1)nk
(
∂
∂Λk
log
(
|Λk|−1/2
)
+
∂
∂Λk
(
−1
2
(
yn−µ (t+1)k
)
Λ−1k
(
yn−µ (t+1)k
)T))∣∣∣∣∣
Λ(t+1)k
= 0
N
∑
n=1
p(t+1)nk
(
−Λ−1k +Λ−1k
(
yn−µ (t+1)k
)T (
yn−µ (t+1)k
)
Λ−1k
)∣∣∣∣∣
Λ(t+1)k
= 0.
Thus the update of Λk is
Λ(t+1)k =
∑Nn=1 p
(t+1)
nk
(
yn−µ (t+1)k
)T (
yn−µ (t+1)k
)
∑Nn=1 p
(t+1)
nk
In this classical EM framework, the mixing coefficients ωk are updated using the La-
grange multipliers method to enforce the constraint ∑Kk=1ωk = 1. The updated mixing
coefficients must be chosen so that they satisfy
∂
∂ωk
Q
(
ΞK
∣∣∣Ξ(t)K )+λ
(
1−
K
∑
k=1
ωk
)∣∣∣∣∣
ω(t+1)k
= 0
N
∑
n=1
p(t+1)nk
∂
∂ωk
log(ωk)+
∂
∂ωk
λ
(
1−
K
∑
k=1
ωk
)∣∣∣∣∣
ω(t+1)k
= 0
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N
∑
n=1
p(t+1)nk
1
ωk
−λ
∣∣∣∣∣
ω(t+1)k
= 0.
And thus, the update of the mixing coefficients is
ω(t+1)k =
∑Nn=1 p
(t+1)
nk
∑Nn=1∑
K
k=1 p
(t+1)
nk
=
∑Nn=1 p
(t+1)
nk
N
.
3.2 Theme and variations over the EM algorithm in
medical imaging
3.2.1 Bias Field correction
Due to variations occurring in the main magnetic field during the process of image
acquisition, a smoothly varying intensity inhomogeneity (IIH) may be observed in the
images [131]. This artefact, also called bias field (BF), can be modelled as a multiplica-
tive linear combination of basis functions. At the spatial position vn, the noisy signal
exp(ycn) is modified into
exp(yn) = exp(BF(vn)) · exp(ycn) ,
where the bias field can be expressed as
BF(vn) =
M
∑
m=1
cmχm (vn) ,
where cm is the vector of d linear coefficients (one for each modality) of the basis func-
tion χm. The appropriate coefficients, needed to model the bias field, can be obtained
progressively within the EM framework, as presented by Van Leemput et al. [163].
In this solution, the bias field coefficients C = {c1, · · · ,cM} are considered as parame-
ters to optimise and the complete set of parameters ΞK is then {ΘK,ωK,C}. In order
to facilitate the optimisation of such parameters, the intensities of the image are log-
transformed, as mentioned in Section 3.1, which renders the bias field additive instead
of multiplicative. Despite the log-transformation, the observed noise is still assumed to
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be Gaussian [164] and the corrected intensity vector at voxel n is expressed as
ycn = yn−BF(vn)
= yn−
M
∑
m=1
cmχm(vn).
Considering the bias field to be independent between acquisitions and the covariances
diagonal, each coefficient cdm can be optimised separately. TheQ function to be max-
imised with respect to the bias field coefficients is then
Q
(
ΞK
∣∣∣Ξ(t)K )= N∑
n=1
K
∑
k=1
p(t+1)nk log
(
1
(2pi)D/2 |Λk|1/2
exp
(
−1
2
(ycn−µ k)Λ−1 (ycn−µ k)T
))
+
N
∑
n=1
K
∑
k=1
p(t+1)nk log(ωk) .
The first derivative along cmd in the expectation conditional maximisation (ECM)
framework is
∂
∂cmd
Q
(
ΞK
∣∣∣Ξ(t)K )= N∑
n=1
χm (vn)
K
∑
k=1
p(t+1)nk
σ2kd
(
ynd−µkd−
M
∑
m′=1
cm′dχm (vn)
)
,
where σ2kd is the value of the diagonal coefficient of the covariance matrix Λk for chan-
nel d. Nulling all the first partial derivative with respect to the bias field coefficients for
channel d in cd(t+1) =
{
c(t+1)1d , · · · ,c(t+1)Md
}
leads to the following vectorial expression:

N
∑
n=1
χ1 (vn)∑
k
p(t+1)nk
σ2k
(ynd−µkd)
...
N
∑
n=1
χM (vn)∑
k
p(t+1)nk
σ2kd
(ynd−µkd)

=

N
∑
n=1
χ1 (vn)
K
∑
k=1
p(t+1)nk
σ2kd
M
∑
m′=1
cm′dχm′ (vn)
...
N
∑
n=1
χM (vn)
K
∑
k=1
p(t+1)nk
σ2kd
∑
m′
cm′dχm′ (vn)

∣∣∣∣∣∣∣∣∣∣∣∣∣
cd(t+1)
.
Introducing τnd and y¯nd such that
τnd =
K
∑
k=1
p(t+1)nk
σ2kd
y¯nd =
∑Kk=1
p(t+1)nk
σ2kd
µkd
∑Kk=1
p(t+1)nk
σ2kd
,
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the previous equality constraint can be simplified in

N
∑
n=1
χ1 (vn)τnd (ynd− y¯nd)
...
N
∑
n=1
χM (vn)τnd (ynd− y¯nd)
=

N
∑
n=1
χ1 (vn)τnd
M
∑
m=1
cm′dχm′ (vn)
...
∑
n=1
χM (vn)τnd
M
∑
m′=1
cm′dχm′ (vn)

∣∣∣∣∣∣∣∣∣∣∣∣
cd(t+1)
.
Denoting the matrices χ , ϒd and the vector rd as
χ =

χ1 (v1) · · · χ1 (vN)
... . . .
...
χM (v1) · · · χM (vN)
 ϒd = diag(τnd) rd =

y1d− y¯1d
...
ynd− y¯nd
 ,
the update for cd(t+1) can thus be expressed as follows:
χ Tϒdrd = χ Tϒdχcd(t+1).
3.2.2 Spatial a priori knowledge
As underlined by Fraley et al. [165], the EM algorithm may suffer from a poor initialisa-
tion. One of the partial solutions proposed to tackle this problem has been to introduce
a priori spatial anatomical information to the model through statistical atlases. The use
of such atlases is quite common in the field of medical imaging and they represent at
each location the a priori probability to belong to a certain tissue class [166]. Such
information is usually obtained by the averaging of individual segmentations of a pop-
ulation. These priors can then be aligned to the image before the segmentation [163], or
aligned during the EM optimisation [167]. When compared to the initial EM algorithm,
the introduction of statistical atlases is equivalent to the transformation of the global a
priori mixing weights ωk into spatially varying mixing weights ωnk. In this case, the
mixing weights are not updated anymore and the normalised responsibilities become
p(t+1)nk =
f
(
yn
∣∣∣zn = ek,Ξ(t)K )ωnk
∑Kk′=1 f
(
yn
∣∣∣zn = ek′,Ξ(t)K )ωnk′ .
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However, as the populations used to build the atlases are not necessarily representative
of the type of image being segmented, the validity of such a priori information has
been challenged in the literature [168]. In fact, in the case of the commonly used
ICBM atlas (http://www.loni.usc.edu), the scans were taken from healthy
young volunteers and therefore may not be appropriate for an ageing population in
which atrophy can be observed [49]. In order to account for this problem, atlases can
be progressively adapted to a specific subject [168, 169]. This model assumes that
the spatially varying mixing priors are derived from a Dirichlet distribution, noted D ,
that is chosen as the natural conjugate prior to a labelling multinomial distribution.
Using the˜diacritic mark to denote the adapted version of the spatially varying a priori
mixing coefficients, the maximisation of the log-likelihood must take into account the
prior distribution over the atlases. A new term log
[
f
(
Ω˜
)]
is added to the expression
to maximise and the M-step is transformed in the optimisation of
f
(
Ω˜
)
=
N
∏
n=1
D (ω˜n,ϑ n)
=
N
∏
n=1
∏Kk=1 ω˜
(ϑnk−1)
nk
B(ϑ n)
,
whereB is a Beta function and ϑ n the vector of Dirichlet prior parameters for voxel n
such that ϑn j = 1+ εωn j, where ε is a positive parameter assessing the strength of the
applied relaxation. The E-step is kept unchanged but the M-step consists now in the
optimisation of
f
(
X
∣∣ΘK,Ω˜,C) · f (ΘK,Ω˜,C)
with respect to the parameters and theQ function becomes
Q
(
ΞK
∣∣∣Ξ(t)K )= N∑
n=1
K
∑
k=1
p(t+1)nk log
(
1
(2pi)D/2 |Λk|1/2
exp
(
−1
2
(yn−µ k)Λ−1 (yn−µ k)T
))
+
N
∑
n=1
K
∑
k=1
p(t+1)nk log(ω˜nk)+ log
(
N
∏
n=1
∏Kk=1 ω˜
(ϑnk−1)
nk
B(ϑ n)
)
.
The Laplace multipliers method is used to solve the update of the parameters constrain-
ing the sum of the mixing coefficients to 1 at each voxel. At each voxel n, for each tissue
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k, the maximisation process must then satisfy
∂
∂ω˜nk
Q
(
ΞK
∣∣∣Ξ(t)K )+λ
(
1−
K
∑
k=1
ω˜nk
)∣∣∣∣∣
ω˜(t+1)nk
= 0
∂
∂ω˜nk
(
p(t+1)nk + εωnk
)
log ω˜nk +λ
(
1−
K
∑
k=1
ω˜nk
)∣∣∣∣∣
ω˜(t+1)nk
= 0
p(t+1)nk + εωnk
ω˜(t+1)nk
= λ
ω˜(t+1)nk =
p(t+1)nk + εωnk
λ
.
Furthermore, the value chosen for λ is such that
λ =
K
∑
k=1
(pnk + εωnk)
= 1+ ε
and consequently the final update is
ω˜(t+1)nk =
p(t)nk + εωnk
ε+1
.
However, as a consequence of the assumption of independence between observations,
the responsibilities lack in smoothness. Therefore, the atlases obtained with such a
direct update may not be as smooth as usual statistical atlases. To address this con-
cern, a Gaussian kernel Gσ with standard deviation σ is applied by convolution to the
responsibilities as a form of spatial regularization, similarly to previously described
methods [168, 169]. Eventually, the update for the a priori mixing coefficients is
ω˜(t+1)nk = (1−κ)ωnk +κ(Gσ ? p(t+1)nk ),
where κ =
1
(ε+1)
and ? represents the convolution operator.
3.2.3 Spatial consistency through Markov Random Field
Again, as a result of the voxelwise independence assumption, labelling configurations
may present a limited neighbourhood consistency. In order to promote such consis-
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tency, the introduction of contextual constraints through Markov Random Fields (MRF)
is a common solution. Using an energy-based approach, the added constrain consists
in requiring a higher energy for unlikely neighbourhood configurations and make the
labelling at one voxel dependent on the labeling of its neighbours. In the following, Nn
denotes the 6-neighbourhood (east, west, north, south, top and bottom) of a given voxel
n and ZNn = {zi}i∈Nn . In this approach, the density function of the labelling given the
parameters is
f (Z|Ω) ∝
N
∏
n=1
exp(−UMRF (zn|zNn))
K
∏
k=1
ωzn jn j ,
where UMRF (zn|zNn) = znH ∑
m∈Nn
zm
and H is the matrix containing the energy value constraints. In order to account for the
possible anisotropy of the data, the sum over the neighbourhood Nn can be weighted
by the inverse of the distance between the central voxel n and its neighbour m. Given
a matrix representation, different energy constraints can be applied to different tissue
combinations. The main concern with this spatial consistency constrain lies in the
intractability of the expectation step, that would require to take into account the whole
space of possible configurations. To circumvent this computational difficulty, a well
adopted approximation, known as the mean field approximation can be used. This
mean field approximation consists in assuming that the dependence of the central value
to all its surrounding can be approximated by its dependence to the mean of its nearest
neighbours [170]. This approximation can be expressed as
f (zn|Ω)' exp(−UMRF(zn|E[ZNn]))
K
∏
k=1
ωznknk
= exp(−UMRF(zn)|PNn))
K
∏
k=1
ωznknk
f (zn = ek|Ω)' exp(−UMRF(ek)|PNn))ωnk
∑Kk′=1 exp(−UMRF (ek′|PNn))ωnk′
,
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where ZNn = {zi}i∈Nn and PNn = {pi}i∈Nn . Thus the normalised responsibilities are
transformed into
p(t+1)nk =
f
(
yn
∣∣∣zn = ek,Ξ(t)K )exp(−UMRF(ek∣∣∣P(t)Nn))ωnk
∑Kk′=1 f
(
yn
∣∣∣zn = ek′,Ξ(t)K )exp(−UMRF(ek′|P(t)Nn))ωnk′ .
3.2.4 Constraint over covariance matrix
Under the assumption that the noise model does not change across the different tissues,
it can be enforced by constraining the covariance matrix of the Gaussian components.
Assuming the initial intensities for a component are random variables such that
exp(y) = BF · (exp(µ )+ e) ,
where e represents a Gaussian white noise, then the log-transformed intensities follow
y = BF+µ + log
(
1+
e
exp(µ )
)
' BF+µ + e
exp(µ )
.
Considering that e follows the same Gaussian distribution in the whole image, for each
tissue, then for all k, the prior distribution of Λk can be modelled as an Inverse-Wishart
distribution W −1 of parameters SkΨSk and N denoted W −1SkΨSk,N (Λk) where Sk is a di-
agonal scaling matrix such that Sk(d,d) =
1
exp(µkd)
. Depending on the parameters Ψ
and ν = N, the prior distribution over Λk follows
W −1SkΨSk,N (Λk) ∝
|SkΨSk|
N
2
|Λk|
N+D+1
2
exp
[
−1
2
Tr
(
Λ−1k SkΨSk
)]
,
where Tr refers to the trace of the matrix. The inclusion of such a constraint in the
covariance matrix contributes to a change in theQ function [171] that becomes
Q
(
ΞK
∣∣∣Ξ(t)K )= N∑
n=1
K
∑
k=1
p(t+1)nk uk (yn|ΞK)+
N
∑
n=1
K
∑
k=1
p(t+1)nk sk (zn|ΞK)+ log
(
K
∏
k=1
W −1SkΨSk,N (Λk)
)
.
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When optimising first the constraint parameter Ψ, the differentiation leads to the fol-
lowing constraint:
∂
∂Ψ
K
∑
k=1
[
log |Ψ|N/2− 1
2
Tr
(
S(t)k ΨS
(t)
k Λ
−1
k
)]∣∣∣∣∣
Ψ(t)
= 0
KNΨ(t)−1 =
K
∑
k=1
S(t)k Λ
−1
k S
(t)
k .
At this stage of the update, Λk can be approximated by
∆(t)k =
∑Nn=1 p
(t)
nk
(
yn−µ (t)k
)T (
yn−µ (t)k
)
∑Nn=1 p
(t)
nk
and the update of Ψ is thus
Ψ(t)−1 =
∑Kk=1 S
(t)
k ∆
(t)−1
k S
(t)
k
N ·K .
The differentiation with respect to Λk for the update of the covariance matrix verifies
∂
∂Λk
N
∑
n=1
K
∑
k=1
p(t)nk uk (yn|ΞK) =
1
2
N
∑
n=1
p(t)nk
(
Λ−1k (yn−µ k)T (yn−µ k)Λ−1k −Λ−1k
)
∂
∂Λk
log
(
W −1SkΨSk,N (Λk)
)
=
∂
∂Λk
log
(
|Λk|−(N+D+1)/2
)
− 1
2
Tr
(
SkΨSkΛ−1k
)
=−N+D+1
2
Λ−1k +
1
2
Λ−1k SkΨSkΛ
−1
k .
The updated covariance form is then derived to satisfy
1
2
(
N
∑
n=1
p(t)nk
[
Λ−1(t)k
(
yn−µ (t)k
)T (
yn−µ (t)k
)
Λ−1(t)k −Λ−1(t)k
])
−N+D+1
2
Λ−1(t)k +
1
2
Λ−1(t)k S
(t)
k Ψ
(t)S(t)k Λ
−1(t)
k = 0
Λ−1(t)k ∆
(t)
k Λ
−1(t)
k +
Λ−1(t)k S
(t)
k Ψ
(t)S(t)k Λ
−1(t)
k
∑Nn=1 p
(t)
nk
= Λ−1(t)k +
N+D+1
∑Nn=1 p
(t)
nk
Λ−1(t)k
Λ−1(t)k
N
∑
n=1
p(t)nk∆
(t)
k +Λ
−1(t)
k S
(t)
k Ψ
(t)S(t)k =
N
∑
n=1
p(t)nk +(N+D+1)
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Λ(t+1)k =
∆(t)k +
S(t)k Ψ
(t)S(t)k
∑Nn=1 p
(t)
nk
1+
N+D+1
∑Nn=1 p
(t)
nk
.
Since µ k is included is the definition of the Inverse Wishart distribution through the Sk
matrix, the update for µ k should also be altered. For the univariate case for instance,
the update of µk should then satisfy:
N
∑
n=1
p(t)nk µ
(t+1)
k −
ψ(t)
Λk(t)
exp(−2µ(t+1)k ) =
N
∑
n=1
p(t)nk yn−N
Assuming a slow change in the update of the parameters and considering the mode
for Λk to be in
exp(−2µk)Ψ
N+D+1
, the variation due to the inclusion of the Inverse Wishart
distribution is considered negligeable and the update of µ is therefore not altered.
3.3 Model selection and evolution
In the context of GMM, an important parameter is the number of Gaussian components
used to model the data. In the case of the classical EM optimisation, this information
has to be chosen beforehand but is crucial to avoid both under- and overfitting. Vari-
ous strategies have been developed to select the appropriate number of components in
such a model. Figure 3.1 displays a possible classification of such strategies. Firstly
it separates stochastic and resampling strategies from deterministic options that are
usually based on a penalisation function. The second level indicates if the model se-
lection process is performed on a comparison basis after convergence of the algorithm
(end process comparison) or if this is done within the algorithm itself in a evolutionary
framework (Within evolution). Lastly, the third criterion, defines the type of evolution
that is applied to the model in terms of number of Gaussian components. Four types
can be defined:
Static: when the number of components is constant throughout the evolution. It is
generally related to an end process comparison framework.
Increasing: when the number of components can only increase.
Decreasing: when the number of components can only decrease.
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Model selection
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Within
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Oscillating
[182]
End Process
Comparison
Static
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Deterministic
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Oscillating
[177] [178] [179] [180]
Decreasing
[175] [176]
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Comparison
Increasing
[173] [174]
Static
[172]
Figure 3.1: Classification of the different available strategies of model selection when consid-
ering GMM.
Oscillating: when the number of components can alternatively increase and decrease.
Such algorithms generally do not require any more comparison with other models
at convergence.
The shaded nodes in Figure 3.1 correspond to model selection processes for which split
and merge strategies have been designed.
3.3.1 Examples of SM strategies for model selection
The split and merge (SM) strategies have not initially been introduced for the purpose
of model selection but in order to deal with other drawbacks of the EM algorithm as
documented by Fraley et al. [165]: the initialisation problem and the propensity of the
EM to converge towards a local minimum [172]. Such problems arise from the non-
optimal distribution of the Gaussian components over the data space. In the field of
medical imaging, as developed in Section 3.2.2, when the Gaussian components can
be matched with related anatomical tissues whose distribution is spatially well known,
the initialisation problem can be partly solved through the introduction of anatomical
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atlases. However, as soon as the model based on a unique Gaussian component per tis-
sue is set aside, as with the solution of Ashburner et al. [167] where a fixed number of
Gaussian components is assigned to each anatomical tissue, this issue may arise again.
The split and merge strategies aim then to modify the distribution of the components by
allowing Gaussian components for which the corresponding data observations are far
from following a Gaussian distribution to be split in two and redundant Gaussian distri-
bution pairs to be merged together. These modifications contribute to the redistribution
of the components over the data space. In the static method using an end process
comparison [172], at each iteration of the algorithm, a candidate triplet of Gaussian
components is selected for a new model resulting in the split of the first component and
the merge of the last two. The model is tested by running an EM until convergence on
the proposed configuration. The log-likelihood of the model serves as objective func-
tion to decide whether to accept or not the tested model. The algorithms stops once all
triplets configurations have been tested without meeting the acceptance criterion. This
SM strategy designed for the reorganisation of the components over the data space can
also be embedded in a model selection process. To that purpose, the algorithm is run
over a range of number of components and the obtained models are tested against an
objective function. The objective function is then the log-likelihood, penalised by a cost
function that takes into account the complexity of the model. In the "increasing" frame-
work using an SM strategy as presented by Blekas et al. [174], the split and the merge
operations are decoupled: the split operation is always accepted and the subsequent
tested merge operation is accepted only if the log-likelihood of the model increases.
It evolves until reaching Kmax Gaussian components in the model. To be used in a
model selection perspective, this scheme requires a model comparison over a range of
Kmax. Conversely, in the "oscillating" framework, the model selection process can be
integrated within the framework, not requiring the comparison of a set of models at the
end of the process. The model operations (split or merge) are decoupled, tested in an
order defined in the method and checked for an increase in an objective function. A
SM operation is generally tested after convergence of the EM [178, 180] but the SM
operations can also be designed within the EM framework at each iteration [177]. The
advantage of the split and merge strategies in the oscillating framework is that they
allow for the simultaneous optimisation of the model parameters in a flexible manner
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that may avoid local minima of the log-likelihood and the dynamic estimation of the
appropriate number of model components.
3.3.2 Model evolution in SM strategies
For all the previously described SM strategies, three main problems related to the SM
operations remain:
Initialisation problem How is a new model initialised after a split or a merge opera-
tion?
Precedence problem What is the precedence of the operations?
Acceptance criterion problem How to compare models and check for improve-
ments?
Different solutions have been proposed in the literature to answer these three questions.
The following subsections describe in more details the options adopted in the rest of
this work.
3.3.2.1 Initialisation problem
In this subsection, a component with index k can be split into two Gaussian components
k1 and k2. Respectively, for a merge operation, the components k1 and k2 can be merged
into the component k. In order for a change to be tested, the new components of the
model must be initialised. In order to preserve some initial information between the
previous model and the newly tested configuration, an equality constraint over the first
two probabilistic moments of the components is applied, as justified by Richardson et
al. [182]. Such a constraint can be expressed as follows:
ωk = ωk1 +ωk2
ωkµ k = ωk1µ k1 +ωk2µ k2
ωk
(
µ kµ
T
k +Λ
T
k Λk
)
= ωk1
(
µ Tk1µ k1 +Λk1Λ
T
k1
)
+ωk2
(
µ Tk2µ k2 +Λk2Λ
T
k2
)
In the case of a merge operation, such a constraint can be solved straightforwardly,
since the problem is well-posed. Following the solutions of Richardson and Zhang et
al. [182, 183], the initial parameters for the component resulting of a merge operation
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are
ωk = ωk1 +ωk2
µ k =
ωk1µ k1 +ωk2µ k2
ωk1 +ωk2
Λk =
ωk1
(
Λk1 +
(
µ k1−µ k
)T (µ k1−µ k))+ωk2 (Λk2 + (µ k2−µ k)T (µ k2−µ k))
ωk1 +ωk2
.
The two last equations can be justified with the work by Zhang et al. [183]:
µ k =
1
N
N
∑
n=1
yn p(yn|`n = k)
=
1
N
N
∑
n=1
yn
ωk1
ωk
p(yn|`n = k1)+ynωk2ωk p(yn|`n = k2)
=
ωk1µ k1 +ωk2µ k2
ωk
.
In the same way, the value for the covariance matrix is obtained as
Λk =
1
N
N
∑
n=1
yTn yn p(yn|`n = k)−µ Tk µ k
=
1
N
N
∑
n=1
yTn yn
ωk1
ωk
p(yn|`n = k1)+yTn yn
ωk2
ωk
p(yn|`n = k2)−µ Tk µ k
=
1
N
N
∑
n=1
yTn yn
ωk1
ωk
p(yn|`n = k1)− ωk1ωk µ
T
k1µ k1 +
ωk1
ωk
µ Tk1µ k1
+
1
N
N
∑
n=1
yTn yn
ωk2
ωk
p(yn|`n = k2)− ωk2ωk µ
T
k2µ k2 +
ωk2
ωk
µ Tk2µ k2
−µ Tk µ k
=
ωk1
(
Λk1 +µ
T
k1µ k1
)
+ωk2
(
Λk2 +µ
T
k2µ k2
)
ωk
−µ Tk µ k.
As highlighted by Zhang et al. [183], these merging equations guarantee the new covari-
ance matrix to be symmetric positive definite and allow the first and second moments
not to be treated independently [172].
While the initialisation of the parameters when merging is well-posed, this is not
the case for the splitting operation. Different methods have been proposed to solve
this problem using for example the orthogonal decomposition of the covariance ma-
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trix [183].
Symmetric positive definite, the covariance matrices can be decomposed as a product
of orthogonal matrices under the following form:
Λk = QTk Qk =
D
∑
d=1
q(k)Td q
(k)
d
q(k)i q
(k)T
j =
0, if i 6= jþ(k)i otherwise ,
where ðþ(k)=
{
þ(k)1 , · · · ,þ(k)D
}
are the positive eigenvalues of the covariance matrix Λk
ordered by decreasing value.
Relying on the work of Richardson [182] and Zhang et al. [183], the initialisation of
the components results of a splitting operation is obtained as follows:
ωk1 =ωkð
µ k1 =µ k−
√
ωk2
ωk1
ηq(k)1
ωk2 =ωk (1−ð)
µ k2 =µ k +
√
ωk1
ωk2
ηq(k)1
Λk1 =
ωk2
ωk1
Λk +
ωk
ωk1
(
ξ −ξ η2−1)q(k)T1 q(k)1 +q(k)T1 q(k)1
Λk2 =
ωk1
ωk2
Λk +
ωk
ωk2
(
ξ η2−ξ −η2)q(k)T1 q(k)1 +q(k)T1 q(k)1 .
The free parameters ð,η , and ξ are all set to 0.5 similarly to what is chosen by Li et
al. [178].
3.3.2.2 Operation precedence
In all the aforementioned SM strategies, a crucial aspect is the precedence of the oper-
ations. Intuitively it seems sensible to try to split a model component that does not fit
correctly the corresponding observations whereas a merge operation may be more jus-
tified if it occurs between two distributions that are very similar. Again, various criteria
have been described to sort the operations by likelihood of occurrence. Among them,
the Kullback-Leibler divergence (KLD) or relative entropy, which measures how much
information is lost when approximating a distribution P1 by a distribution P2, can not
only be used for both the split and the merge operations but is also not biased by the
relative weight of the different mixture components. Denoted DKL (P1||P2), the KLD is
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generally defined as
DKL (P1||P2)≡∑
y
P1 (y) log
(
P1 (y)
P2 (y)
)
.
The symmetric version of this expression, written as
KLD(P1||P2) = DKL (P1||P2)+DKL (P2||P1) ,
will be used in the remaining of this work. In the splitting case, the KLD is defined
between the model distribution M and the normalised frequency observations associ-
ated to the distribution. It measures how much information is lost when approximating
the frequency distribution of the observations p(Y,θk) by the density functionM with
parameters θk, M (Y|θk). The normalised frequency distribution of the observations
for component k, p(Y|θk) is defined such that
p(y|θk) =
N
∑
n=1
pnkδ (y−yn)
∑Nn=1 pnk
,
where δ represents the Dirac distribution. The measure of KLD used for a split opera-
tion, KLDS is defined as
KLDS(k|ΞK) = DKL (p(Y|θk)||M (Y|θk))+DKL (M (Y|θk)||p(Y|θk))
=∑
y
[
p(y|θk) log
(
p(y|θk)
M (y|θk)
)
+M (y|θk) log
(
M (y|θk)
p(y|θk)
)]
.
For the merging operation the symmetric KLDM measures how close the density dis-
tributions from two separated components are one from the other.
KLDM(k1,k2|ΞK) =
N
∑
n=1
M (yn
∣∣θk1) log
(
M (yn
∣∣θk1)
M (yn
∣∣θk2)
)
+
N
∑
n=1
M (yn
∣∣θk2) log
(
M (yn
∣∣θk2)
M (yn
∣∣θk1)
)
.
This criterion is commonly used to choose the order in which to test the different model
changes.
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3.3.2.3 Model acceptance criterion
The last problem to solve in an SM framework is the question of the acceptance crite-
rion. Among the deterministic model selection frameworks making use of SM strate-
gies, such a criterion is based on the maximisation of an objective function that com-
bines a measure of the goodness of fit of the model to the observed data and a cost func-
tion penalising the complexity of the model. The penalty function is designed to avoid
overfitting, while for the goodness of fit, the log-likelihood is the natural choice. Since
the problem has been raised in the context of model selection by Akaike [184], many
criteria have been developed to promote such a balance. Among those model selection
criteria, the widely used Bayesian Inference Criterion (BIC) has been shown to perform
well for GMM [185] and its derivation, following [186] and using the Bayesian-Laplace
approximation is detailed hereafter. The BIC objective function is
f (K|Y) ∝ f (Y,K) ,
where, assuming that the priors on the parameters given the model are flat enough
around the estimator of the set of parameters Ξ̂K and the prior on the number of com-
ponents is also flat, the likelihood can be expressed as follows:
f (Y,K) = f (K) f (Y|K)
= f (K)
∫
ΞK
f (ΞK|K) f (Y|ΞK)dΞK
≈ f (K) f
(
Ξ̂K
)∫
ΞK
f (Y|ΞK)dΞK
= f (K) f
(
Ξ̂K
)
·
∫
ΞK
exp [L (Y : ΞK)]dΞK
≈ f (K) f
(
Ξ̂K
)
exp
[
L
(
Y : Ξ̂K
)]
·
∫
ΞK
exp
[
−1
2
(
ΞK− Ξ̂K
)T
IL
(
Y : Ξ̂K
)(
ΞK− Ξ̂K
)]
dΞK
= f (K) f
(
Ξ̂K
)
exp
[
log f
(
Y, Ξ̂K
)]
·
∫
ΞK
exp
[
−1
2
(
ΞK− Ξ̂K
)T
IL
(
Y : Ξ̂K
)(
ΞK− Ξ̂K
)]
dΞK
= f (K) f
(
Ξ̂K
)
f
(
Y
∣∣∣Ξ̂K) (2pi)F(K)/2∣∣∣IL (Y : Ξ̂K)∣∣∣1/2 .
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IL
(
Y : Ξ̂K
)
=
[
− ∂ 2∂ϑm∂ϑlL (Y : ΞK)
]∣∣∣
ΞK=Ξ̂K
is the Fisher information matrix of size
F(K)×F(K) where F(K) is the number of free parameters ϑ to determine and
L (Y : ΞK) =
N
∑
n=1
log f (yn|ΞK)
IL
(
Y : Ξ̂K
)
=
N
∑
n=1
IL
(
yn : Ξ̂K
)
.
Applying the law of large numbers, 1N IL
(
Y : Ξ̂K
)
can be approximated as
E
f
(
Y
∣∣∣Ξ̂K)
[
IL
(
yn : Ξ̂K
)]
. This approximation is further used to derive
∣∣∣IL (Y : Ξ̂K)∣∣∣
with IF(K) the identity matrix of dimension F(K), number of free parameters in the
mixture:
∣∣∣IL (Y : Ξ̂K)∣∣∣≈ ∣∣∣∣N ·E f(Y∣∣∣Ξ̂K) [IL (yn : Ξ̂K)]
∣∣∣∣
=
∣∣∣∣N · IF(K)E f(Y∣∣∣Ξ̂K) [IL (yn : Ξ̂K)]
∣∣∣∣
= NF(K) ·
∣∣∣∣E f(Y∣∣∣Ξ̂K) [IL (yn : Ξ̂K)]
∣∣∣∣ .
Using the above approximations and applying the log to the likelihood results in
log f (Y,K) ∝ log
 f (K) f (Ξ̂K) f (Y∣∣∣Ξ̂K) (2pi)F(K)/2∣∣∣IL (Y : Ξ̂K)∣∣∣1/2

= log f (K)+ log f
(
Ξ̂K
)
+L
(
Y : Ξ̂K
)
+
F(K)
2
log2pi− 1
2
log
∣∣∣IL (Y : Ξ̂K)∣∣∣
≈ log f (K)+ log f
(
Ξ̂K
)
+L
(
Y : Ξ̂K
)
+
F(K)
2
log2pi− F(K)
2
logN− 1
2
log
∣∣∣∣E f(Y∣∣∣Ξ̂K) [IL (yn : Ξ̂K)]
∣∣∣∣ .
When N→∞ only the terms function of N remain and the final expression is obtained:
log f (Y,K)≈L
(
Y : Ξ̂K
)
−P (K) = BIC(K).
withP (K) =
F(K)
2
logN.
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In the case of a GMM using K Gaussian components in D modalities, the number of
free parameters in the expression of the log-likelihood is
F(K) = D ·K︸︷︷︸
means
+K · D · (D+1)
2︸ ︷︷ ︸
covariance
+ K−1︸ ︷︷ ︸
mixing coeffs.
= K · D
2+3D+2
2
−1
The value of K−1 for the mixing coefficient takes into account the constraint they sum
to 1.
Decimation of the number of independent elements: Assuming independence be-
tween the observations enables the direct calculation of the complete log-likelihood,
but this strong assumption should be considered carefully. Applying the BIC in such
conditions would indeed be completely meaningless for medical images in which the
number of voxels is extremely large ( 106). As proposed by Worsley et al. [187, 188]
and applied by Groves et al. [189], a correction can be applied to this assumption by us-
ing a decimating factor that accounts for the proportion of observations that are actually
independent. This decimating factor has been shown to be approximated by
ν =
(
4log2
pi
)3/2
∏
r∈{x,y,z}
1
FWMHr
where FWMH2r =−
2log2
corrr
,
with corrr the correlation between adjacent voxels in the r direction. Considering mul-
tispectral vectorial images, the correlation for the multispectral dataset is estimated as
the mean of the correlations calculated for the D channels [190] using directly the log-
transformed normalised data corrected for bias field. The corrected BIC can thus be
expressed as:
BIC(K) = νL
(
Y : Ξ̂K
)
− F(K)
2
log(νN) .
Chapter 4
Model selection with split and merge
strategies
In this chapter, the tools described in previous chapters are assembled in order to build
a hierarchical adaptive split and merge GMM model selection framework. When build-
ing the presented schemes, the main motivation was to use the final model to distinguish
damaged from healthy white matter as separated Gaussian components. A naive model
and its limitations is first presented before detailing BaMoS (Bayesian Model Selec-
tion) with its needed refinements and implementation adjustments.
4.1 Naive model: BiASM
Naively, one may design an algorithm that encompasses these SM concepts and the
anatomical prior information so as to define directly the number of Gaussian compo-
nents necessary to model each tissue class appropriately. In this framework named
BiASM, standing for Bilayered Anatomically-constrained Split and Merge expectation
maximisation algorithm [191], J tissue classes, indexed by j, are modelled as a mixture
of K j Gaussian components, leading to a bilayered graphical model displayed in Figure
4.1 .
Within a brain segmentation application, the tissue classes are defined as the grey
matter (GM), the white matter (WM), the cerebrospinal fluid (CSF) and the non-brain
(NB) tissues (bone, fat, skin, muscle and others which remain after skull-stripping).
The model is anatomically constrained using statistical atlases and an MRF constraint.
Even though BiASM is able to separate different tissue types from lesions, it suffers
from various limitations that are described hereafter:
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Figure 4.1: Example of the hierarchical description of the naive bilayered model.
Automatic selection Due to the variability of lesion location within the brain and the
smoothness of the statistical atlases, the Gaussian components that could be in-
terpreted as lesion-related are not solely associated to white matter. Without
knowledge about what to consider as normal healthy tissue, an automatic selec-
tion of the lesion-related elements is therefore problematic.
Transfer problem The ability of the framework to add new Gaussian components in-
creases the flexibility to the intensity modelling. Thus, the priors become more
important in constraining the segmentation as a new Gaussian distribution can be
created to accommodate a region with high a priori probability. In BiASM, the
GM/CSF partial volume is regularly modelled as pure GM, leading to problem-
atic results.
Bias Field Not accounting for the presence of atypical intensities may contribute to a
poor modelling of the bias field effect.
4.1.1 Introducing the outlier modelling
In order to deal with the limitations of the naive model, the modelling of outliers can
be further investigated. As evoked in Section 2.3.2, such methods are popular when
applied to images with WMH. Indeed, the EM algorithm is known to have a break-
down point of 0 [148], meaning that the presence of only one unexpected observation
(outlier) may affect considerably the final result. The breakdown occurs when a degen-
erate component with singular covariance matrix is assigned to the outlier element, the
likelihood being then unbounded. To ensure an appropriate convergence of the EM in
the presence of outliers, without directly modelling the outlier distribution, a solution
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is to limit the impact of the outliers by rejecting them from the parameters optimisa-
tion using the Trimmed Log-Likelihood [97, 101, 124, 192]. These only consider the
fraction of elements best in line with the current estimator for the parameters update.
Another solution is to weigh the contribution of each sample to the updated parameters
by introducing a measure of outlierness either for each component of the GMM [79] or
globally [148]. This allows to downweight the influence of the outlier observations. As
the distributions of these unexpected observations are not known and can be sparse, a
popular way has been to model their presence by the addition of a uniform distribution
(U ) [193] over the range of possible intensities:
f (yn|Ξ) =
K
∑
k=1
ωkG (yn|θk)+ωK+1U
where ωK+1 is the weight attributed to the uniform distribution so that∑K+1k=1 ωk = 1. As
stated by Schroeter et al. [148], the use of the uninformative uniform distribution helps
tackling the problem of the number of GMM components. Combining the idea of a re-
jection class with a SM strategy allows for modelling the different types of outliers and
separating hyperintense lesions in the white matter from hypointense iron deposition
that are linked in many neurodegenerative disorders [194].
4.1.1.1 Mahalanobis distance
As mentioned in Section 1.3.3, the choice of a threshold measuring the outlierness
of an observation can be obtained through the use of the Mahalanobis distance. It is
possible to draw a link between this measure and the probability for such observations
to occur. When handling normally distributed multidimensional data of parameters
µ ,Λ, the Mahalanobis distance dMahal is often used to measure how far an observation
vector y is from the corresponding mean of the distribution and defined as
dMahal(y,µ ,Λ) =‖ y−µ ‖Λ
=
√
(y−µ )Λ−1 (y−µ )T .
The value of 3 for the Mahalanobis distance has been widely used as threshold to con-
sider observations as outliers [79]. Denoting τMahal the Mahalanobis distance threshold
value above which the observations y should be treated as outliers, according to [195]
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the probability for such an observation can be derived as
P(‖ y−µ ‖Λ≥ τMahal) = 1−P(‖ y−µ ‖Λ≤ τMahal)
= 1− 1
(2pi)D/2 |Λ|1/2
∫
y∈R
exp
(
−1
2
dMahal (y,µ )2
)
dy,
with R = y|dMahal(y,µ )≤ τMahal. By the change of variable ρ = Λ−1/2 (y−µ ) and
using the fact that the Jacobian of the transformation is |Λ|1/2, the previous equation
can be transformed into
P(‖ y−µ ‖Λ≥ τMahal) = 1− 1
(2pi)D/2 |Λ|1/2
∫
‖ρ‖≤τMahal
exp
(
−1
2
‖ ρ ‖2
)
|Λ|1/2dρ
= 1− 1
(2pi)D/2
∫
‖ρ‖≤τMahal
exp
(
−1
2
‖ ρ ‖2
)
dρ .
Thanks to the rotational invariance of the integrand, denoting r =‖ ρ ‖ with SD−1(r)
the sphere of radius r in dimension D-1, dr and dA respectively the length and the
area parts of the elementary volume dρ , and noting that AD−1(r) = rD−1AD−1(1) with
AD−1(1) = 2pi
D/2
Γ(D/2) the transformation into spherical coordinates leads to
P(‖ y−µ ‖Λ≥ τMahal) = 1− 1
(2pi)D/2
∫ τMahal
0
∫
SD−1(r)
exp
(−r2/2)dAdr
= 1− 1
(2pi)D/2
∫ τMahal
0
exp
(−r2/2)∫
SD−1(r)
dAdr
= 1− 1
(2pi)D/2
∫ τMahal
0
exp
(−r2/2)AD−1(r)dr
= 1− AD−1(1)
(2pi)D/2
∫ τMahal
0
exp
(−r2/2)rD−1dr
= 1− AD−1(1)2
D/2−1
(2pi)D/2
∫ τ2Mahal/2
0
e−tt
D
2−1dt
= 1− 1
Γ(D/2)
∫ τ2Mahal/2
0
e−tt
D
2−1dt
by the change of variable t = r2/2. Eventually the previous equation can be simplified
into
P(‖ y−µ ‖Λ≥ τMahal) = 1−
γ(D/2,τ2Mahal/2)
Γ(D/2)
,
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Number of modalities
Mahalanobis distance value
2 2.5 3 3.5
1 0.0455 0.0124 0.0027 0.000465
2 0.1353 0.0439 0.0111 0.0022
3 0.2615 0.1001 0.02993 0.0066
Table 4.1: Probabilistic correspondence of Mahalanobis distance for different number of
modalities
where the lower incomplete Gamma function is defined as γ(D2 ,τMahal)=
∫ τMahal
0 t
D
2−1e−tdt
and the Gamma function computed in D2 is Γ(D/2) =
∫ ∞
0 t
D
2−1e−tdt . It corresponds
to the value of the cumulative distribution of the χ2 law with D degrees of freedom
taken in τ2Mahal. Table 4.1 presents the corresponding probabilistic values for different
choices of Mahalanobis distance with varied number of modalities.
4.1.2 SM strategy with uniform distributions
In models that consider outliers under a uniform distribution as mentioned in Section
4.1.1, the application of a SM strategy requires the definition of a split of the uni-
form distribution. Many solutions such as transforming a uniform distribution into a
Gaussian or splitting it into two Gaussian distributions can be proposed. As uniform
distributions provide a trace probability to all observations, thus acting as a regulariser,
they should be preserved in the model. The split of a uniform distribution is therefore
defined as the transformation of a uniform distribution into one Gaussian and a remain-
ing uniform distribution.
The next problem at hand is to define the parameters to initialise the newly formed
Gaussian distribution. Using the mean of the observations corresponding to the uniform
distributions is not truly meaningful since the presence of outliers at both extremes of
the data spectrum would have a cancelling effect. As the choice of the initial covari-
ance matrix for such a component is also problematic, a simple K-means algorithm
can be used to separate the cluster corresponding to the uniform distribution into two
subclasses. The solution of the K-means then provides an initial estimation of the mean
and the covariance of the Gaussian component.
The problem is thus simplified into finding meaningful initial guesses for the
means of the two clusters to build from the K-means algorithm. The two classes of
the K-means are initialised using the mean and the mode of the distribution under con-
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Figure 4.2: Example of the hierarchical description of BiASM modified for outlier detection
in two distinctive layers. For the outlier mixture the node with a lighter shade on
Level 2 correspond to the remaining uniform distribution.
sideration, where the mode is obtained through kernel density estimation. The initial
parameters for the new Gaussian component are the mean and the covariance of the
class with the lowest variance out of the two clusters obtained after running the K-
means with the defined initial values. This educated guess of the initial estimation of
the parameters of the Gaussian component resulting from the split of a uniform dis-
tribution is crucial to the evolution of the model and could be further improved and
redefined in the future. An extra empirically-defined constraint prevents merges be-
tween uniform and Gaussian distributions. An example model is displayed in Figure
4.2, where the lighter shade in the outlier mixture correspond to the remaining uniform
component.
4.1.3 Need for spatial separation for outliers
While from a purely theoretical point of view BiASM provides an interesting model
of anatomy, several problems are present because of the intensity similarities between
flow artefacts mostly present in the CSF and white matter lesions. Thus, in order to spa-
tially separate outliers originating from different tissue classes, a three-level Gaussian
Mixture model named BaMoS (Bayesian Model Selection) is now explored.
4.2 BaMoS
4.2.1 Class hierarchy
Considering an inlier/outlier differentiation on top of the anatomical tissue classifica-
tion produces the following three-layer architecture [196]:
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Level 1 At the first level (Level 1), indexed by l, the model is robustly divided into two
density functions I and O, that correspond respectively to the inlier part (I), mod-
elling the healthy tissues, and to the outlier part (O), related to the unexpected
observations, such that
f (yn|ΞK) = bII (yn|ΞK)+bOO(yn|ΞK) ,
with bI + bO = 1 and bl ≥ 0, and introducing b the vector formed with these
parameters. Note that O(yn|ΞK) is a full mixture model, contrary to previously
proposed models which assumed a uniform distribution for O [193].
Level 2 The second level (Level 2), indexed by j characterizes the anatomical tissue
classes (i.e. if an inlier or outlier voxel belongs to WM, GM, CSF or other non-
brain (NB) tissues). The number of anatomical classes Jl is considered the same
for both the inlier and outlier classes since the model is built under an assumption
of symmetry, simplifying JI = JO = J. The distribution is thus:
f (yn|ΞK) = ∑
l∈I,O
bl
J
∑
j=1
al jΦ
(
yn
∣∣Θl j) ,
where bl , al j and Φ
(
yn
∣∣Θl j) are respectively the mixing weight of l, the class
weight for l j and the likelihood of the data at voxel n for the tissue class l j. At
this point, a denotes the vector of mixing weights al j satisfying ∑
J
j=1 al j = 1 and
al j ≥ 0, ∀l ∈ {I,O}.
Level 3 The third level (Level 3), indexed by k, characterizes the multiple intensity
clusters of each inlier or outlier tissue class and models the acquisition noise
in the observations from the expected biological mean signal. Each anatomical
class density distribution is modelled by a mixture of multiple components with
distributionM , that can be Gaussian (G ) and/or uniform (U ) such that
Φ
(
yn
∣∣Θl j)= Kl j+1∑
k=1
wl jkM
(
yn
∣∣∣θl jk)
=
Kl j
∑
k=1
wl jkG
(
yn
∣∣∣θl jk)+wl jKl j+1Ul j
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Figure 4.3: Example of the hierarchical description of BaMoS in three distinctive layers. Note
that on the outlier part of the tree, the nodes with lighter shades on Level 3 corre-
spond to remaining uniform distributions.
where Kl j is the number of Gaussian components in class l j, wl jk is the mixing
proportion (≥ 0) of class l jk and θl jk are the corresponding Gaussian parameters.
The uniform distribution in each class l j is only parametrised by the mixing coef-
ficient wl jKl j+1
with amplitude 1 over the range of intensities normalised between
0 and 1. The mixing coefficients for class l j are gathered in the vector wl j , with
W being the set of all such vectors that satisfy ∑
Kl j+1
k=1 wl jk = 1, ∀l ∈ {I,O} and
∀ j ∈ {1, · · · ,J}.
Adopting the notation ωl jk = blal jwl jk with pi = {b,a,W} the set of a priori mixing
weights at the different hierarchical levels and considering the observations as inde-
pendent and identically distributed (iid), the multi-layered mixture model can finally
be expressed as follows:
f (Y|ΞK) =
N
∏
i=1
∑
l∈I,O
J
∑
j=1
Kl j+1∑
k=1
ωl jkM
(
yn
∣∣∣θl jk)
.
An example of a possible hierarchical model is displayed in Figure 4.3, where at Level
1 l takes the values I or O and j the values in {GM, WM, CSF, NB}.
In such a design, an atlas adaptation on both Level 1 and Level 2 is possible when
adopting a symmetric modelling (symmetric in the J anatomical tissues modelled) pro-
viding at Level 1 new information on the possible location of the outliers. The problem
mentioned in the case of BiASM is more easily solved due to the above differentiation
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BiASM BaMoS
Number of hierarchical layers 2 3
Automatic selection of number of components Yes Yes
Atlas adaptation using Dirichlet priors No Yes
Automatic post-processing for pathology segmentation No Yes
Table 4.2: Characteristics comparison between BiASM and BaMoS
between inliers and outliers. As detailed later in Section 5.1 when applied to the lesion
segmentation problem, this three layered model and especially the inlier/outlier separa-
tion enables an easier selection of the lesion-related elements based on comparison to
the parameters used for the inlier-related GMM. Table 4.2 summarises the differences
between the initial BiASM model and BaMoS.
4.2.2 EM extensions in BaMoS
4.2.2.1 Spatial knowledge and Dirichlet priors
The inclusion of statistical atlases to enforce some spatial knowledge is possible when
the interpretation of the classes is a priori provided which is the case at Level 1 and
Level 2. Thus, such anatomical atlases are introduced to inform on spatial location of
the tissues at Level 2. At Level 1, the class mixing proportion is initially not spatially-
variant. However, if a singular value is assigned to all voxels, such as in Section 3.2.2,
then the mixing proportions can be modelled as a Dirichlet prior both at Level 1 and
Level 2. Denoting B and A the atlases used at Level 1 and Level 2 respectively and
Ω˜ =
{
B˜, A˜,W
}
, and noting the symmetry of the model between inliers and outliers,
the prior distribution over the atlases becomes:
f
(
Ω˜
)
= f
(
B˜
)
f
(
A˜
)
=
N
∏
n=1
D
(
b˜n,β n
)
D (a˜n,α n)
=
N
∏
n=1
∏l∈I,O b˜
(βnl−1)
nl
B(β n)
∏Jj=1 a˜
(αn j−1)
n j
B(α n).
Adapting directly the solution derived in Section 3.2.2, the decoupled update of the
atlases is solved as:
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b˜(t+1)nl =
ε1bnl + p
(t+1)
nl
ε1+1
a˜(t+1)nl =
ε2an j + p
(t+1)
n j
ε2+1
,
with
p(t+1)nl =
J
∑
j=1
Kl j+1
∑
k=1
p(t+1)nl jk
p(t+1)n j = ∑
l∈I,O
Kl j+1
∑
k=1
p(t+1)nl jk
.
Similarly to what is presented in Section 3.2.2, a Gaussian smoothing Gσ is applied to
the responsibilities and the final update for the spatially varying mixing coefficients is
b˜(t+1)nl = (1−κ1)bnl +κ1(Gσ ? p(t+1)nl )
a˜(t+1)n j = (1−κ2)an j +κ2(Gσ ? p(t+1)n j ),
where κi =
1
εi+1
and ? represents the convolution operator.
4.2.2.2 Complete model
As detailed in Section 3.2.3, a spatial regularisation was added through a Markov Ran-
dom Field at Level 2 and 3. The expression of the MRF with the matrix H allows for
a different treatment between a Level 2 neighbourhood and a Level 3 neighbourhood.
The constraint over the Gaussian covariances detailed in Section 3.2.4 was introduced
in order to account for the difference between the biological variability of the tissues
modelled through the various split operations and the noise due to the acquisition of
the image itself and approximated as Gaussian throughout the full image. The bias
field correction detailed in Section 3.2.1 was also applied to the log-transformed inten-
sities. Within this framework, the E-step of the EM contributes to the update of the
responsibilities so that
p(t+1)nl jk
=
φ c(t)nl jk
b˜(t)nl a˜
(t)
n j w
(t)
l jk
ψ(t)nl jk
∑
l′∈I,O
J
∑
j′=1
K j′
∑
k′=1
φ c(t)nl′
j′
k′
b˜(t)nl′ a˜
(t)
nl′
j′
w(t)l′
j′
k′
ψ(t)nl′
j′
k′
,
where the condensed notations
φ (t)nl jk
= f
(
yn|zn = el jk ,ΞK(t)
)
ψ(t)nl jk
= exp
(
−UMRF
(
el jk |P
(t)
Nn,H
))
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are adopted. The remaining parameters can be updated as
w(t)l jk
=
N
∑
n=1
p(t)nl jk
Kl j+1
∑
k′=1
N
∑
n=1
p(t)nl jk′
µ (t)l jk
=
N
∑
n=1
p(t)nl jk
yc
(t)
n
N
∑
n=1
p(t)nl jk
∆(t)l jk
=
N
∑
n=1
p(t)nl jk
(
yc
(t)
n −µ (t)l jk
)(
yc
(t)
n −µ (t)l jk
)T
N
∑
n=1
p(t)nl jk
Ψ−1(t) =
∑l∈I,O∑Jj=1∑
Kl j
k=1 S
(t)
l jk
∆−1(t)l jk
S(t)l jk
N ·∑l∈I,O∑Jj=1∑
Kl j
k=1 1
Λ(t)l jk
=
∆(t)l jk
+
S(t)l jk
Ψ(t)S(t)l jk
∑n p
(t)
nl jk
1+
N+d+1
∑n p
(t)
nl jk
.
4.3 Algorithm implementation
The algorithm can be separated into three main steps:
• Preprocessing
• Initialisation
• Model selection
4.3.1 Preprocessing
The preprocessing of the data used in this work combines the most common steps
evoked in Section 2.1. It consists first, when needed, in the spatial coregistration of
the different modalities. When available, the T1 image is chosen as reference image
due to the good contrast between healthy tissues observed in this modality. An affine
transformation is used to register the modalities in order to avoid inconsistencies known
to arise when applying non rigid registration to pathological data [69].
As detailed in Section 4.2.2.1, statistical atlases are used at Level 1 and 2 of the
hierarchy. For Level 1, no a priori statistical information is known about the location
of the outliers. The outliers are thus initially probabilistically defined according to the
Mahalanobis distance as derived in Section 4.1.1.1 [195]. Therefore, the mixing pro-
portions at Level 1 are initialised so that ∀n, bnO = bO and bnI = 1− bO. The value
for bO has been set to 0.01 in all our experiments, (equivalent to the probability of en-
countering a sample with Mahalanobis distance superior or equal to 3 when using two
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modalities). Note however that this value does not correspond to the density estimate
of a sample at Mahalanobis distance 3 from the mean of the distribution. As underlined
by Van Leemput et al. [79], such a value would change according to each tissue distri-
bution. Conversely, for Level 2, tissue-specific probabilistic maps are used to describe
the prior probability of the four main tissues (GM, WM, CSF and NB). Two strate-
gies can be adopted to obtain these probability maps. The first consists in choosing
the smooth maps from the ICBM template (ICBM452) that are then aligned with the
observed data and re-normalised between 0 and 1 before use. The alignment of the at-
lases is obtained by registration of a T1 atlas template to the target image using first an
affine transformation [197] followed by a non-rigid registration [197]. The smoothness
of the template helps preventing the problems mentioned earlier when using non-rigid
registration on pathological data. The second strategy is to use the output of the label
fusion of tissue segmentations obtained via application of the Geodesic Information
Flow (GIF) pipeline [198].
Besides, for computational, normalisation and complexity purposes, images are
roughly skull-stripped before segmentation. Here again two strategies have been used.
The first one consists in the application of morphological operation on the brain ex-
traction obtained via the method detailed in [199]. The masks obtained for brain ex-
traction are filled to include the ventricles and sulcal CSF. This operation considers the
CSF as part of the features to segment and may allow the segmentation of subarach-
noid vessels. Furthermore, it has been noted that in the presence of large and highly
pathological lesions, appearing as very hypointense on the T1 modality, errors in the
brain extraction process can occur at the ventricles’ borders. The initial elimination of
some periventricular lesions can then be corrected by the morphological operations of
dilation and filling. As a trade-off however, the dilation of the initial mask has been
seen in some cases to contribute to the inclusion of some fat, skin, dura matter and
bony structures neighbouring the external CSF, justifying further the inclusion of the
NB class in the model. The second strategy is derived as for the atlas from the applica-
tion of the GIF pipeline and is simply the output of the total intracranial volume (TIV)
mask.The main contribution of the mask regards the process of image normalisation
since the histograms on which the GMM will be fitted is defined at this stage. The po-
tential presence of extreme intensity outliers outside of the mask region would greatly
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increase the complexity of the segmentation if a mask was not used. It may indeed
affect the normalisation and the shape of the histogram hindering the stability of the
model evolution. The evaluation of the impact of these preprocessing choices is further
detailed in Section 5.4.
4.3.2 Initialisation
The initial model Kinit is initialised as KI j = 1 and KO j = 0 ∀ j, meaning that each
inlier tissue component is being modelled by a single Gaussian, and the outlier tissue
components are modelled by a uniform distribution. As the inlier mixtures are assumed
to be governed only by Gaussians, there is no uniform distribution for the inlier classes
(weight fixed at 0). Thus, the initial model attributes one Gaussian component for each
inlier tissue component and one uniform component for each outlier tissue component,
allowing for a different treatment of inliers and outliers despite the flat priors. When
building the mixtures for the outliers, the differences between inliers and outliers is
driven by the differences in the statistical priors adapted after the first EM convergence.
To avoid overfitting, the bias field correction is only optimised on the initial model
Kinit. Outliers that are not correctly detected during this first EM, may therefore con-
tribute slightly adversely to the bias field modelling. Furthermore, to allow for a
smoother and progressive modelling of the bias field, the maximal polynomial order
of the basis functions is progressively increased. As far as the atlas adaptation is con-
cerned, the adopted solution consists of relaxing the atlases only after convergence of
the initial EM and considering them static afterwards. Practically, the segmentation
obtained after convergence of the initial EM is smoothed and serves as atlas in the fol-
lowing steps of the process, as constantly evolving atlases within the model selection
process could actually cause the instability in the model. Other strategies such as up-
date and relaxation within the log-likelihood optimisation instead can also be preferred
as well as alternative choices for κ . A constant value of σ = 1 has been used for all
smoothing operations. The convergence threshold for the EM has been set at 10−6.
4.3.3 Model selection
The model selection consists in the following steps:
Step 1 Computation of the list of possible SM model changes ListSM: given the cur-
rent model, an ordered list of possible operations is defined by an alternating
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sequence of splits and merges. Merges are ordered by increasing KLD and splits
by decreasing KLD as detailed in Section 3.3.2.2. Priority is given to splits over
uniform distributions. As a hard constraint, and mostly for computational rea-
sons, Gaussian components with wl jk/∑
Kl j+1
k′=1 wl jk′ < 0.01 are not allowed to split.
Merges can only occur between Gaussian components from the same mixture l j.
Step 2 Initialisation of a new model: the first element of ListSM is used to initialise the
current model according to Sections 3.3.2.1 and 4.1.2. The shape of the matrix
H, used to define the MRF neighbourhood rules, is adapted to the new model.
Step 3 Optimisation of the tested model using the EM algorithm.
Step 4 Test of the new model using the BIC: the new model is accepted only if the
relative change in the objective function is above 10−4. For computational and
stability reasons, Gaussian components with a relative weight w jkl below 0.01
are removed from the model.
Step 5 Conditional check: if the model is accepted, the process restarts at Step 1. If
not, the first element of ListSM is removed from the list and the process restarts
at Step 2, thus testing the next model change. If all the elements in the list have
been tested, the algorithm terminates.
4.3.3.1 Remarks on the application of the BIC criterion
Practically, since the bias field is not updated after the first EM convergence, the BIC
criterion developed in Section 3.3.2.3 is applied for the model selection without con-
sidering the bias field parameters as additional degrees of freedom. Alternative consid-
erations over the number of degrees of freedom of the parameter space could account
for:
• The strength of the priors over the covariance matrices.
• The weight of each subcomponent.
• The exchangeability of the Gaussian components for each tissue class with the in-
clusion of ∑l∈I,O∑Jj=1 ln(Kl j!) in the number of degrees of freedom as mentioned
by Bishop [200].
The model selection algorithm is graphically displayed in Figure 4.4.
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Figure 4.4: Graphic scheme of the model selection process performed in BaMoS.
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Chapter 5
Application of BaMoS to white matter
lesion segmentation and validation
In this chapter, the proposed data model is applied to segment white matter hyperin-
tensities. The first part highlights the segmentation process and the correction for po-
tential false positives. The remaining of the chapter is devoted to the validation of the
WMH segmentation. Firstly, in Section 5.2, the various possible validation assessment
measures are described and discussed. Then, after describing the different datasets in
Section 5.3, the BaMoS lesion segmentations are internally evaluated in terms of ro-
bustness and performance in Section 5.4. Comparison to other existing algorithms is
presented in Section 5.5.
5.1 WMH segmentation using BaMoS
5.1.1 Segmentation process
Once the appropriate model for the data has been selected, the result can be used to
localise and delineate specific types of outliers such as white matter lesions. However,
due to the high variability both in appearance and location of intensity outliers, WM
hyperintensities can be modelled by more than one Gaussian component (Level 3 of
the model). The selection of the appropriate clusters related to lesions can be obtained
automatically based on intensity comparisons in a fashion similar to [79, 97, 101] as
mentioned in Section 1.3.3. Eventually, those clusters are combined to produce the
final lesion segmentation.
The model components relevant for lesion segmentation are selected from the out-
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lier part of the model if spatially associated to the GM or the WM. Discarding the
outlier part of the model associated with CSF or NB tissues prevents the inclusion of
flow artefacts present in the CSF and most of the structures related to skin muscle or fat
remaining in the mask. However, due to the smoothness of the GM and WM statistical
atlases both tissue origins have to be further considered according to heuristic intensity
comparisons rules stated hereafter:
l jk ∈ L if

l j = OWM
or
l j = OGM
and
µ(FLAIR)l jk
> µ(FLAIR)IWM
µ(T2)l jk
> µ(T2)IWM
µ(PD)l jk
> µ(PD)IWM
,
with Patho = {FLAIR, T2, PD} and L the set of possible lesion-related components.
When the FLAIR modality is not available, a further refinement on the selected
components is required in order to avoid the inclusion of voxels related to partial vol-
ume effect at the GM-CSF border. Such components present themselves as very hy-
pointense on the T1 modality and slightly but not strikingly hyperintense on the T2
image. Since the change in intensities is monotonous with lesion severity for both T1
and T2 intensities (respectively decreasing and increasing) but with a much stronger
slope for the T2 compared to the T1 [51, 52], it can be assumed that very low intensi-
ties on the T1, would only correspond to a very severe lesion and thus an even higher
hyperintensity level on the T2 image. To address this correspondence, in cases where
a potential lesion-related component with a very hypointense mean on T1 (i.e. a mean
lower that the mean observed for the GM inliers), the corresponding mean on the T2
was checked to be hyperintense compared to the mean of unsuspicious lesion compo-
nents. Such components must present a hyperintense mean on T2 (lesion-like) and a
mean on T1 higher than the mean of the GM inliers.
Mathematically, the set L of components that are presumed to be related to lesions
is split into two groups: T L, standing for true lesion (or undisputed lesion), and DL,
standing for disputed lesion such that
DL =
{
s ∈ L
∣∣∣ µ(T1)s < µ(T1)IGM }
T L =L\DL.
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The refined set of lesion RL is then defined as
RL = T L+
{
s ∈ DL
∣∣∣ µ(T 2)s ≥ µ(T 2)T L } .
where µ T L denotes the mean intensity of the T L set.
It must be emphasised that this refinement is not needed in the case where the
FLAIR modality is available. Indeed, at the CSF-GM interface, intensities do not ap-
pear hyper-intense on the FLAIR image. Furthermore, the monotonous evolution of
intensities with lesion severity does not hold in the case of the FLAIR modality due
to the inversion recovery process of the acquisition [52]. A similar selection process
is performed voxelwise for the remaining uniform distributions. The main strength of
such selection process relies on its post-processing characteristic. As it occurs after
obtaining the final model, it remains independent of the definition of the outliers of
interest. Furthermore, this postprocessing step remains flexible and adaptable to differ-
ences in definitions according to the available modalities or clinical subtleties in fields
that lack standard definitions [4]. It is for instance possible to include the CSF outliers
and correct afterwards for the inclusion of false positives.
Figure 5.1 illustrates how BaMoS was able to separate different types of lesion
in clinical data. Other types of outliers, such as areas of iron deposition in the basal
ganglia with much darker intensities on FLAIR images were also assigned their own
cluster. A visual example of BaMoS’ ability to stratify different types of WM and deep
GM sub-clusters is presented in Figure 5.1.
5.1.2 Weighting of lesion-related components
With the previous step, Gaussian components are selected to be consequently consid-
ered as related to the final lesion segmentation. However, naively combining these
selected components cannot account for the fact that they have been split based on
their intensities and therefore model different levels of hyperintensity or partial volume
effect with the surrounding normal tissues in the image. To convey this refined infor-
mation in the final segmentation result, a multiplicative downweighting of the Gaussian
components has been introduced. Focusing on the modalities that convey information
about the pathology (T2, FLAIR, PD), the lesion-related components whose Maha-
lanobis distance towards the mean of the WM inliers above 3 are weighted with the
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(a) (b) (c) (d)
(e) (f) (g) (h)
Figure 5.1: WM segmentation for clinical data. First row: Images of two modalities used T1
(a) and FLAIR (b) and the two subclasses obtained for the inliers of the WM (c-
d). Second row: 4 subclasses classified under the WM part of the outliers with
hyperintensities (e-f) and hypointensities (g-h).
maximum value 1. The others are attributed a lower weight according to the ratio of
their Mahalanobis distance towards the WM inliers with respect to the threshold value
3 chosen for the weighting. Alternatively, the weighting can also be performed in a
voxelwise fashion to avoid being dependent on the model structure. This is also the
strategy adopted for the weighting in the uniform components. While this weighting
accounts for lesion severity and partial volume, it should however be further refined in
order to truly model the partial volume effect using for instance the contrast observed
between WM and GM.
The lesion-related sub-components from the BaMoS model obtained from simu-
lated data are displayed as an enlarged axial section in Figure 5.2. Note that different
clusters are formed according to the intensity of the underlying voxel.
5.1.3 Correction for false positives
The tissue separation between outliers enables the correction for outliers that mimic
WMH in the CSF due mostly to flow artefacts, but other regions were observed to be
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(a) (b) (c) (d) (e)
Figure 5.2: Enlarged section on an axial slice of the T2-weighted (a) simulated image with se-
vere lesion load. Overlayed with the lesion segmentation ground truth (b), the total
segmentation obtained with BaMoS (c) and the two separated components lesion-
related (d-e). Note that the separation between the lesion-related components is
linked to the outlierness of the lesion.
prone to false positives (FP) after the simple lesion extraction step detailed in Sec-
tion 5.1.1. Their occurrence was mostly observed in known controversial areas with
ambiguous WMH definition [59] often described as normal occurrence in FLAIR im-
ages [57]. The septum pellucidum and its extension toward the genu and the splenium
of the corpus callosum as well as the lining of the third ventricle were naturally classi-
fied as lesion-related whereas the manual segmentation omitted these regions. Due to
the inclusion of the GM related outliers, FLAIR hyperintense areas in the cortical sheet
were sometimes considered as lesions. Some of the aforementioned false positives can
be easily corrected for. The correction for these misclassifications is based on three
types of analysis:
Segmentation Refers to the binarisation of some classification in order to assess the
lesions individually.
Lesion characterisation Refers to the features associated with each lesion used for
their classification.
Lesion classification Refers to the final taxonomy associated to each lesion according
to the features previously derived.
5.1.3.1 Segmentation previous to false positives correction
The following steps are performed:
Global segmentation The global segmentation for the anatomical tissues under study
T = {GM, WM, CSF, NB} is obtained by first combining the subclasses of each
general tissue class. As far as the outlier components are concerned, they are nat-
urally associated with their inlier counterparts. The lesion segmentation obtained
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previously is reassigned to the WM. In the case of pronounced atrophy, it may
also happen, that part of the CSF is more spatially associated with WM for which
the corresponding voxels are outliers. The associated tissue for these elements
is easily corrected to obtain a more appropriate tissue segmentation. For each of
the tissues in T , the corresponding classification based on maximum probability
is denoted ST . This roughly corrected segmentation remains however suboptimal
since some subclasses that may arise due to partial volume between tissues are
binarily associated to one or the other tissue, only based on their Level 2 belong-
ing. Furthermore, the corrections performed here in a post-processing manner
may modify the model obtained after convergence.
Lesion binary segmentation The binary lesion segmentation can also be performed
in different ways that are listed below from the more conservative to the least
conservative:
Thresholding zn = lesion if p(zn = lesion)> 0.5
Tissue segmentation zn = lesion if p(zn = lesion) > max
T
p(zn = T ) with T ∈
{GM,WMI,CSF,NB}, WMI being the white matter inlier tissue.
Subpart of WM segmentation zn = lesion if SWM(n) = 1 and p(zn = lesion)>
max
k∈[1;KIWM ]
p(zn = IWMk)
The differences in volumes seem very marginal but a more careful assessment is
still needed.
Ventricles segmentation Using the statistical atlas corresponding to the internal CSF,
a rough segmentation is obtained applying the following rule:
zn = Ventricle if SCSF(n)×AICSF(n)> 0
where AICSF denotes the statistical atlas corresponding to the internal CSF.
5.1.3.2 Lesion characterisation for false positives correction
Once the overall binarised lesion segmentation is obtained, the connected components
(CC) are determined applying the algorithm detailed by Borgefors et al. [201]. For each
5.1. WMH segmentation using BaMoS 123
of the connected components (i.e. each of the individual lesions), various measures
related to its location and the surrounding tissue segmentation is assessed.
As far as the neighbourhood characteristics are concerned, they can be classified
in different subclasses :
Distance
• Distance for each direction between the centre of gravity of the lesion and
the centre of gravity of the mask that is the
{
CGLesion(t)−CGImage(t)
}
,
where CG denotes the centre of gravity and t one of the three Euclidean
axis.
• Closest distance to the ventricle based on the ventricle segmentation per-
formed in Section 5.1.3.1 that is min
bl∈Bl ,bv∈Bv
d(bl,bv) where Bl (resp. Bv)
denotes the border of the lesion (resp. the border of the ventricles).
• Distance to each of the tissues based on the classification of the inlier part
of the model only.
Neighbourhood
• Binary statement of neighbourhood between tissues
• Proportion of voxels on the external lesion border that belong to one of the
4 inlier tissues or to the outliers
Specific location Based on the initial statistical atlases of deep gray matter (DGM)
ADGM and internal CSF (ICSF) AICSF
• Possibility to be in the DGM if ∃n ∈ CCl|ADGM(n)> 0
• Proportion of voxels in the lesions with high probability (>0.45) to be inside
the ventricles
5.1.3.3 Potential lesions taxonomy - False positives correction
Based on the descriptors defined in Section 5.1.3.2, each of the individual connected
components was finally classified in a taxonomy of regions accepted or not as lesions.
The taxonomy is:
Lesions
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Periventricular lesion: Lesion neighbourhing the ventricles, with most of their
neighbours belonging to the normal appearing white matter.
Subcortical lesion: Lesion completely embedded in white matter or located in
the area of the deep gray matter, but not in the medial part of the brain.
Subcortical lesion close to cortical sheet: Lesion with neighbours belonging
to the GM but with a higher proportion of WM neighbours and not be-
longing to the DGM.
Discarded regions
Out region: All regions of hyper-intensities close to the image mask. It con-
cerns mostly the voxels related to muscle, fat or skin remaining in the mask.
Figure 5.3: Example of the out region correction, with the FLAIR image on the left and the FP
to be corrected (red) on the right.
Septum Pellucidum In those regions, the proportion of neighbours belonging
to the three main tissues is quite high and the distances toward the midline
and the centre of gravity of the mask relatively low.
Figure 5.4: Example of the septum pellucidum/corpus callosum region correction, with the
FLAIR image on the left and the FP to be corrected (red) on the right.
Cortical Sheet Regions with none or almost no neighbours in the white matter,
not close to the ventricles and not belonging to the susceptible deep gray
matter area.
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Figure 5.5: Example of the cortical sheet region correction, with the FLAIR image on the left
and the FP to be corrected (red) on the right.
Third ventricle Areas close to GM, WM and CSF for which the cortical sheet
classification does not apply the proportion of WM neighbours is low com-
pared to GM, and the location of the centre of gravity close to the midline
is more temporal than the centre of gravity.
Figure 5.6: Example of the third ventricle region correction, with the FLAIR image on the left
and the FP to be corrected (red) on the right.
Fourth ventricle Regions for which the proportion of neighbours belonging to
WM is lower than those of GM, whose distance to the CSF is lower than
the distance to the ventricles and whose centre of gravity is lower than the
centre of gravity of the mask.
Figure 5.7: Example of the fourth ventricle/Sylvean aqueduct region correction, with the
FLAIR image on the left and the FP to be corrected (red) on the right.
Choroid plexus/Inside Ventricle Regions for which the proportion of WM
neighbours is very low, the location is compatible with being in the ven-
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tricles and the proportion of surrounding CSF voxels is higher than the pro-
portion of GM surrounding voxels.
Figure 5.8: Example of the choroid plexus region correction, with the FLAIR image on the left
and the FP to be corrected (red) on the right.
5.2 Lesion segmentation assessment: measures and
limitations
Validation of automated segmentation methods is usually performed based on a gold
standard (GS) that is difficult to acquire for clinical data and is commonly based on
manual segmentation. As the total volume load is currently the clinical standard for the
assessment of lesions, correlations between the automated and manual lesion volumes,
here considered as a clinical gold standard, is a common form of validating and compar-
ing segmentation strategies [79, 90, 108]. Contrarily to the lesion count, lesion volume
has been found to be related to the clinical outcome and to cognitive decline [62] when
investigating age-related white matter changes
5.2.1 Volumetric assessments
Since the volume is a popular way of assessing the lesion burden, the Pearson’s correla-
tion coefficient between volumes has been widely used to compare lesion segmentation
performance on a population. An other evaluation measure directly related to volume,
that is applied on an individual case basis is the volume difference (VD) expressed in
percent and defined as 100
∣∣∣∣1− ]vSeg]vRef
∣∣∣∣, where Seg refers to the lesion segmentation,
Ref to the gold standard and ]v to the number of voxels in the considered set. Gen-
erally, ] denotes the cardinality of a set. This measure suffers from the fact that it is
not defined for a null reference volume, that is for a normal case in which no lesion
has been segmented. However, as noticed by Schmidt et al. [90], such volume assess-
ments are insufficient to assess the quality of the segmentation since a good agreement
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in terms of volume does not mean that the segmentation in itself is accurate. A score
of 0 for the volume difference can be obtained without any overlap between the two
compared segmentations.
5.2.2 Dice Similarity Coefficient: Popular but limited
As a measure of spatial overlap, the Dice Similarity coefficient (DSC), defined as
DSC =
2]v (Ref∩Seg)
]vRef+ ]vSeg
=
2TP
2TP +FP +FN
is a very popular measure of agreement. However its application to the lesion segmen-
tation context has been challenged.
As evoked by Schmidt et al. [90] and Anbeek et al. [80], the DSC is dependent on
the lesion load: the same volumetric amount of misclassification will affect more the
small than the large lesion loads. In addition, the same volumetric amount of error, out-
line errors will affect differently the results according to error type, shape and number
of lesions, modifiers of the surface/volume ratio and of the volume per lesion.
5.2.2.1 Error configurations - Impact of individual lesion volume
Simplistic examples allow for a better illustration of this effect and the impact on the
similarity coefficient. Assuming isotropic images with unit voxel element, individual
lesions are simple shapes characterised by a single length a. The volume of an in-
dividual lesion is denoted Va. With a systematic error of one voxel at the outline of
each individual lesion to segment, three error configurations are studied. These three
examples of error configurations are described hereafter:
UnderSeg Each individual lesion of volume Va is undersegmented with an outline er-
ror of one voxel thus resulting in a volume Va−2. See Figure 5.9 b.
OverSeg Segmentation resulting from the systematic overestimation of the individual
reference lesions by one voxel at the outline, resulting in individual lesions of
shape characteristic a+2 of volume Va+2. See Figure 5.9 c.
TransSeg Segmentation resulting from the translation along the main diagonal by one
voxel of the reference lesion producing individual lesions of volume Va. See
Figure 5.9 d.
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(a) (b) (c) (d)
Figure 5.9: Presentation of the three studied configurations of errors UnderSeg (b), OverSeg (c)
and TransSeg (d) with respect to the segmentation of reference (a). In the compared
segmentations, green refers to TP, red to erroneous segmentation (FN or FP) and
white to true negatives.
The three studied configurations are shown in Figure 5.9 and the type and amount of
errors are recapitulated in Table 5.1.
The influence of the error on the DSC is then expressed for the three configurations
as follows:
UnderSeg
FN =Va−Va−2
TP =Va−2
DSC =
2Va−2
Va+Va−2
OverSeg
FP =Va+2−Va
TP =Va
DSC =
2Va
Va+Va+2
TransSeg
FN + FP = 2Va−2Va−1
TP =Va−1
DSC =
Va−1
Va
The DSC is therefore linked to the volume of an individual lesion, the DSC being
much more affected by errors at the border for small individual lesions as illustrated in
Figure 5.10.
5.2.2.2 Shape impact
It can also be noted that the shape chosen for individual lesions in this simplistic model
affect the DSC to different extents. Considering now individual lesions of spherical
shape, their individual number of elements when considering a radius a is Va =
4pia3
3
Seg Volume TP FP FN
UnderSeg Va−2 Va−2 0 Va−Va−2
OverSeg Va+2 Va Va+2−Va 0
TransSeg Va Va−1 Va−Va−1 Va−Va−1
Table 5.1: Errors and volumes for an individual lesion of cubic shape with three configurations
of outline error.
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Figure 5.10: Influence of the individual volume and the type of segmentation error on the DSC
in a cubic configuration.
and the corresponding surface is Sa = 4pia2. Similarly to the previous derivation, with
an error at the border of one element as in the OverSeg configuration, the DSC becomes
in the spherical case:
DSCspheric =
2Va
Va+Va+1
=
2 ·Va
Va+
4pi
3
((
3Va
4pi
)1/3
+1
)3 .
When considering a regular tetrahedron with a side of length a, and of volume Va =√
2
12
a3 the DSC can in turn for the same type of outline error be expressed as
DSCtetrahedric =
2Va
Va+Va+2
=
2Va
Va+
√
2
12
((
12Va√
2
)(1/3)
+2
)3 .
Again, the DSC is directly linked to the volume of individual lesion but the equation
differs due to the shape of the individual lesions considered. Table 5.2 summarises
the effect in Dice score for different lesion size (in number of elements) for the cu-
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Number of voxels per
individual lesion
DSC (%)
Cubic Spheric Tetrahedric
27 35.5263 43.1657 59.9524
125 53.4188 60.3769 73.7665
1000 73.3138 77.9502 86.0601
3375 81.4431 84.8073 90.5300
8000 85.8001 88.4247 92.8327
27000 90.3494 92.1652 95.1794
125000 94.1237 95.2439 97.0876
Table 5.2: Effect on the DSC (%) of a one element border error in overestimation according to
shape and volume of individual lesions.
bic, spherical case and tetrahedrical case while Figure 5.11 displays graphically the
corresponding results.
5.2.3 Voxelwise and cardinal assessment
Since global volumetric comparison may be limited in their assessment of the actual
overlap with a reference segmentation and the use of a unique overlap assessment
measure may be biased by the ground truth characteristics, other ways of assessing the
quality of a given segmentation have been developed. As underlined in both reviews by
Lladó et al. [50] and García-Lorenzo et al. [110], there is no unique scalar evaluation
measure able to summarise globally the quality of the segmentation and these measures
Figure 5.11: Dependence of the DSC on shape and volume of lesion when considering a sys-
tematic overestimation by one voxel at the border (OverSeg).
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have strengths and limitations. Their combined use may not only help in the evaluation
of a given segmentation with respect to a reference but also allow to better understand
the origin of potential disagreements. Such strategy has been used for the MICCAI
2008 challenge on MS segmentation [159].
Additionally, these measures may be apply either at the voxel level or at the car-
dinal level. When needed the subscripts v and c are used to distinguish between these
two levels. At the cardinal level, a lesion or connected lesion component is defined as
a maximal set of spatially connected lesion voxels. The degree of connectivity is let to
the user discretion. True positives are then lesions that share at least one voxel in the
Seg and Ref images. A false negative is a lesion whose voxels are only classified as le-
sion in the Ref image. On the contrary, none of the voxels of a false positive lesion can
be found in the Ref image. The sets of true positive, false positive and false negative
lesions are respectively denoted TPc, FPc and FNc.
Three families of measures can then be separated to assess the segmentation qual-
ity:
• Purely voxelwise,
• With voxel and cardinal definition,
• Mixing cardinal and voxelwise definitions.
Purely voxelwise
Average distance (AvDist) The average distance, mentioned by Datta et al. [99]
and Styner et al. [159] measures the average distance between the two lesion
outlines
AvDist(Ref,Seg) =
∑s∈∂Seg mins∈∂Seg d(s,r)+∑r∈∂Ref mins∈∂Seg d(s,r)
]v∂Seg+ ]v∂Ref
where ∂Seg (resp. ∂Re f ) denotes the border in the 18-neighbour connectiv-
ity of the Seg (resp. Ref) set. and d(s,r) is the Euclidean distance between
element s and r. It must be however noted the difficult definition of such an
assessment measure when one of the volumes is 0.
With voxel and cardinal definition
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True positive rate (TPR) The true positive rate (TPR) that can be defined either
at the voxel or cardinal level is expressed as
]TP
]Ref
and takes its values in [0 ;
1] with 1 as best value. With this measure, a perfect score at the voxel level
can be reached for a suboptimal segmentation if the errors are exclusively
false positives. In the cardinal form, the ratio becomes dependent of the
lesion spatial connectivity since joined lesion are only counted once.
False positive rate (FPR) The false positive rate, as the TPR expressed as a ra-
tion taking its values in [0 ; 1] (best value 0), can also be defined in its
voxelwise or cardinal version and is expressed as
]FP
]Seg
. Both the voxelwise
and the cardinal definition reach their limit when no false lesion is detected.
However, empty results are not defined for this measure.
False negative rate (FNR) The false negative rate, also taking its values in [0
; 1] (best value 0) is again to be defined voxelwise or cardinalwise and is
expressed as
]FN
]Ref
or 1−TPR.
It must be additionally noticed that the cardinal version of TPR and FPR, that
is using the number of connected lesions instead of the number of voxels, gives
a similar weight to the connected lesions independently of their volume. Thus
errors made on very small lesions, that are generally harder to detect will be em-
phasised, whereas massive errors in the outline of bigger lesions will be overseen.
Similarly to the volume difference problem, it must be noted that neither TPR nor
FPR are defined when the amount of ground truth lesions (]Ref) is 0. The DSC
detailed earlier can also be classified under this category.
Mixing voxel and cardinal definitions Recently, new inter-rater assessment mea-
sures with application to MS lesion segmentation have been developed. These
have shown to be less dependent than the DSC to the assessed lesion bur-
den [202].
Detection error (DE) The detection error is the volume of error measured car-
dinally and is expressed as
DE = ∑
F∈FPc
]vSegF + ∑
F∈FNc
]vRefF .
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Name Equation Best Range
DSC 100× 2](Ref∩Seg)]Ref+]Seg 100 (%) [0 ; 100]
VD 100×
∣∣∣1− ]Seg]Ref ∣∣∣ 0 (%) [0 ; ∞]
FPR ]Seg−](Ref∩Seg)]Ref 0(%) [0 ; 100]
TPR 100× ](Ref∩Seg)]Ref 100 (%) [0 ; 100]
FNR ]Ref−](Ref∩Seg)]Ref 0(%) [0 ; 100]
AvDist
∑
s∈∂Seg
min
r∈∂Ref
d(s,r)+ ∑
r∈∂Ref
min
s∈∂Seg
d(s,r)
]∂Ref+]∂Seg 0 (mm) [0 ; ∞]
DE ∑F∈FPc ]vSegF +∑F∈FNc ]vRefF 0 (mL) [0 ; ∞]
OER 100× ∑T∈TPc ]v(RefT∪SegT )−]v(RefT∩SegT )]vRef 0 (%) [0 ; ∞]
Table 5.3: Table of lesion segmentation evaluation measures.
Outline error rate (OER) The OER is measured as the ratio between the vol-
ume of voxelwise error found for the true positive components and the Ref
volume.
OER =
∑T∈TPc ]v(SegT ∪RefT )− ]v(SegT ∩RefT )
]vRef
.
Table 5.3 gathers the measures used for assessment in the BaMoS experiments in
comparison to other algorithms along with the best possible value obtained for each of
them. In order to better assess the origin of the errors, based on the definition by [202],
additional evaluation may be carried out:
OE/TotF Measures the proportion of total error (TotF) that is related to the outline
error.
FP/TotF Measures the proportion of error that is false positive.
OEFP/FP Measures among the false positives, the proportion that relates to the outline
error.
OEFN/FN Measures among the false negatives, the proportion that relates to the out-
line error.
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5.2.4 Consistency appraisement
Although they account for different aspects of the segmentation assessment, all the
previously presented measures rely on the existence of a reference segmentation. Gold
standard based assessments evaluate the algorithm’s ability to reproduce human be-
haviour rather than its true ability to detect abnormal biological signal. One should
thus be cautious when assessing an algorithm entirely based on manual segmentations
since the high inter- and intrarater variability may lead to inconsistencies in the refer-
ence with respect for instance to the intensities. FLAIR intensities standardised with
respect to the normal appearing WM (NAWM) also known as Z-scores can be used to
assess such intensity consistency. The FLAIR Z-score with respect to the WM inliers
for voxel n is defined as Z =
yFLAIRn −µFLAIRIWM
σFLAIRIWM
. In order to check intensity consistency,
the following evaluations can be introduced:
PropLes : Proportion of segmented lesion whose intensity Z-score range overlaps with
the one of the NAWM.
PropWM : Proportion of WM whose intensity Z-score range overlap with the one of
the segmented lesion
DistMin : Difference in Z-score between the minimal intensity segmented as lesion
and the maximal intensity considered as normal WM.
DistQuant : Difference in Z-score between the first quartile of intensity Z-score for
the lesion segmentation and the third quartile of the intensity Z-score for the WM
segmentation.
5.3 Data description
In order to investigate the behaviour of BaMoS in a large set of conditions and exper-
iments, different datasets were used and their main characteristics and strengths are
detailed in this section.
5.3.1 Brainweb
García-Lorenzo et al. [110], consider the use of synthetic data for the validation of
any lesion segmentation algorithm as an imperative step in any validation framework.
Publicly available, the MR simulated Brainweb brain images http://brainweb.
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bic.mni.mcgill.ca were used. This simulator allows for a model of MS lesions
at three different lesion loads (Mild, Moderate, Severe). The ground truth segmen-
tations are provided as maps of fuzzy membership. The simulator makes available 3
modalities (T1 T2 and PD) and allows for different level of noise and bias field inten-
sity. The validation was performed on all combinations of the modalities, at various
noise levels (3%, 5% and 7%) and at different strengths of intensity inhomogeneity
(0%, 20% and 40%) for the three available lesion loads (0.4 mL, 3.5 mL, 10.1 mL).
Since the quality of imaging data is very heterogenous, assessing the robustness of a
given method against the level of noise is an important validation step. The range of
noise between 3% and 7% (as defined in Brainweb) was found to be comparable to
the range of noise of 3T and 1.5T clinical scans, and was thus used for comparison.
The noise model in Brainweb consists in adding Gaussian white noise on both the real
and imaginary components of the image with a standard deviation chosen based on a
reference tissue signal such that the ratio between the standard deviation and the signal
is the percentage value of the noise model. The obtained noise on the magnitude image
thus follows a Rician distribution. As the signal for the reference tissue varies through
modalities, the observed effect of noise is also modality-dependent. For the binary
segmentation assessment, the ground truth maps were thresholded at 0.5. The main
strength of such synthetic data is the existence of an indisputable ground truth which is
not the case for any manual segmentation. It is complemented by the possibility to test
for various image quality conditions (noise and bias field).
5.3.2 T2DB (Type 2 diabetes)
Type 2 diabetes has been reported as a risk factor for the presence of WMH in ageing
populations [203]. For this study, brain images from Type 2 Diabetes patients and
matched controls with increased cardiovascular risk (age > 50) were acquired on a
3T Philips scanner. Multi-slice FLAIR images (0.958 × 0.958 × 3 mm3) and T1-
weighted 3D registered images were used. Further details about the acquisition and
preprocessing can be found at http://mrbrains13.isi.uu.nl. WMH were
manually segmented on twenty FLAIR images giving a total lesion load (TLL) range
between 0 mL and 35.48 mL (median 6.02 mL, interquartile range 9.22 mL) and used
as gold standard for the evaluation of the automated methods. No WMH was detected
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by the human rater for one of the twenty subjects.
5.3.3 MICCAI MS
The MICCAI MS Challenge 2008 (http://www.ia.unc.edu/MSseg/) dataset
was used to validate BaMoS for MS. For this dataset, 20 T1, T2 and FLAIR images
are provided along with the corresponding manual segmentations. All images are re-
sampled isotropically to the space of the T1 image. Comparison between methods
was performed using T1 and FLAIR images. This dataset is the only one dedicated to
MS and therefore allows for the study of an application apart from ageing population
WMH. Additionally manual segmentation of the lesions are available allowing for a
comparison across algorithms.
5.3.4 ADNI 92
Part of a starting study in the context of manual protocol segmentation evaluation, 92
datasets with T1 and FLAIR pulse sequence from the ADNI database were selected.
The ADNI (Alzheimer’s disease Neuroimaging Initiative) project was launched in 2003
as a public-private partnership, whose primary goal has been to test whether serial
magnetic resonance imaging, positron emission tomography (PET), other biological
markers, and clinical and neuropsychological assessment can be combined to measure
the progression of mild cognitive impairment (MCI) and early Alzheimer’s disease
(AD). Information about the study can be found at www.adni-info.org. Being
a multi-centre study, these 92 scans were acquired at eight different sites, spanning
three MR manufacturers. In the ADNI protocol, the T1 images are of resolution 1.19
× 1.0 × 1.0 mm3 and the FLAIR images are of resolution 0.89 × 0.89 mm2 in the
axial plane with 5 mm slice thickness. The main strengths of such a dataset are its
variability in terms of acquisition conditions for a given protocol and the large slice
thickness that allows for testing on low resolution images. Furthermore, volumes of
WMH, segmented according to [204] are made available online allowing for a partial
comparison.
5.3.5 POPPY
The data used came from 71 subjects scanned as part of the POPPY study that investi-
gates the relationship between HIV status, cardiovascular risk factors and neuroimag-
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ing findings. With a mean age of 58.5 years, this mixed population of HIV positive
and negative (54% HIV+) underwent brain MRI. Among the sequences, T1-weighted
and FLAIR images with both 2D Axial and 3D protocols were acquired. MR protocol
acquisition parameters with the resolutions and field of view (FOV) given in the order
Foot Head (FH), Anterior Posterior (AP) and Left Right (LR) in mm and the times in
ms were the following:
T1-weighted TR (repetition time) = 6.6 ms; TE (time to echo) = 3.1 ms; voxel size =
1.11 × 1.11 × 1.12 mm3; FOV = 270 ×253 × 203 mm3
FLAIR 2D (FLAIR2) TR = 8000 ms; TI (time at inversion pulse) = 2400 ms; TE =
125 ms; voxel size: 3.0 × 1.0 × 1.0 mm3; FOV = 240 × 180 × 150 mm3
FLAIR 3D (FLAIR3) TR = 4800 ms; TI = 1650 ms; TE = 282 ms; voxel size = 1.04
× 1.04 × 0.56 mm3; FOV = 250 × 267 × 180 mm3
The most important strength of this dataset is the joint availability of 2D and 3D FLAIR
images acquired during the same MR scanning session.
5.3.6 SABRE
This cohort study is based on a tri-ethnic population and aims to assess the risks of
diabetes and cardiovascular disease including small vessel disease in the brain [205].
All participants underwent MRI according to a standard protocol on a Philips Achieva
3.0-Tesla scanner. The series included the following imaging sequences:
T1-weighted 3D sagittal T1-weighted FFE (Fast Field Echo): TR = 6.9 ms; TE = 3.1
ms; voxel size = 1.0 × 1.0 × 1.0 mm3; FOV = 256 × 256 × 180 mm3
T2-weighted 3D sagittal T2-weighted TSE (Turbo spin echo): TR = 2500 ms; TE =
222 ms; voxel size = 1.0 × 1.0 × 1.0 mm3; FOV = 256 × 256 × 180 mm3
FLAIR sagittal 3D FLAIR (Fluid attenuated inversion recovery): TR = 4800 ms; TI =
1650 ms; TE = 125 ms; voxel size = 1.0 × 1.0 × 1.0 mm3; FOV = 256 × 256 ×
180 mm3
An imaging data comprising 84 participants was used with mean age 71.3 years
(SD=5.7). All images were reviewed for incidental pathology and scan quality. Two
participant’s scans were discarded from the analysis due to severe motion artefacts.
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5.4 Internal consistency validation
Generally an algorithm is built to answer specific questions or requirements and choices
of parameters or fixed inputs may strongly alter the results. As mentioned in Chapter
2, parameters such as discriminative thresholds can be tuned by cross-validation based
in the case of lesion segmentation on databases of manual segmentations. For instance,
Wang et al. [124] use this strategy for the choice of the trimming parameter while
Schmidt et al. [90] recommend it to decide on the initial threshold to apply on the
belief maps. When a few scalar parameters are involved [89, 113, 120], the space of
solutions is jointly optimised against databases of manual segmentations. Others have
investigated the influence of the choice of a given scalar parameter, fixing all the oth-
ers, on the robustness of their proposed solution. In such investigations as performed
by Van Leemput et al. [79] or García-Lorenzo et al. [101], the parameter of interest is
discretely sampled within a range and a new segmentation result is obtained for each
of them. If those parameter choices can be of paramount importance in the perfor-
mance of the given method, other aspects of the process appear also to affect greatly
the outcome. In methods requiring the normalisation of the intensities for comparison
purposes, Steenwijk et al. [118] present evidence that the initial choice of normalisation
strategy affects the results. Skull-striping strategies, initialisation choices with statis-
tical priors, registration methods and parameters are as many aspects, often indirectly
related to the core of the method and blamed for failure cases, whose impact is rarely
investigated despite its potential importance. Other considerations that may affect the
results are the reference space/discretisation in which the images are segmented or the
choice of pulse sequences whose influence is notably studied by Guizard et al. [112]
and Dyrby et al. [81]. As underlined in Section 2.6, the question of robustness beyond
the simplified question of noise level and bias field strength, as can be evaluated with
the Brainweb database (cf Section 5.3.1), can be studied under the perspective of clin-
ical trials. This implies the evaluation of the acquisition protocol influence as well as
the image resolution. The impact of the resolution on the segmentation results is for
instance evaluated by Schmidt et al. [90] using resliced images. Finally, postprocessing
strategies may further affect the final results. Comparisons of postprocessing solutions
are for instance performed by Steenwijk et al. [118] on the topic of the minimal lesion
size and in Gibson et al. [156] on the probabilistic threshold for the WM mask and the
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connectivity to the template.
In the case of the BaMoS framework, the list of potential sources of variability in
the outcome is long and investigating the joint space of such variations and their inter-
actions would prove intractable. Among the scalar parameters, choices of the outlier
initial probability map or energy choices in the MRF matrix come quickly to mind.
The choice for the convergence criteria or the weight attributed for the atlas relaxation
arise also naturally. At a secondary level, one may also want to investigate the im-
pact of the initialisation of the K-means algorithm in the initialisation of the splitting
of a uniform component. With respect to the outlier probabilistic priors, the choice of
the outlier probability threshold will lead to differences in the initial classification as
outlier used to build the subject-specific outlier atlas (cf Section 3.2.2). Moreover, it
must be noted that the classification as inlier or outlier is impacted differently for the
various anatomical tissues considered. At a stage where there is no constraint yet on
the covariance matrix, the change in inlier/outlier classification will be more important
in tissues for which the covariance matrix is larger and therefore display a flatter prob-
ability distributions such as the CSF. A variant in the building of the outlier atlas that
will be developed in Section 7.2 is to use typicality maps as defined by VanLeemput et
al. [79] so that such class-dependent outlierness assessment is avoided. A parameter is
also available to tune the conservatism of the outlier definition.
Regarding the values of the MRF energy matrix, lower values will offer more
flexibility in the segmentation, that may therefore appear noisier, while higher values
will contribute to a smoother segmentation to the expense of a loss in details. Further
tuning could involve a different weighting between tissues or even local choices of
energy matrix.
For the choice of the MRF energy matrix, a trade off must be found between the
spatial regularisation and the lack of detail. In order to behave similarly to the MRF
weighting of 0.15 used in the segmentation process of the VBM tool included in SPM8
and also by Ortiz et al. [206], the symmetric matrix H containing the neighbourhood
energy cliques for the MRF is defined as:
H(l jk, l
′
j′k′) =
 0 if j = j′0.15 otherwise
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Enforcing spatial consistency only at Level 2 of the hierarchical model should avoid the
smoothing of relatively small but very hyperintense lesions that will be detected thanks
to the inlier/outlier separation.
Different aspects of BaMoS behaviour are here investigated with respect to dif-
ferent potential modifiers. In Section 5.4.1, the impact of preprocessing choices are
evaluated using the ADNI92 dataset. Then, three models of evolution of BaMoS are
tested in the simulated cases as well as with the MICCAI MS and the T2DB datasets.
Generalisability issues with respect to choice of modalities are then presented in Sec-
tion 5.4.3 using the simulated Brainweb data and the SABRE dataset. The issue of
protocol MR acquisition and image resolution is examined in Section 5.4.4 using the
POPPY dataset. Finally the postprocessing stage and its influence on assessment re-
sults is discussed in Section 5.4.5. Such evaluations are indeed pivotal to understand
the degree of robustness of a given algorithm and assess the uncertainty related to mea-
surements according to the conditions of application.
5.4.1 Impact of preprocessing
In order to investigate the impact of preprocessing choices, three possible modifiers
were selected:
Segmentation space Since the model selection process uses different pulse sequences,
a common space must be chosen to perform the segmentation and images regis-
tered together. Although a manual segmentation is likely to be performed in the
native space of the FLAIR image, automatic methods are often applied in the T1
space to which the FLAIR image is registered. Indeed, the T1 image is generally
of higher resolution and may be used in a preprocessing step before consideration
of the FLAIR image. Note however that the impact of the registration parameters
is not investigated here.
Intracranial volume extraction In BaMoS, mask extraction methods may prove an
important aspect since it is the basis of the intensity normalisation. Additionally,
changes in the brain mask can contribute in different sources of potential false
positives and affect the post-processing if this one is based on distance to the
border of the mask.
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Statistical atlases Statistical atlases that hold a priori information on the anatomy are
inherent elements of the segmentation process. Naturally, the choice of such
information may affect the final outcome.
5.4.1.1 Experiments
For the masking strategy, two options (mentioned in Section 4.3.1) were considered: the
first consisted in applying morphological operations (dilation by 2 voxels, filling and
erosion by 1 voxel) on the brain delineation obtained as output of BrainMAPS [207]
while the second consisted in directly using the total intracranial mask obtained from
the pipeline based on the Geodesic Information Flow (GIF) method developed by Car-
doso et al. [198]. With respect to the statistical priors, the ICBM priors registered non-
rigidly [208] to the studied cases was compared to the tissue priors obtained as fusion
of propagated tissue segmentations through GIF. Figure 5.12 illustrates the differences
in masks and atlases.
GIF-TIV BrainMaps
GIF ICBM
Figure 5.12: The top row presents the masks used overlayed on the T1 weighted image pre-
sented on the left with the TIV obtained with GIF on the left and the morpho-
logically modified BrainMAPS on the right. The bottom row presents the GM
statistical atlases obtained with GIF on the left and the ICBM template on the
right.
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FLAIR to T1 T1 to FLAIR WMHU
GIF GIF-BM ICBM-BM ICBM GIF GIF-BM ICBM-BM ICBM
Mean 5.52 6.37 6.26 5.52 6.91 6.05 6.58 6.93 7.08
SD 6.06 6.59 6.33 6.07 7.39 6.5 6.97 7.28 7.73
Median 3.39 4.16 4.21 3.59 4.12 4.07 4.56 4.35 4.34
IQR [1.66 6.74] [1.75 7.87] [2.03 7.56] [1.53 6.56] [1.95 8.79] [1.58 7.72] [1.89 8.76] [2.20 8.26] [2.42 8.44]
Table 5.4: Volumetric measurements obtained in the different conditions of processing.
WMHU indicates the volumes reported online. All volumes are given in mL.
GIF-BM GIF ICBM-BM ICBM
T1toFLAIR
R2 0.89 0.92 0.87 0.93
Slope 0.79 0.92 0.84 0.91
Cons 0.46 0.46 0.66 0.54
FLAIRtoT1
R2 0.92 0.91 0.91 0.82
Slope 0.82 0.751 0.78 0.72
Cons 0.64 0.24 0.76 0.47
Table 5.5: Regression results obtained when comparing the different measures obtained to the
publicly reported WMH volumes.
BaMoS was performed on all combinations of space, masks and atlases resulting
in eight measurements for each of the 92 cases. Due to the skewness of the data,
Wilcoxon tests were used to compare the medians. Linear regression parameters were
also evaluated.
5.4.1.2 Results
Table 5.4 presents the summary of the volumetric measures for the different combina-
tion of processing choice. The choice of priors is indicated as ICBM or GIF while the
indicator BM is used when the BrainMAPS algorithm is used. Secondly, the regression
coefficients between the eight measurements and the measures reported online for the
WMH volumes are presented in Table 5.5. In turn, Table 5.6 summarises the com-
parisons between registration space for the four other parameter combinations. Lastly
the pairwise comparisons of the results obtained in both spaces between choice of sta-
tistical atlases and choice of intracranial volume definition is presented in Table 5.7.
GIF-BM GIF ICBM-BM ICBM
R2 0.93 0.93 0.83 0.82
Slope 0.98 0.79 0.83 0.75
Cons 0.45 0.05 0.80 0.29
p-value 0.12 <0.0001 0.7202 <0.0001
Table 5.6: Regression results for each set of parameter between the results obtained in the T1
space and the results obtained in the FLAIR space.The p-value refers to the compar-
ison in volumes using a paired Wilcoxon test.
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TIV Atlases Crossed
Comparison GIF-BM
GIF
ICBM
ICBM-BM
GIF-BM
ICBM-BM
ICBM
GIF
GIF-BM
ICBM
ICBM-BM
GIF
T1toFLAIR
R2 0.95 0.93 0.88 0.95 0.95 0.91
Slope 0.86 1.01 0.88 0.96 0.87 0.9
Cons 145 275 284 286 33 356
p-value <0.0001 0.006 0.11 0.55 <0.0001 0.0136
FLAIRtoT1
R2 0.96 0.87 0.95 0.88 0.86 0.95
Slope 1.07 0.89 1.01 0.94 1.00 1.02
Cons 478 -72 32 335 828 633
p-value <0.0001 0.0002 0.71 0.12 0.0001 <0.0001
Table 5.7: Comparison between WMH volume measurements when changing intracranial vol-
ume extraction method or statistical atlases.
Instead of building a common segmentation, consistency measurements as defined in
Section 5.2.4 are used to evaluate the delineations. These results are gathered in Table
5.8. Segmentation results appeared to be heterogenous in the infratentorial region and
an example of such variability is presented in Figure 5.13. In order to further highlight
the impact of the mask on the normalisation and its consequent effect on the lesion
segmentation, Figure 5.14 presents the segmentations and their overlap for each choice
of statistical atlas.
5.4.1.3 Discussion
Although it can be meaningful to investigate the absolute differences between measure-
ments performed under different tested and controlled conditions, these comparison do
not bring much information on whether or not it is possible to reliably trust one setting
of measurements or find reliable ways to compare it to measures performed under other
conditions. Such conversions are expressed in the results of linear regressions. Here,
FLAIR to T1 T1 to FLAIR
GIF GIF BM ICBM BM ICBM GIF GIF BM ICBM BM ICBM
PropWM
Mean 0.12 0.14 0.12 0.14 0.12 0.11 0.13 0.13
SD 0.03 0.03 0.04 0.04 0.03 0.03 0.04 0.11
Median 0.12 0.13 0.11 0.12 0.11 0.11 0.13 0.12
IQR [0.10 0.14] [0.11 0.16] [0.10 0.16] [0.10 0.17] [0.10 0.14] [0.10 0.13] [0.11 0.16] [0.10 0.15]
PropLesion
Mean 0.55 0.54 0.57 0.58 0.23 0.52 0.52 0.54
SD 0.03 0.03 0.04 0.04 0.03 0.03 0.04 0.11
Median 0.54 0.53 0.56 0.57 0.19 0.50 0.49 0.52
IQR [0.41 0.66] [0.42 0.66] [0.42 0.70] [0.46 0.70] [0.15 0.26] [0.40 0.63] [0.39 0.66] [0.40 0.69]
DistQuant
Mean 2.37 2.37 2.32 2.23 2.54 2.62 2.52 2.39
SD 0.50 0.50 0.58 0.48 0.50 0.46 0.49 0.87
Median 2.39 2.40 2.38 2.29 2.50 2.69 2.53 2.53
IQR [2.00 2.73] [2.05 2.69] [1.97 2.64] [2.00 2.55] [2.97 3.75] [2.97 3.36] [2.88 4.07] [2.90 3.65]
Table 5.8: For each of the preprocessing combination, the statistical results of the consistency
measurements are summarised.
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FLAIR Mask overlap
GIF GIF BM ICBM BM ICBM
Figure 5.13: On the top row, the FLAIR image on the left and the overlapped masks are pre-
sented. In red the TIV mask obtained through GIF and in purple blue the mask
obtained after morphological operations on the BrainMaps results. On the bot-
tom row are presented the four segmentations according to choices of atlases and
masks.
the following conclusions can be drawn from the combinations of the three choices.
With respect to the space of reference, a high correlation (R2=0.93) was observed
when using GIF atlases whereas the use of ICBM atlases led to a slightly reduced
value (R2=0.83). Furthermore, the volume detected in the FLAIR space was higher
than when segmented in the T1 space and this difference was significant when using
the TIV directly obtained with GIF. This difference could be partly related to the lower
resolution of the FLAIR images for which each individual voxel corresponds to a larger
volume. Additionally, the results for the difference between the third quartile of the
healthy white matter and the first quartile of the lesion distribution appeared to be higher
when segmenting in the FLAIR space than in the T1 space in all other considered
conditions. Reasons for such a systematic difference may implicate the influence of
partial voluming introduced when resampling the 2D FLAIR image onto the higher
resolution isotropic T1 image thereby producing fuzzier lesion boundaries. As exposed
on Figure 5.14, most of the difference across masks and prior choices occurred at the
border of lesions. It must also be noted that the space of reference especially when
associated to a change in resolution may also affect the masks and statistical priors
themselves. For both ICBM and GIF priors, the application of morphological changes
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FLAIR Mask overlap
GIF TIV BrainMaps Combined
ICBM
GIF
Figure 5.14: On the top row, the FLAIR image and the overlapped masks are presented. Again,
the TIV mask in red encompass all the blue brainmask morphologically transform
from the BrainMaps output. The middle row presents the segmentations obtained
for each mask when applying the ICBM priors and their combination while the
bottom presents the segmentations when the priors obtained through GIF are used.
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on the BrainMAPS output led to a stronger additive bias than when using the TIV
output of GIF.
When studying the pairwise comparisons within each reference space, one can ob-
serve that when using GIF atlases, the strategy of TIV extraction affected significantly
the volume obtained but the correlation was very high (R2=0.95 and 0.96 according to
the segmentation space), thus reflecting directly the variation in intensity normalisation
mentioned earlier. The choice of the atlases appeared to have a different impact ac-
cording to TIV extraction method and segmentation space chosen. The impact of the
choice of priors was made visible through the variability of the consistency measures;
in all cases the standard deviation of the measures were higher when using the ICBM
atlases compared to the GIF tissue priors. Such difference could be interpreted as the
consequence of the sharpness of the used atlases in the case of GIF, potentially reducing
the variation due to registration issues that may occur with varying anatomies.
Using as a reference the volumes of WMH reported online, the GIF statistical at-
lases appeared to yield higher correlations. Caution must however be applied when
using such reference volumes since they can themselves be subject to errors and per-
formance variability.
5.4.2 Impact of model evolution
5.4.2.1 Experiments
In order to assess the impact of the model selection process and the importance of the
model’s adaptability, BaMoS was compared to two simpler versions of itself in which
the automatic selection of lesion is implemented. The following variants of BaMoS
were used for comparison: the first one, called BaMoS-static consists in the static so-
lution obtained without allowing for a change in the number of model components, i.e.
performing the first initial EM, the atlas adaptation and a final EM refinement. The
second simpler version of BaMoS, denoted BaMoS-NoCov is the one detailed in the
work presented at the MICCAI 2014 conference [196], i.e. without any constraint on
the covariances. Finally the final version of BaMoS is simply denoted BaMoS. Both
the simulated Brainweb data and the T2DB dataset were used to assess the performance
of the three versions.
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Assessment method
DSC VD FPR TPR FNR AvDist DE OER
M
ild
BaMoS-NoCov 36.9 94.3 62.9 44.2 55.8 8.3 84.3 101.7
BaMoS 51.4 46.4 44.9 52.0 48.0 2.7 40.9 86.5
BaMoS-static 48.6 43.1 25.6 42.9 57.1 4.5 45.8 74.5
M
od
er
at
e BaMoS-NoCov 55.7 75.3 91.6 72.1 27.9 1.3 507.6 104.8
BaMoS 70.2 22.9 33.6 72.8 27.2 0.8 173.9 55.3
BaMoS-static 65.0 33.9 20.8 60.2 39.8 1.3 309.2 51.3
Se
ve
re BaMoS-NoCov 77.2 37.5 46.3 91.2 8.8 0.5 71.6 54.3
BaMoS 81.2 23.2 32.6 90.5 9.5 0.4 33.6 41.7
BaMoS-static 79.7 20.1 16.4 77.9 22.1 0.4 50.1 38.0
Table 5.9: Comparison for the different assessment measures of the segmentation method for
the T1T2 combination modality. The results are taken as the mean over all level
noise and IIH at the three different lesion loads.
5.4.2.2 Results on simulated data
The various lesion segmentation assessment measures for T1/T2 input data are gathered
in Table 5.9 across noise and IIH level and for each lesion load.
The robustness to the noise level for the different lesion loads is presented us-
ing the DSC in Figure 5.15 for which the methods are applied on the T1T2 modality
combination.
At each noise level, the errorbars present the minimum and maximum result ob-
tained when varying the intensity inhomogeneity level from 0 to 40% by steps of 20%.
Table 5.10 congregates the assessments at various noise levels, supporting the no-
tion that BaMoS is robust to this effect.
When increasing the noise level, a decrease in FP was observed. As shown by the
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Figure 5.15: Comparison of DSC results for the automated methods with noise level variation
at mild (left), moderate (middle) and severe (right) lesion load. The errorbars refer
to the minimum and maximum obtained when varying the intensity inhomogene-
ity level.
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Load Noise DSC VD FPR TPR FNR AvDist DE OER
M
ild
3 56.8 64.9 54.3 75.4 24.6 1.3 42.7 108.4
5 54.9 17.7 39.1 50.0 50.0 2.1 32.0 77.5
7 42.6 56.6 29.7 30.5 69.5 4.7 48.0 73.7
Mean 51.4 46.4 41.1 52.0 48.0 2.7 40.9 86.5
M
od
er
at
e 3 75.3 10.3 28.2 79.2 20.8 0.5 44.0 50.1
5 70.5 33.5 38.3 82.3 17.7 0.6 59.3 66.9
7 64.8 24.9 24.3 56.8 43.2 1.4 418.3 49.1
Mean 70.2 22.9 30.3 72.8 27.2 0.8 173.9 55.3
Se
ve
re
3 81.9 28.7 27.2 93.7 6.3 0.4 45.3 40.9
5 79.9 34.6 30.3 93.7 6.3 0.4 30.0 46.8
7 81.7 6.2 20.7 84.2 15.8 0.4 25.3 37.4
Mean 81.2 23.2 26.1 90.5 9.5 0.4 33.6 41.7
Table 5.10: Assessment of BaMoS for various measures at different noise level and lesion load
for the T1T2 modality combination (mean over various intensity inhomogeneity
levels). AvDist is given in mm, DE in µL and all other measures in %.
related changes in DE and OER, misdetection of lesions increased only for the change
between 5 and 7% noise on the moderate case. The number of subclasses necessary
to model the data was negatively correlated with the noise level, as the wider class
variance makes it hard to justify the need to use more Gaussian classes under the BIC
model.
5.4.2.3 Results on clinical data
On the MICCAI MS dataset, when comparing the three versions of BaMoS, the only
significant differences observed were related to the DSC and the TPR for which BaMoS
performed significantly better than BaMoS-static.
The comparison between the three versions of BaMoS on the T2DB dataset, is
presented in Figure 5.16. The apparently surprising observation that BaMoS-static did
not contain any DSC of 0 is caused mostly by the fact that the lesion segmentation is
performed on a voxelwise basis for this method. The only DSC of value 0 observed
for BaMoS corresponds to the case where only 24 voxels were manually segmented
as lesion. Overall, BaMoS performed significantly better than BaMoS-static for global
assessment measures (DSC, VD, TPR) but no significant difference was observed for
the Average distance, DE and OER. BaMoS-NoCov performed significantly better than
BaMoS-static for VD, TPR but not for DSC. BaMoS-static performed significantly
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Figure 5.16: Comparison of the three versions of BaMoS in terms of DSC, FPR and TPR. Note
the existence of low outliers for the DSC in the BaMoS-NoCov version. The only
outlier for BaMoS corresponds to the case with only 0.06 mL of lesion.
better in terms of FPR compared to BaMoS and BaMoS-NoCov but this observation is
directly linked to the low TPR. The seeming discrepancy in results showing a higher
median for DSC and TPR of BaMoS-NoCov compared to BaMoS, but a significant
improvement of the DSC results of only BaMoS over BaMoS-static is related to the
presence of outliers in the results of BaMoS-NoCov. This outlines the positive impact
on the robustness of the method when including the prior over the covariance.
5.4.2.4 Discussion
Comparing three versions of the proposed methodology: BaMoS-static, BaMoS-
NoCov and BaMoS in its full version, BaMoS was observed to be more robust to IIH
than BaMoS-NoCov and more robust to noise than both BaMoS-static and BaMoS-
NoCov. BaMoS-static appeared to perform reasonably well as the Brainweb data can
be modelled by a limited number of Gaussian components. However, the TPR was
clearly lower for BaMoS-static than for the other BaMoS versions. The constraint over
the covariance matrix for the lesions contributed to promote smaller covariances and
thus encourage a more detailed characterisation of difference in levels of lesion sever-
ity and partial volume effect.
When comparing the subversions of BaMoS for the clinical data with the eight
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different assessment measures presented in Table 5.3, the static version of BaMoS ap-
peared to be less sensitive to the presence of lesion. BaMoS performed significantly
better than BaMoS-static in terms of DSC for both clinical datasets. This tends to illus-
trate the improvements brought by the use of a higher number of Gaussian components
in the data modelling. In turn, despite performing marginally worse than BaMoS-
NoCov in terms of median (BaMoS 42.6% vs BaMoS-NoCov 53.2%), BaMoS was
found to be more stable as shown in Figure 5.16 (illustrated by a higher mean BaMoS
46.2% vs BaMoS-NoCov 45.2% ). The lower sensitivity to lesion in BaMoS-static ex-
pressed itself both in terms of a significantly lower TPR and a significantly better FPR
when compared to BaMoS and BaMoS-NoCov for the T2DB dataset. The higher ro-
bustness of BaMoS compared to BaMoS-NoCov was further exemplified in the case of
the clinical MS dataset for which significant differences between subversions was only
observed for BaMoS which performed significantly better than BaMoS-static in terms
of DSC, FNR and TPR.
5.4.3 Impact of available modalities
5.4.3.1 Simulated data
Applied to the Brainweb data, the graphs in Figure 5.17 show the impact of the noise
level on the result for BaMoS at various lesion loads for the different modality com-
binations, while Table 5.11 gathers the mean DSC across noise and IIH level for the
compared versions performed on those combinations.
3 5 7
0
10
20
30
40
50
60
70
80
90
100
Noise level (%)
D
SC
 (%
)
Mild lesion load
 
 
T1PD
T1T2
T1T2PD
T2PD
3 5 7
0
10
20
30
40
50
60
70
80
90
100
Noise level (%)
D
SC
 (%
)
Moderate lesion load
 
 
T1PD
T1T2
T1T2PD
T2PD
3 5 7
0
10
20
30
40
50
60
70
80
90
100
Noise level (%)
D
SC
 (%
)
Severe lesion load
 
 
T1PD
T1T2
T1T2PD
T2PD
Figure 5.17: Comparison of the DSC results for BaMoS at different noise levels for different
modalities combinations for mild (a), moderate (b) and severe (c) lesion load.
The errorbars indicate the minimum and maximum obtained when varying the
IIH level.
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Modality combination
Load Method T1PD T1T2 T1T2PD T2PD
M
ild
BaMoS-NoCov 10.3 36.9 35.8 17.9
BaMoS 11.1 51.4 47.5 18.0
BaMoS-static 10.0 48.6 40.9 16.7
M
od
er
at
e BaMoS-NoCov 29.1 55.7 56.7 28.4
BaMoS 27.5 70.2 63.5 29.3
BaMoS-static 23.8 65.0 59.9 32.2
Se
ve
re BaMoS-NoCov 40.0 77.2 72.3 60.6
BaMoS 42.2 81.2 77.3 60.2
BaMoS-static 32.8 79.7 77.8 57.9
Table 5.11: Mean DSC (%) over noise and IIH level for the different modality combinations
across the different lesion loads for the three compared versions of BaMoS.
5.4.3.2 Clinical data
In this experiment about the behaviour of BaMoS in various conditions of modality
choice, the effect of the inclusion of the information coming from a T2-weighted image
was investigated applying this time BaMoS to the SABRE dataset described in Section
5.3. In BaMoS, when presenting from the start three modalities, the high degree of free-
dom in the evolution may lead to biologically implausible models. In order to constrain
the model evolution, a third modality is incorporated sequentially to the model: after
an initial optimisation for two modalities, the obtained model is used as initialisation
point when including the third modality. Alternatively, one may have further enforce
the shape of covariance matrices or derive tissue-specific complexity criteria but these
avenues were not investigated.
In a first stage, the segmentations obtained with 2 (T1FLAIR) and 3 modalities
(T1FLAIR + T2) are compared. Secondly, the order in which the modalities are incor-
porated (T1FLAIR + T2) or (T1T2 + FLAIR) is evaluated. As in the previous section,
volumetric linear regressions are performed on the log-transformed data. The segmen-
tation comparisons were performed using the T1FLAIR+T2 segmentation as reference.
The total volumes detected in the three tested cases are presented in Table 5.12.
With respect to the inclusion or not of the T2 modality, the raw linear regression
over total lesion volumes led to a R2 value of 0.97 while the R2 on log-transformed
volumes was of 0.88. The plot of the linear regression on the log-transformed volumes
is presented in Figure 5.18 left while the relationship between DSC and volumes of
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T1T2+FLAIR T1FLAIR+T2 T1FLAIR
Mean 3.42 3.87 3.83
SD 4.30 4.72 4.72
Range [0.32 21.84] [0.38 25.28] [0.13 24.28]
Median 1.38 1.71 2.17
IQR [0.75 4.46] [0.83 4.61] [0.75 4.72]
Table 5.12: Statistics of volumes for the different modality choices. All volumes are presented
in mL.
WMH is displayed in Figure 5.18 right.
An illustration of the discrepancies between the two segmentations in the frontal
areas is presented in Figure 5.19.
When comparing the order of modality inclusion, the R2 of the regression between
global volumes was of 0.97 and the one on the log-transformed volumes of 0.87. The
linear regression between log-transformed volumes is plotted in Figure 5.20 left and
the relationship between DSC and volumes in Figure 5.20 right.
Periventricular frontal areas were more prone to disagreements between segmen-
tations. These regions do have high priors to belong to GM due to their proximity to
basal ganglia regions and voxels with a limited outlierness may or not be classified as
lesions. But it is mostly in the infratentorial regions, regions for which the FLAIR ac-
quisition is known to provide less reliable signal, that more WMH are detected when
using the FLAIR image first. Such a behaviour is exposed in Figure 5.21.
As for the measures of similarities, Table 5.13 summarises the statistics for the
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Figure 5.18: Left) Global log-transformed volumetric linear regression between T1FLAIR
and T1FLAIRT2 segmentations Right) Relationship between DSC using the
T1FLAIR+T2 as reference and the WMH volumes of this reference segmenta-
tion.
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T2 FLAIR Reference Difference
Figure 5.19: Example of discrepancies of segmentation in the frontal areas when using 2 or 3
modalities. The reference segmentation is the one using T1FLAIR+T2 modalities
while the difference is obtained by (T1FLAIR)-(T1FLAIR+T2). The blue voxels
correspond to the false negatives with respect to the reference image i.e the voxels
considered as lesion when using the three modalities but not when using only T1
and FLAIR while red voxels are the false positives.
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Figure 5.20: Left) Global log-transformed volumetric linear regression between T1FLAIR+T2
and T1T2+FLAIR segmentations. Right) Relationship between DSC of the
T1T2+FLAIR segmentation compared to the T1FLAIR+T2 segmentation and the
volume of the T1FLAIR+T2 segmentation.
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DSC AvDist TPR FPR OEFP/FP OEFN/FN OE/TotF FP/TotF
T1FLAIR
Mean 65.5 1.98 66.1 47.3 70.7 65.2 67.3 47.3
SD 17.3 1.91 19.4 20.8 13.0 17.8 14.5 20.8
Range [19.6 93] [0.19 8.99] [12.2 92.1] [2.3 87.5] [19.4 90.6] [23 90.8] [34.3 88.9] [2.3 87.5]
Median 71.6 1.20 71.4 48.8 71.9 70.6 70.3 48.8
IQR [52.7 77.9] [0.63 2.93] [54.3 81] [31.8 63.9] [64.1 81.1] [47.5 79] [56.1 79.8] [31.8 63.9]
T1T2+FLAIR
Mean 72.2 1.86 69.8 20.2 66.4 57.8 62.5 35.7
SD 18.6 1.88 21.4 18.3 15.9 19.2 15.9 25.9
Range [25.4 96.3] [0.1 8.76] [18.3 97.5] [0.6 68.9] [36.2 93.6] [12.3 87.1] [29.1 86.4] [1.4 93.4]
Median 76.8 1.21 75.4 14.1 68.2 60.8 64.0 29.1
IQR [58.6 88.7] [0.45 2.62] [58.4 87.8] [4.5 30.6] [52.7 79.3] [40.3 73.6] [47.9 76.1] [13.2 57.0]
Table 5.13: Summary of the similarity metrics and origin of errors when comparing the choice
and the order of the chosen modalities. AvDist is given in mm while all other
measures are given in %.
different comparison assessments taking as reference the segmentation obtained using
T1FLAIR+T2 modalities.
With a mean DSC above 65% in both situations, the agreement between segmen-
tations can be judged as excellent. In both cases, most of the differences reflected a
disagreement in the definition of the lesion borders with an outline error percentage of
67.4 when using only T1FLAIR and 62.5 when employing the T2 modality first.
5.4.3.3 Discussion
The very strong correlation (R2=0.97 on raw volumes, 0.88 on log-transformed vol-
umes) between volumetric assessment of lesion when using T1, FLAIR and T2 or not
shows the stability of the algorithm when complementing the data information with an
additional modality. This strong agreement is reassuring in two ways. First it shows
the consistency in the extracted information and second it provides a reliable way of
transferring a measurement performed with one set of modalities to another. The dis-
agreement was concentrated in regions where tissues with intensities close to the nor-
mal GM are likely to occur and may or not provide the satisfactory criteria to contribute
T2 FLAIR T1T2+FLAIR T1FLAIR+T2
Figure 5.21: Illustration of differences in segmentation according to the order in which modal-
ities are considered for the infratentorial regions. The slight hyperintensities in
the FLAIR image are classified as lesion when using the FLAIR (T1FLAIR+T2)
before the T2 modality (T1T2+FLAIR).
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to the initial outlier maps such as the periventricular frontal regions. A slight shift in the
model parameters due to the inclusion of the T2 modality may then transform slightly
the GM inlier/outlier separation in those regions for which GM priors are usually high.
The use of three modalities contributes to a higher volume of WMH detection in those
areas. In contrast, more WMH is detected in the mid zone of the frontal region when
using only two modalities. Knowing that most of the FP are coming from the outline
of the lesions (71%), this can be explained by the fact that FLAIR images tend to over-
estimate the extent of lesions compared to T2 images. The excellent overall agreement
between results using two (T1FLAIR) or three (T1FLAIR+T2) modalities guarantees
that if the T2 modality is missing from one dataset, this one can still be processed and
the resultant WMH segmentation used with confidence. Regarding the order in which
the modalities are introduced, performing first the model optimisation on the T1T2 cou-
ple before incorporating the FLAIR or including the FLAIR modality first also led to a
strong agreement between results both on raw (R2=0.97) and on log-transformed vol-
umes (R2=0.87). Frontal periventricular and infratentorial regions appeared as before
to be more prone to disagreements than other brain areas.
5.4.4 Impact of acquisition resolution
5.4.4.1 Experiment
Using the POPPY dataset, the lesion segmentation was performed for each subject
using T1 and the 2D FLAIR (FLAIR2) images and the T1-weighted and the 3D ac-
quired FLAIR (FLAIR3) images. In order to understand relationship and differences,
linear regressions between extracted volumes of lesions were performed. Additionally,
the two segmentations were compared to examine the source of differences using the
FLAIR3 segmentation as reference.
5.4.4.2 Results
The lesion volumes segmented using the 2D acquisition led to a median volume of
2.09 mL (IQR =[1.28 3.49]) ranging from 0.19 to 3.24 mL while the 3D acquisition
had a median of 0.84 mL (IQR=[0.37 1.91]) with a range from 0.13 to 2.17 mL . Given
the high skewness of the data, regressions and correlations were estimated on the log-
transformed data. The overall R2 between the two obtained volumes was of 0.70 for the
log-transformed data and 0.94 for the raw data. Figure 5.22 left displays the regression
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Figure 5.22: Left) Linear regression between log-transformed WMH volumes segmented on
2D and 3D acquired FLAIR images. Right) Relationship between DSC and vol-
ume of FLAIR 3 segmentation.
between log-volumes and Figure 5.22 right the relationship between DSC and volumes.
As far as similarity measures are concerned, the DSC followed the pattern with
large variability for low volumes with commonly lower values and a plateauing effect
at larger volumes as illustrated in Figure 5.22 right. Due to the very low volume of
WMH in this dataset and the known relationship between the accuracy measure and
the lesion volume, the DSC and TPR appear to be lower than normal as presented in
Table 5.14.
Upon visual inspection of the areas of greatest difference, multiple explanations
can be put forward: compared to the 3D acquisition, FLAIR2 images presented more
artefacts around the fourth ventricle and the Sylvian aqueduct which despite the false
positive correction step resulted in the observed segmentation difference in the posterior
fossa. This observation is in accordance with reports of the reduction of artefacts in
this area in 3D acquired FLAIR compared to 2D images [160, 161, 209]. Figure 5.23
presents the comparison of data and lesion segmentation for such artefacts.
DSC AvDist TPR FPR OEFP/FP OEFN/FN OE/TotF
Mean 27.8 6.07 46.3 77.8 54.1 60.3 55.4
SD 17.5 3.80 18.6 16.5 19.8 14.2 17.6
Range [2.1 73.8] [0.69 18.09] [8.0 89.2] [2.9 98.8] [7.2 97.3] [30.8 84] [10.5 94.9]
Median 22.0 5.54 44.9 83.0 51.9 61.0 54.0
IQR [13.7 37.9] [2.98 7.83] [31.2 60.0] [70.5 90.4] [40.9 65.2] [49.6 71.9] [43.6 68.0]
Table 5.14: Comparison assessments between segmentations taking the FLAIR3 as reference.
AvDist is given in mm and all other measures in %.
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2D FLAIR Lesion segmentation 3D FLAIR
Figure 5.23: Occurrence of flow artefacts with the 2D acquisition (left) segmented as lesion
(middle) and the corresponding 3D acquisition.
2D FLAIR Lesion segmentation 3D FLAIR
Figure 5.24: Occurrence of artefacts in the temporal lobe with the 2D acquisition (left) seg-
mented as lesion (middle) and the corresponding 3D acquisition.
Other types of artefacts may arise as shown in the temporal lobes in Figure 5.24.
However, 3D acquisition can also be prone to artefacts such as a strong bias field
that even corrected may prevent the detection of some lesions as presented in Figure
5.25.
Additionally, close to vessels, flow artefacts may appear in 2D acquisition pro-
ducing mimics of small lesions, whereas other small lesions about the size of the slice
thickness are blurred or invisible in 2D but well defined in the 3D acquisition. Exam-
ples of these two situations are presented in Figure 5.26.
When comparing the two acquisition protocols, the lesions acquired in a 2D man-
ner appeared fuzzier with smoother and more extended boundaries. Due to the variation
in pulse sequence and acquisition parameters, contrast between tissues varied from one
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acquisition to the other. In this example, the contrast between GM and WM appeared
stronger in the 3D than the 2D acquisition while the contrast between lesions and GM
seemed stronger in the 2D acquisition. As a consequence, the normalisation of intensi-
ties is also altered and the behaviour of the algorithm is affected in its decision on the
level of outlierness of the tissues. The impact on lesion segmentation is presented in
Figure 5.27.
Such differences in classification are most important in regions in which the a
priori probability to belong to GM is high as may occur close to the ventricles or in the
occipital region. To be classified as outlier, the voxels have then mostly to be outliers
to the GM distribution and not only to the WM.
5.4.4.3 Discussion
In this experiment, a good agreement was observed between log-transformed total le-
sion volume obtained by segmentation of 2D or 3D acquired FLAIR images registered
in the space of an isotropic T1-weighted image with a R2 regression coefficient of 0.7.
Compared to the evaluations performed in Schmidt et al [90] in which the 3D FLAIR
images were downsampled to simulate images with larger slice thickness, differences
in scanning protocol led to noticeable changes in image appearance with tissue con-
trast differences and occurrence of different types of artefacts. If most of the flow and
Initial image Bias field corrected image Lesion segmentation
2D
3D
Figure 5.25: Initial image (left), skull-stripped, log-transformed, normalised and bias field cor-
rected (middle) and resulting segmentation (right) for the 2D (top row) and 3D
(bottom row) acquisitions.
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2D FLAIR Segmentation on 2D FLAIR 3D FLAIR Segmentation on 3D FLAIR
Figure 5.26: On the three rows, the 2D (resp 3D) acquisition and resulting segmentation are
presented on the left (resp right) side of the figure. The top row presents the com-
plete slice while the middle row presents a case of artefact in the 2D acquisition
absent of the 3D and the bottom row zooms on a small lesion made invisible in
the 2D acquisition.
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2D FLAIR Segmentation on 2D FLAIR 3D FLAIR Segmentation on 3D FLAIR
Figure 5.27: Differences in segmentation due to change in contrast and blurriness with the 2D
(resp 3D) acquisition and the corresponding lesion segmentation on the left (resp.
right).
pulsation artefacts were present with greater strength in the 2D acquisition as reported
by Naganawa et al. [161] and Lummel et al. [160], the effect of the bias field appeared
stronger in some examples for the 3D acquisition and led to the misclassification of
lesions as normal tissues. Although highly correlated, the differences in contrast may
justify a different choice in tuning parameters across acquisitions. Practically, this re-
lates to the use of multi-centre data, accounting for scanner upgrade or changes in
protocol. Per site/acquisition covariates can be used to increase the number of mea-
surements, as volumes were found to correlate up to a linear correction factor. One
may also consider discarding local parts of the information in order to ensure a more
reliable correspondence. Such analyses would enable the use of complementary or lon-
gitudinal datasets in which clinical relationships could be better highlighted despite a
slight increase in measurement uncertainty.
5.4.5 Impact of postprocessing
In order to assess the importance of the postprocessing stage, BaMoS and its non cor-
rected version (BaMoS-nc) were performed on the T2DB and the obtained segmenta-
tions were assessed against the available manual segmentation. Figure 5.28 presents the
results comparison for the DSC, the TPR and the FPR. The stability in TPR supports
the appropriateness of the FP detection.
Despite the carefulness with which the FP detection detailed in Section 5.1.3 has
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Figure 5.28: Effect of the FP correction on BaMoS in terms of DSC, FPR and TPR. The cor-
rection reduces the FPR but does not affect the TPR. BaMoS-nc refers to the result
of BaMoS uncorrected for FP.
been made, remaining minor errors were observed in the cortical sheet. Additionally,
some FP were also found at the border of some lesions especially for hyperintensies on
the FLAIR modality presenting a certain hypointensity on the T1 image that were not
considered as lesion in the manual segmentation.
In many methods specially dedicated to the segmentation of white matter lesions,
a post processing step is needed to avoid taking into account the hyperintense voxels
due to flow artefacts in FLAIR images [94, 210] or voxels at the border between GM
and WM [119], or other types of false positives [125]. The FP correction in this work
is adapted according to the lesion selection rules. However, it must be underlined that
the false positive correction performed here is based on the connected components and
is not processed at a voxelwise level which may lead to discard or accept areas that are
a mixing of lesion and artefactual voxels.
5.5 External comparison
On top of all internal consistency assessments, the performance of BaMoS was also
compared to other families of algorithms in simulated cases using the Brainweb simu-
lated database, and two clinical datasets: MS pathology (MICCAI MS) and age-related
WMH (T2DB).
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5.5.1 Points of comparison
The competing automated algorithms for lesion segmentation were selected if
the corresponding software was available online and had minimal preprocess-
ing requirements (e.g skull-stripping). The first one was the classic EMS al-
gorithm [79] that belongs to the same family of methods as BaMoS and thus
enables a very similar set-up. The EMS code, available online (https://
mirc.uzleuven.be/MedicalImageComputing/downloads/ems.php?
EMSsection=download&pagePath=2) allows for a similar choice in the pa-
rameters (atlases, MRF), thus decreasing the comparison bias otherwise induced by
preprocessing and parameter choice. The default value of 3 for the Mahalanobis dis-
tance, noted to be the most suitable [79] and used for comparison by García-Lorenzo
et al. [110] was chosen in all experiments. As far as the MRF parameter choice is
concerned in this case, two points of comparison were chosen, one taking the same H
matrix defined for BaMoS (noted EMS-C in the following) and the default adaptive
MRF detailed by Van Leemput et al. [163] (noted EMS-D from now on).
The second algorithm, named Lesion Segmentation Tool (LST) and developed by
Schmidt et al. [90], is a toolbox of the SPM8 package and available online at
http://www.applied-statistics.de/LST_1.2.3.zip. Among the va-
riety of proposed method in the literature, this method has been validated both for
applications in the context of Multiple Sclerosis and age-related WMH with a differ-
ence on a single threshold parameter. According to [108], the default value of 0.30 is to
be chosen for MS applications (LST-MS) whereas the value of 0.25 is more appropriate
when applied to age-related WMH (LST-WMH).
The third comparison point was the Lesion-TOADS (TOADS) algorithm [78] part of
the MIPAV platform that belongs to the family of fuzzy methods but also corrects
for IIH within its scheme is also made available at http://www.nitrc.org/
projects/toads-cruise/.
5.5.2 Results
5.5.2.1 Brainweb simulated data
Similar measures to those assessed in Section 5.4.2 were evaluated for the external com-
parison. For the T1T2 modality, the various assessment measures across the different
5.5. External comparison 163
Assessment method
DSC VD FPR TPR FNR AvDist DE OER
M
ild
BaMoS 51.4 46.4 41.1 52.0 48.0 2.7 40.9 86.5
EMS-D 2.6 4851.6 98.7 58.3 41.7 40.0 13207.9 1063.9
EMS-C 10.7 724.3 93.9 49.1 50.9 37.4 2600.4 82.8
LST-WML 22.8 56.1 58.8 16.0 84.0 13.4 186.8 67.2
LST-MS 22.3 70.6 49.2 14.5 85.5 13.5 146.8 66.7
TOADS 0.8 983.8 99.5 4.9 95.1 24.9 4190.6 137.3
M
od
er
at
e
BaMoS 70.2 22.9 30.3 72.8 27.2 0.8 173.9 55.3
EMS-D 20.4 582.6 88.1 76.5 23.5 16.5 13197.8 188.0
EMS-C 44.9 91.8 65.4 67.0 33.0 15.8 2935.0 65.8
LST-WML 62.9 30.2 23.3 53.6 46.4 3.9 693.9 42.1
LST-MS 62.6 34.7 20.5 51.9 48.1 4.0 648.9 42.4
TOADS 15.0 64.2 87.8 19.9 80.1 7.8 1362.3 185.0
Se
ve
re
BaMoS 81.2 23.2 26.1 90.5 9.5 0.4 33.6 41.7
EMS-D 39.9 195.5 73.0 78.4 21.6 10.0 13105.7 88.7
EMS-C 64.1 42.0 41.9 74.1 25.9 8.7 2596.9 49.6
LST-WML 77.3 13.1 16.6 72.5 27.5 0.9 310.8 38.8
LST-MS 77.1 15.8 15.2 71.2 28.8 0.9 286.6 38.9
TOADS 64.6 6.1 33.3 62.6 37.4 2.1 838.2 60.6
Table 5.15: External comparison for the different assessment measures of the segmentation
method for the T1T2 combination modality. The results are taken as the mean over
all level noise and IIH at the three different lesion loads. AvDist is given in mm,
DE in µL and all other assessments in %.
methods at all lesion loads are assembled in Table 5.15.
In turn the behaviour with respect to noise level for the different measures is plot-
ted in Figure 5.29.
As in Section 5.4.3.1, the mean DSC over noise and IIH are calculated for the
different lesion loads and the various algorithms across the possible modality combi-
Mild lesion load Moderate lesion load Severe lesion load
Figure 5.29: Comparison of DSC results for the automated methods with noise level variation
at mild (left), moderate (middle) and severe (right) lesion load. The errorbars refer
to the minimum and maximum obtained when varying the intensity inhomogene-
ity level.
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Modality combination
Load Method T1PD T1T2 T1T2PD T2PD
M
ild
BaMoS 11.1 51.4 47.5 18.0
EMS-D 0.7 2.6 3.0 1.2
EMS-C 5.7 10.7 7.1 4.9
LST-WML 0.0 22.8 / /
LST-MS 0.0 22.3 / /
TOADS 0.8 0.8 / /
M
od
er
at
e
BaMoS 27.5 70.2 63.5 29.3
EMS-D 7.4 20.4 24.9 14.4
EMS-C 22.8 44.9 43.0 22.3
LST-WML 0.0 62.9 / /
LST-MS 0.0 62.6 / /
TOADS 14.0 15.0 / /
Se
ve
re
BaMoS 42.2 81.2 77.3 60.2
EMS-D 13.9 39.9 46.2 34.0
EMS-C 26.3 64.1 61.2 37.7
LST-WML 0.0 77.3 / /
LST-MS 0.0 77.1 / /
TOADS 65.1 64.6 / /
Table 5.16: Mean DSC (%) results over noise and IIH levels for the compared methods for
various modality combinations at the three lesion loads. The slash (/) sign indicates
that the combination was not possible to use for the given method.
nations and presented in Table 5.16.
As neither TOADS nor LST are able to handle the T1T2PD and T2PD combina-
tions, the results are not provided. The visual comparison between the segmentation
obtained for the automated methods (BaMoS, EMS-C, LST-MS and TOADS) is pre-
sented in Figure 5.30.
5.5.2.2 MICCAI MS data
Due to its low performance in the previous experiments, the results obtained for EMS-
D are not presented in the remaining of the figures. The suggested LST-MS parameter
(0.30) was used for the MS experiment and the LST-WML parameter (0.25) was used
for the WMH experiment.
Using the dataset from the MICCAI MS Challenge defined in Section 5.3, com-
parisons between methods were performed using T1 and FLAIR images. For the as-
sessment methods described in Table 5.3, statistical results are gathered in Figure 5.31
where each reference method (in rows), is compared against all other methods using all
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T1 T2 GS BaMoS EMS-C LST-MS TOADS
Figure 5.30: Simulated Brainweb multiple sclerosis model with severe lesion load case. Each
row displays in a different orientation (axial, coronal and sagittal) from left to right
the T1 image, the T2 image, the ground truth (GT) for the lesion segmentation and
the corresponding results for BaMoS, EMS-C, LST-MS and TOADS.
assessment measures.
In this infographic, green corresponds to a significantly better performance, grey to
a non statistically significant difference in performance and red to a significantly worse
performance. For each measure, the diagonals are kept white. For this dataset, BaMoS
and LST both appear to perform better than TOADS and EMS. Figure 5.32 presents an
example of the obtained segmentations for the different automated methods.
5.5.2.3 T2DB data
The comparison between the automated methods is summarised in terms of statistical
significance in Figure 5.33 showing that for this application, BaMoS outperformed
EMS and LST and performed similarly to TOADS.
Figure 5.31: Colour-coded statistical difference significance summary for each assessment
measure on the MS dataset, where each automated reference method: BaMoS
(B), EMS (E), LST (L) and TOADS (T) is tested against another method (col-
umn) for a specified assessment measure. Green relates to a significantly better
performance, Red to a significantly worse performance and Grey to a non statisti-
cally significant difference.
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T1 FLAIR GS BaMoS EMS-C LST-MS TOADS
Figure 5.32: Comparison of segmentation results for an MS patient. Each row displays in a
different orientation (axial, coronal and sagittal) from left to right the T1 image,
the FLAIR image, the gold standard (GS) for the lesion segmentation and the
corresponding results for BaMoS, EMS-C, LST-MS and TOADS.
Since the measure of global TLL has been related with cognitive decline, TLL cor-
relations between the automatic and manual segmentations were studied using both the
Pearson’s R2 correlation coefficient and the slope of the linear regression for the twenty
cases. The quantitative results for both lesion segmentation assessment measures and
TLL regression are presented in Table 5.17. In this table, the last line, corresponding
to the TLL linear regression is performed over the 20 subjects whereas all the other
assessments are summarised for subjects with a positive TLL. BaMoS slightly under-
estimated the lesion volume (linear coefficient of 0.88) but the correlation was high
when compared to the other methods (R2=0.96). The volumetric results are presented
visually in Figure 5.34.
Figure 5.33: Summary of statistical differences observed between the automated methods for
each assessment measure in a Green Grey Red code for the age-related WMH
dataset. Each method used as a reference (row) is compared to the other three
(column). Significantly better and worse performances for a specific assessment
are coded in green and red respectively. No statistically significant difference is
coded in grey. Diagonals stay white.
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Method BaMoS EMS-C LST-WML TOADS
DSC 46.2 27.92 30.9 52.1
26.5 18.77 25.0 17.6
VD 52.0 105.6 75.7 183.2
29.0 193.8 21.4 644.0
FPR 24.4 51.4 15.1 32.1
14.2 27.5 23.0 26.1
TPR 37.7 20.9 21.7 44.5
25.8 13.9 20.1 12.9
FNR 62.3 79.1 78.3 55.5
25.8 13.9 20.1 12.9
AvDist 6.8 7.7 10.2 3.8
11.6 5.6 12.4 6.9
DE 364 520 692 393
215 330 392 254
OER 52.7 69.2 49.7 86.1
23.4 15.8 0.7 100.2
R2 0.96 0.86 0.94 0.90
Slope 0.88 0.41 0.63 0.53
Table 5.17: Comparison of the different methods according to the various lesion segmentation
assessment measures for the T2DB dataset of 19 subjects with positive TLL. All
the measures are given in a two lines format with the mean on the first and the
standard deviation on the second. AvDist is given in mm, DE in µL. The last set of
lines gives the Pearson’s R2 correlation coefficient for the twenty subjects and the
corresponding linear coefficient (Slope).
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Figure 5.34: Left) Comparison of TLL per patient for the five automated methods against the
manual segmentation and Right) Bland-Altman plot of the automated methods
against the manual gold standard segmentation. The markers represent the twenty
cases from the T2DB dataset and the line the corresponding linear fit TLLauto -
TLLmanual.
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The Bland-Altman plot shows less bias for BaMoS. The plot of automated TLL
per patient ordered by increasing manually segmented TLL highlights a potential prob-
lem regarding lesion overestimation in TOADS for very mild cases. The analysis of the
errors observed in BaMoS with respect to the manual segmentation showed that 12%
of the FN corresponded to missed lesions, the rest being related to the outline of the
lesions (i.e. border disagreement). Among those missed lesions, 87% of this amount
corresponded to lesions with a volume lower than 0.1 mL. When comparing the num-
ber of missed lesions in the automated methods, no significant difference was observed
between BaMoS, EMS and TOADS, and all were able to detect significantly more le-
sions than LST. The periventricular region, known to be prone to partial volume effect
due to resampling and shining through effects on the ventricular lining was the most
prone to FN outline errors. In turn, false positives, that represent 20% of the errors
occurred 65% of the time at the outline of lesions. For the erroneously detected FP
lesions, 66% of the volume corresponded to lesions of less than 0.1mL. Those FP le-
sions were mostly located close to the ventricular lining. Thanks to the BIC constraint,
the number of subclasses observed for the inlier classes was stable across the clinical
dataset.
5.5.3 Discussion
With respect to the simulated data, compared to the other three families of methods,
BaMoS appeared more robust to noise, especially compared to TOADS and EMS, a
feature that is particularly important for milder cases of lesion load. Naturally, the
number of Gaussian components needed to model the lesions decreased with an in-
crease in the noise level. BaMoS was reasonably stable when presented with different
combinations of modalities and when compared to the other automated techniques that
are optimised towards specific combinations. This can be of real interest when con-
sidering clinical studies for which some imaging modalities might not be available for
certain subjects. Further investigation would be needed to better understand the bio-
logical correlates between various modalities and observed signal as well as the direct
impact on lesion detection and segmentation.
In the age-related WMH dataset, R2 of the linear regression between volumes
was 0.96 for BaMoS compared to 0.88 for EMS-C, 0.94 for LST-WML and 0.90
5.5. External comparison 169
for TOADS. As mentioned in Section 5.2.1, the TLL is however insuficient in char-
acterising the segmentation accuracy, lesion shape, localisation accuracy and over-
lap [50, 90, 157]. In order to better understand the origin of the segmentation errors,
the eight segmentation evaluation measures defined in Table 5.3 were used to assess
the automated segmentations. BaMoS obtained comparable, and many times improved
results when compared to automated methods in both MS and age-related WMH con-
texts with a tendency to slightly underestimate the lesion volume. However, BaMoS
had consistently good results when compared to the heterogeneous performance of
competing methods.
An extensive comparison of the automatic results provided by BaMoS with the
manual segmentation used as ground truth for the T2DB data showed a pattern in the
occurrence of false negatives (FN). The corresponding voxels were usually classified
as inliers of the GM or as CSF outliers. Three main types of FN can be distinguished:
Periventricular GM false negatives These FN elements are located in the periven-
tricular regions, at locations where the WMH are similar in appearance to GM
and where, due to the existence of DGM structures, the anatomical statistical at-
lases can further support the classification under the GM label. The presence of
these FN is further explained by the fact that this area is particularly prone to
partial volume effect due to image resampling.
Periventricular CSF false negatives These FN elements are located in the periven-
tricular regions, mostly at the horns of the ventricles regions in which the cor-
responding CSF statistical atlas is higher than the WM one, thus enforcing the
classification of the corresponding lesions as outliers spatially related to CSF.
They are undetected if the CSF outliers are discarded in the lesion selection pro-
cess.
Subcortical false negatives These FN elements are located near the cortical sheet and
are generally undetected due to their level of hyperintensity combined with the
high support of the statistical atlas for GM that do not allow to separate them
from GM inliers.
Outline false negatives These FN elements are located at the border of segmented
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lesions and are generally classified as WM inliers. Their level of hyper-intensity
is lower compared to the local TP and in most of the cases, the corresponding T1
values are isointense compared to the WM inliers.
5.6 Consistency based validation
When focusing on the provided manual segmentations, some intensity discrepancies
were observed in the classification as lesion or not especially at the lesion boundaries.
The partial inclusion of the ventricles in the lesion delineation contributed for instnace
to the accumulation of FN findings while as mentioned in Section 5.4.5 at the border of
the lesions, slightly hyperintense FLAIR voxels that presented T1 hypointensity were
in turn not considered as belonging to the lesion. Such observations led to the need for
a test of the manual segmentation in terms of intensity consistency.
5.6.1 Sources of segmentation inconsistency
With this analysis of the DSC, the investigation of the origin of possible false negatives
in BaMoS as presented in Section 5.5.2 showed that the undetected regions were mostly
small lesions of less than 0.01 mL. Lesion segmentation accurracy was also found to be
negatively correlated with the proportion lesion voxels with WM-like intensities. This
observation relates strongly to the segmentation protocol defined by Filippi et al. [211]
for the segmentation of MS lesions in which a conservative segmentation of lesions
promoting false negatives over false positives for mildly hyperintense regions is en-
couraged to enable the observation of change over time.
Based on the T2DB dataset (ageing population with diabetes and/or cardiovascular risk)
presenting WMH for which the data provided was already corrected for intensity inho-
mogeneities, the intensity distribution of the segmented WM was compared to that of
the manually segmented lesions. This intensity-based assessment appears easier to per-
form on an age-related dataset than on an MS dataset on which iso/hypointense FLAIR
regions surrounded by an hyperintense rim are considered as lesions [211].
The white matter segmentation used as reference for the distribution of normal in-
tensities was obtained as the intersection of the resultant WM obtained for the four
automated methods and further corrected to retrieve any voxel considered in the man-
ual lesion segmentation. Since in MRI the absolute signal value is not quantitative,
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Figure 5.35: Compared Z-score distribution of manually segmented lesion and WM with re-
spect to WM on the FLAIR modality.
Z-scores and Mahalanobis distances with respect to the mean of the WM were em-
ployed to assess the relative signal distribution. Figure 5.35 presents as an example the
distribution of intensity Z-scores with respect to the WM on FLAIR modality for the
manually segmented lesions and the WM mask across the dataset.
The overlap observed and the fact that the mode of the lesion segmentation is
located on this overlapped region, highlights the difficulty to define consistently the
limit between normal appearing white matter, dirty appearing white matter and lesions.
Such uncertainty impacts directly the assessment of automated lesion segmentation
methods. As an example, Figure 5.36, presents the relationship between the proportion
per manually segmented lesion of voxels whose intensities falls below the threshold
of 2 in Mahalanobis distance compared to the WM and the DSC for this lesion in the
case of BaMoS. As expected, a negative correlation is observed, the DSC decreasing
when the proportion of normal appearing voxels considered as lesion increases (R2
0.48, Linear coefficient -0.96). Thus, assessing the automated results only based on the
manual segmentation might not be sufficient to validate them and evaluating the level
of systematism of such methods might be a further requirement.
5.6.2 Assessment measures - Proof of concept
Figure 5.37 illustrates such behaviours in terms of two possible assessment measures
described in Section 5.2.4 namely DistQuant and PropLes. As a reminder, DistQuant
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Figure 5.36: Illustration of the impact of the intensity overlap between manually segmented
lesions with normal appearing white matter. The DSC per lesion (with volume
>0.05 mL) is plotted (scattered points) with respect to the proportion of manually
segmented voxels that present an intensity at a Mahalanobis distance inferior to
2 compared to the normal WM. The bold and dashed lines represent respectively
the trendline of the correlation and the corresponding 95% confidence interval.
is the difference between the value of the first quartile of Z-scores for the lesion in-
tensities and the third quartile of Z-scores for the normal appearing WM. Z-scores are
calculated with respect to the FLAIR normal appearing white matter observations. In
turn, PropLes is the proportion of voxels classified as lesion whose intensities overlap
with the normal appearing WM intensity distribution. Similarly to the illustration of the
intensity distributions in terms of Z-scores for the lesions and the WM, observed for
the gold standard in Figure 5.35, the behaviour of the four assessed automated methods
is presented in Figure 5.38. The distribution of lesion intensities is very similar for
BaMoS and TOADS with a mode for the lesion intensities close to the extremal value
for the normal WM. As expected from Figure 5.37, the overlap between NAWM and
lesion is higher for TOADS. The shift of the mode for lesion intensities to higher values
of the Z-score in the case of LST, further highlights the risk of a conservative lesion
segmentation.
A high consistency of the algorithm behaviour across the dataset would corre-
spond to a low variance for the intensity assessments. Across all methods, DistQuant
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Figure 5.37: Comparison of consistency in terms of lesion standardised intensities for the four
automated methods and the ground truth in terms of PropLes(left axis) and Dis-
tQuant (right axis).
Figure 5.38: Compared Z-score distribution of automated segmented lesions with respect to
WM on the FLAIR modality for BaMoS, EMS, TOADS and LST.
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was observed to produce the least variations through the dataset. A low proportion
overlap between intensities of normal appearing white matter and segmented lesions as
was observed for LST-WML and BaMoS with a low variance satisfies the problem of
consistency in terms of definition of a lesion compared to white matter. However, asso-
ciated with a large DistQuant value, this can also be the sign of a tendency to classify
the lesion outline as GM or to a conservative definition of lesions. The risk of including
CSF voxels in the final TOADS segmentation expresses itself in the larger proportion
of lesion intensities overlapping with NAWM intensities. The large overlap observed
between NAWM and lesion intensities for the gold standard segmentation as observed
in Figure 5.35 is represented with these consistency measures with the high PropLes
and low DistQuant.
Thus, the measures developed may reflect consistency across a dataset through
the estimation of their variation while their mean values may be representative of the
behaviour of a given algorithm thus allowing for more principled comparisons.
5.7 Discussion
5.7.1 Synthetic data
When compared to the validation on clinical data, the main advantage of using synthetic
images is the availability of a ground truth. Additionally the possibility of modelling
different conditions of image quality enables to test the robustness of a given algorithm
to these effects. The Brainweb data was used here to test the algorithmic stability to dif-
ferent imaging modality combinations, different degrees of image quality with varying
noise level and intensity inhomogeneity. However, the validation using the Brainweb
dataset is limited by multiple factors as previously underlined by García-Lorenzo et al.
[110]. As only one phantom is available, no statistical analysis is possible. Also, syn-
thetic MR simulated images cannot be considered truly realistic. Moreover the range of
lesion load is limited compared to the amount that can be found in clinical cases. Fur-
thermore, although both MS and age-related WMH are evolutionary processes, there
is no longitudinal component in the lesion simulation. Such a longitudinal simulator
based on lesion transfer on clinical data will be developed in Section 7.3.1.
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5.7.2 Local disagreements
Consistently across experiments, systematic areas appeared to be prone to misclassi-
fications in terms of lesion segmentation. With respect to the preprocessing choice,
the impact of modality choice and the acquisition protocol, the infratentorial regions
appeared indeed commonly subject to disagreement.
Different reasons may be presented to explain this local finding. First, the infraten-
torial region is known to present a different contrast in the FLAIR acquisition compared
to the cerebral white matter. Therefore, a change in normalisation due to mask variation
may first lead to segmentation differences as in Section 5.4.1. Such slight hyperintensi-
ties may also be initially considered as susceptible outliers when using first the FLAIR
image instead of the T2 modality when all three are available as described in Section
5.4.3. Such observations led for instance Samaille et al. [95] to adopt specific size rules
to account for potential false positives in this area and Datta et al. [99] to separate the
analysis of the cerebellum from the rest of the image.
Second, critical flow and pulsation artefacts combined with shine through effects
may be present along the Sylvian aqueduct and the fourth ventricle. The false posi-
tive correction supposed to account for these findings depends however heavily on the
statistical priors, healthy tissue segmentation and distance to mask borders, which may
lead to different decisions on the considered lesion elements. Such artefacts, frequently
present in 2D acquisitions of FLAIR images, are reported to be largely reduced in 3D
acquired images [161], observation confirmed in the experiment on the POPPY dataset
(cf Section 5.4.4).
In the various situations, the ventricular lining appeared also prone to segmen-
tation disagreement. As this region has been highlighted as of special interest when
dichotomizing the clinical impact of white matter hyperintensities [18], further work
would be needed to avoid confusion between deep gray matter and WMH. In order to
consistently assess the location of areas of greater uncertainty, one can develop system-
atic location schemes as will be shown in Chapter 6.
5.7.3 Generalisation and segmentation uncertainty
In this segmentation framework, elements of the model that correspond to WMH are
extracted automatically after the model optimisation, providing the final lesion segmen-
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tation described in Section 5.1.
As the model selection framework is independent of the observed pathology,
BaMoS has a large clinical flexibility to different modalities and pathological contexts.
In fact, the final data model is independent from the lesion definition. Segmentation
rules can thus be adapted to the variability in lesion definition contrarily to other models
in which heuristic rules are included in the cost function optimisation. This flexibility
allows for more variation in the clinical description of lesions and further emphasises
the generalisation potential of BaMoS. Thanks to the generic nature of BaMoS, as-
sociations of different types of outliers such as white matter hyperintensity and iron
deposition could be for instance investigated, since iron deposition is known to be as-
sociated with cognitive decline in ageing [194] and observed in the course of MS [212].
Although other than purely biological causes such as partial volume or bias field may
cause model components to split, the separation of lesion elements into different classes
according to their intensity opens the door to a deeper understanding of the underlying
lesion’s pathophysiology. Besides, these levels of intensity may be of further interest
when studying the evolution of the WMH longitudinally since in the elderly it has been
shown that such lesions evolve from pre-existing WM damages [213].
Chapter 6
WMH spatial distribution
Although global WMH lesion burden is reported to be associated with clinical cogni-
tive outcome and various risk factors, further description of WMH appears to be able to
refine clinical correlations and assessments. Longitudinally, progression of WMH has
been observed to occur from preexisting lesions [214]. Investigating the progression
of WMH lesions according to their initial degree of confluency (focal, early conflu-
ent, confluent), a pictorial characteristic often used in visual rating scales, Enzinger et
al. [215] showed differences in the progression patterns of the different lesion groups
with no progression for the focal lesions and a strong accumulation in the case of the
confluent damage. Such distinction is mainly related to the underlying severity of the
pathology [19]. Punctuate lesions correspond usually to a mild tissue damage con-
fined to an area surrounding a dilated periventricular space whereas confluent regions
of hyperintensities are associated to diffuse areas of incomplete parenchymal destruc-
tion with myelin and axonal loss and correspond to a continuum of tissue damage [16].
As underlined by Enzinger et al. [215], using lesion appearance to select a population
can considerably affect the design of clinical trials with respect to the required sample
sizes.
Other than appearance, lesion spatial distribution has been studied both in cross-
sectional and longitudinal investigations on the clinical correlates of WMH. For in-
stance, progression of WMH in the parietal lobe has been reported to be a predictor
of Alzheimer’s Disease [216]. The variability in image acquisition and definition of
region of interest have been highlighted as potential causes for the mixed and contro-
versial findings in the relationships between lesion location and clinical outcome [35].
Lesion spatial distribution is nonetheless prominent in the description of visual rat-
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ing scales, notably when distinguishing between periventricular (PV-) and deep white
matter hyperintensities (DWMH) in their assessment. The Fazekas scale [217] and
the Scheltens scale [218], both widely used clinically, include this separation in their
description of lesions.
As mentioned in Section 1.1.2.2, such distinction has been partly substantiated
by histopathological findings [18, 219] differentiating the ischaemic pathway leading
to DWMH from the the loosening of white matter in the most periventricular lesions.
According to the study performed by Haller et al. [20], level of demyelination assessed
via observation of FLAIR images tended to be overestimated in PV regions compared
to DWM due to the higher interstitial water content in periventricular regions. Compar-
atively, Murray et al. [44] noticed that the oligodendrocyte population was less affected
in DWMH than in PVWMH and that weaker hyperintense lesions did not see the oligo-
dendrocytes affected. This observation was used to infer an order in the degradation of
the WM, the myelin being affected before reaching the core of the oligodendrocytes.
Functionally, this distinction has been assessed in various studies emphasising the
effect of periventricular lesions on executive functioning [35] and of deep white mat-
ter lesions on mood and depression in cross-sectional [33, 220] and longitudinal stud-
ies [42]. The segregation and definition between periventricular and deep white matter
hyperintensities is however known to suffer from various drawbacks and has been chal-
lenged. De Carli et al. [36] underlined the noticeable correlation between DWMH,
PVWMH and total lesion load while Barkhof et al. [221] explained a reported 80% of
PVWMH as resulting from characterisation issues. If the main definition of periven-
tricular lesion relies on the property of continuity of the lesion with the ventricular
surface, other criteria such as maximal distance to the ventricles, shape of the lesion
or maximal extent have also been proposed to account for the common but delicate
case of coalescing lesions [18]. The use of absolute value for the maximal distance
when qualitatively scaling or automating the separation [222, 223] is however prob-
lematic in an ageing population due to the concomitant brain atrophy and ventricular
expansion and the variation between subjects and is not supported by any biological
meaning. As an alternative to this dichotomisation, with the development of automated
segmentation methods, lesion probability maps and the voxelwise relationships with
clinical outcome have also been studied [30]. These methods suffer however from the
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low voxelwise probabilities of lesion occurrence [27].
In this chapter, a systematic patient-specific coordinate frame is developed with
respect to both the distance to the ventricular surface and the lobar position. Compara-
tively, the closest existing location scheme for WMH is the one developed by Van der
Lijn et al. [224] in which the brain is regionally separated into an anterior, posterior
and central region and fifteen layers of absolute distance to the ventricular surface are
drawn. After describing the process of projecting 3D lesion information to a standard-
ised coordinate frame, the relevance of this projection using two examples is explored.
First, the spatial distribution of lesions is studied in a population of pairs of monozy-
gotic twin subjects. Then, the developed scheme is applied to the deconstruction of
visual rating scales for WMH, leading to the creation of a training tool for radiologists.
6.1 Methods
6.1.1 Relative ventricular distance
The aim of the relative ventricular distance is to define a WM radial coordinate system
between the ventricular CSF and the cortical GM.
Similarly to cortical thickness, the WM coordinate frame must be smooth and
allow for bijective correspondences with trajectories normal to the boundary surfaces
on both sides. As proposed by Jones et al. [225], series of equipotential nested surfaces
that fulfil these conditions can be described by the Laplace’s equation. According to
it, a field ψ enclosed between boundaries (here the ventricular surface and the cortical
sheet surface) with different boundary conditions for the potential satisfies
∇2ψ =
∂ 2ψ
∂x2
+
∂ 2ψ
∂y2
+
∂ 2ψ
∂ z2
= 0.
Field lines relating the two surfaces are obtained by integrating the normalised gradient
of the field between the two surfaces. The Laplace equation can be solved numerically
using iterative solutions such as the Jacobi method, referred to by Jones et al. [225]. At
any point (x,y,z) of the volume considered, the second order Taylor expansion of the
field for all neighbours is given by
ψ(x+∆x,y,z) = ψ(x,y,z)+∆x
∂ψ(x,y,z)
∂x
+
∆x2
2
∂ 2ψ(x,y,z)
∂x2
+O(∆x3)
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ψ(x−∆x,y,z) = ψ(x,y,z)−∆x∂ψ(x,y,z)
∂x
+
∆x2
2
∂ 2ψ(x,y,z)
∂x2
+O(∆x3)
ψ(x,y+∆y,z) = ψ(x,y,z)+∆y
∂ψ(x,y,z)
∂y
+
∆y2
2
∂ 2ψ(x,y,z)
∂y2
+O(∆y3)
ψ(x,y−∆y,z) = ψ(x,y,z)−∆y∂ψ(x,y,z)
∂y
+
∆y2
2
∂ 2ψ(x,y,z)
∂y2
+O(∆y3)
ψ(x,y,z+∆z,) = ψ(x,y,z)+∆z
∂ψ(x,y,z)
∂ z
+
∆z2
2
∂ 2ψ(x,y,z)
∂ z2
+O(∆z3)
ψ(x,y,z−∆z) = ψ(x,y,z)−∆z∂ψ(x,y,z)
∂ z
+
∆z2
2
∂ 2ψ(x,y,z)
∂ z2
+O(∆z3).
With a first order approximation, the Laplace equation becomes
ψ(x+∆x,y,z)−2ψ(x,y,z)+ψ(x−∆x,y,z)
∆x2
+
ψ(x,y+∆y,z)−2ψ(x,y,z)+ψ(x,y−∆y,z)
∆y2
+
ψ(x,y,z+∆z)−2ψ(x,y,z)+ψ(x,y,z−∆z)
∆z2
= 0
1
2
(
ψ(x+∆x,y,z)+ψ(x−∆x,y,z)
∆x2
+
ψ(x,y+∆y,z)+ψ(x,y−∆y,z)
∆y2
+
ψ(x,y,z+∆z)+ψ(x,y,z−∆z)
∆z2
)
=
ψ(x,y,z)
∆x2
+
ψ(x,y,z)
∆y2
+
ψ(x,y,z)
∆z2
.
The Jacobi solution consists in progressively updating at iteration t+1
ψ(t+1)(x,y,z) =
1
2
(
1
∆x2
+
1
∆y2
+
1
∆z2
)−1
·
(
ψ(t)(x+∆x,y,z)+ψ(t)(x−∆x,y,z)
∆x2
+
ψ(t)(x,y+∆y,z)+ψ(t)(x,y−∆y,z)
∆y2
+
ψ(t)(x,y,z+∆z)+ψ(t)(x,y,z−∆z)
∆z2
)
.
This iterative process is conducted until the relative change in energy
εt+1− εt
εt
reaches
a threshold ε , the field energy being at iteration t over the N voxels of image I
εt =∑
I
[(
∆ψ
∆x
)2
+
(
∆ψ
∆y
)2
+
(
∆ψ
∆z
)2]1/2
.
As mentioned by Yezzi et al. [226], the values of the harmonic solution on the volume
do not increase proportionally to the arclength following its gradient flow lines. There-
fore, there is no defined level set value of the solution that will cut the trajectories at a
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certain relative length. As proposed by Yezzi et al. [226], a normalised length function
can be defined in order to allow level sets to be drawn directly. Introducing N=
∇ψ
‖ ∇ψ ‖
the normalised tangent field to the trajectories flowing from the inner (ventricular) sur-
face to the outer (cortical) surface, the length along the path coming from the inner
surface LI verifies ∇LI ·N = 1 while the length along the path coming from the outer
surface LO satisfies −∇LO ·N = 1, and the length being equal to 0 at their respective
starting point. The normalised distance from the inner surface at any point P of the
region R is then equal to
LI(P)
LI(P)+LO(P)
. To obtain the distance maps in the case of
images, the backward and forward differences are introduced denoting ht the voxel size
in the t direction and i, j,k the indices in the x, y and z direction respectively so that
D−x L =
L(i, j,k)−L(i−1, j,k)
hx
D−y L =
L(i, j,k)−L(i, j−1,k)
hy
D−z L =
L(i, j,k)−L(i, j,k−1)
hz
D+x L =
L(i+1, j,k)−L(i, j,k)
hx
D+y L =
L(i, j+1,k)−L(i, j,k)
hy
D+z L =
L(i, j,k+1)−L(i, j,k)
hz
Since the gradient can be defined either using backward or forward differences,
the solution is obtained in the direction of the tangent field, thus determining the differ-
entiation scheme to adopt. Therefore, the equation becomes
1 =Nx(i, j,k)
 D−x (i, j,k) if Nx(i, j,k)> 0D+x (i, j,k) otherwise
+Ny(i, j,k)
 D−y (i, j,k) if Ny(i, j,k)> 0D+y (i, j,k) otherwise
+Nz(i, j,k)
 D−z (i, j,k) if Nz(i, j,k)> 0D+z (i, j,k) otherwise
=
Nx(i, j,k)
hx
 L(i, j,k)−L(i−1, j,k) if Nx(i, j,k)> 0L(i+1, j,k)−L(i, j,k) otherwise
+
Ny(i, j,k)
hy
 L(i, j,k)−L(i, j−1,k) if Ny(i, j,k)> 0L(i, j,k+1)−L(i, j,k) otherwise
+
Nz(i, j,k)
hz
 L(i, j,k)−L(i, j,k−1) if Nz(i, j,k)> 0L(i, j,k+1)−L(i, j,k) otherwise
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The solutions for LI(i, j,k) and LO(i, j,k) are then:
LI(i, j,k) =
1+
|Nx|
hx
LI(i∓1, j,k)+ |Ny|hy LI(i, j∓1,k)+
|Nz|
hz
LI(i, j,k∓1)
|Nx|
hx
+
|Ny|
hy
+
|Nz|
hz
LO(i, j,k) =
1+
|Nx|
hx
LO(i±1, j,k)+ |Ny|hy LO(i, j±1,k)+
|Nz|
hz
LO(i, j,k±1)
|Nx|
hx
+
|Ny|
hy
+
|Nz|
hz
where N is taken in (i, j,k),
i±1 =
 i+1 if Nx > 0i−1 otherwise j±1 =
 j+1 if Ny > 0j−1 otherwise k±1 =
 k+1 if Nz > 0k−1 otherwise
and
i∓1 =
 i−1 if Nx > 0i+1 otherwise j∓1 =
 j−1 if Ny > 0j+1 otherwise k∓1 =
 k−1 if Nz > 0k+1 otherwise
The solutions are implemented using a fast-marching algorithm. Indeed, since N is de-
termined and the solution at point (i, j,k) depends on the value of three neighbours, fix-
ing the known values can allow the solution to be obtained with only one pass through
the volume elements. Once the normalised distances are obtained, a discretisation in
layers is possible. Based on the indications of Kim et al. [18], four equally spaced
layers are separated by default. The layers numbering increases with the distance to
the ventricular surface.
6.1.2 Lobar separation
In order to inform the anatomical location of the lesions, frontal, parietal, occipital and
temporal regions are defined for the right and the left hemispheres. Basal ganglia and
infratentorial regions (denoted BGIT) are combined. The regional demarcation orig-
inates from the brain parcellation obtained through the GIF pipeline [198]. Multiple
cortical labels are aggregated into four lobes per hemisphere and BGIT. Euclidean dis-
tance maps are then calculated from these cortical lobar regions and WM voxels are
classified into corresponding regions based on a minimal distance rule. Infratentorial
regions are simply derived from the parcellation while the basal ganglia segmentation
is dilated in order to enclose the WM present between the putamen and the caudate or
thalamus. An alternative to build the lobar separation could have been to propagate the
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labels along the trajectories derived from the Laplace equation or to propagate existing
atlases.
6.1.3 Display
From the lobar division and the layer discretisation, a total number of 36 brain regions
is formed (9 brain regions × 4 layers). Scalar characteristics relative to the lesions in
each region can then be summarised in a single plot through the use of relevant color
scales. In such a plot, represented as a bullseye of concentric layers, the layer number
increases radially while the lobar regions are positioned to reflect their neighbourhood
relationships. The first few letters for each lobe are mentioned, using for instance
FRONT to refer to the frontal lobe. Right and left are indicated on the plot. Relevant
scalar characteristics are, among others, the proportion of regional volume occupied by
lesions (lesion frequency) or the proportion of the total lesion load located in a specific
region (lesion distribution). An example of lesion segmentation, lobar separation and
layer discretisation is displayed in Figure 6.1 for the three orientations and is followed
by the representation of lesion frequency (values increasing from green to red) and
lesion distribution (values increasing from blue to pink).
The two graphical displays are complementary and can be interpreted as follows
in this case: the lesion frequency plot expresses that the parietal periventricular zone
are largely affected by lesions while the lesion distribution plot relates that a large
proportion of the overall lesion volume is actually located in the intermediate zone of
the parietal region.
6.2 WMH spatial distribution in twin population
The standardised description of lesion spatial distribution and the corresponding re-
gional lesion descriptors were applied to the study of a twin population in order to
illustrate the relevance of such a scheme in the assessment of potential similarities of
WMH patterns within twin pairs. After contextualising brain studies with respect to
twin population in Section 6.2.1, the data and performed experiments are detailed in
Section 6.2.2 before presenting the obtained results (Section 6.2.3).
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Figure 6.1: Example of the construction of regional lesion features in lobes and layers and
display of the lesion frequency and lesion distribution on planar bullseyes.
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6.2.1 Clinical context
The assessment of heritability in the context of pathology is especially important to bet-
ter understand the interactions between environmental conditions and genetics. Studies
on populations of twins are conducted in order to assess the heritability of phenotypical
traits, that is the genetic component of the population variance. In turn, measures of
environmental factors can be derived from the differences observed within twin pairs.
In such studies, high heritability has been observed in brain volumes, cortical thickness
and cortical surface [227] while the gyral structures [228] or the white matter tracts
in children [229] appear less correlated. With respect to dynamic changes observed
with ageing, a high heritability is reflected in total brain volumes [230, 231] and in
the corpus callosum shape [230]. Besides, strong genetic factors appear to partially
govern cerebrovascular pathology with for instance genetic predisposition to ischaemic
strokes [232]. Additionally, in the case of small vessel disease, correlations of total
lesion volumes appear to be significantly greater in monozygotic than dizygotic pairs
of twins [233]. However to date, there has been no investigation on potential genetic
based similarities in the pattern of WMH spatial distribution. Furthermore, since the
strength of heritability varies across the brain, it would be of interest to see if such
differences also exist in the case of WMH.
6.2.2 Data and Experiments
For this application, a data subset of the PreclinAD study with 43 pairs of monozygotic
twins recruited from the Netherlands Twin Registry was analysed. This study aims at
describing the biomarkers for amyloid pathology and cognitive decline in a cognitively
healthy elderly population. Following the study protocol, both members of a twin
pair undergo on the same day a battery of neuropsychological and cognitive tests, an
MR session and biosamples draws. During the MR sequence on a Philips 3T Achieva
scanner, T1-weighted and FLAIR sequences are among the acquired pulse sequences
with the following characteristics: 1) T1-weighted 3D Fast Field Echo; TR = 7.9 ms, TE
= 4.5 ms; voxel size 1.0 × 1.0 × 1.0 mm3 and 2) Fluid attenuated Inversion Recovery
: TR=4800 ms, TE=279 ms, TI= 1650 ms; voxel size 0.56 × 1.04 × 1.04 mm3.
BaMoS was applied to the T1 and FLAIR images, registering the FLAIR image
affinely to the T1 space and using anatomical atlases and mask from the label fusion
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GIF pipeline [198]. The WMH were segmented and the local regions constituting the
bullseye plot (4 layers and 9 lobar regions) were built. In order to expose the relevance
of the local information, correlations between vectors of local characteristics were cal-
culated while absolute differences in log and raw global volumes were also derived
within twin pairs. For each twin pair, a random pairing with one of the individuals of
the remaining pairs was performed resulting thus in 42 additional correlation values (or
difference values) for both twins in the studied pair. The Pearson correlation coefficient
R between the local characteristics of subject X and subject Y with N the number of
characteristics is expressed as
R =
1/N∑Nn=1(xn−µx)(yn−µy)
σxσy
,
where µx (resp. µy) is the mean of the characteristics for subject X (resp. Y) and σx
(resp. σy) the corresponding standard deviation. Sorting the correlations from highest
to lowest and the differences from lowest to highest, the rank corresponding to the twin
pairing was determined. 1000 repeats for the random pairing were performed. The
statistics for each tested characteristics were evaluated on the mean over these 1000
random draws. The rest of the analysis, performed in Amsterdam is still undergoing at
the time of writing.
6.2.3 Results
Over the whole set of pairs of twins among which 67.4% were women, the volume of
detected lesions was of a median of 1.99 mL (IQR=[0.76 5.58]) and the average given
Fazekas score was of 1.08 (SD = 0.86). The mean age of the pairs was of 68.3 years
(SD = 8.14) and the total intracranial volume as obtained applying [198] was of 1567
mL (SD = 215). A Kendall tau correlation of 0.64 was found between Fazekas scores
and the segmented lesion volumes. For a twin pair, an example of the FLAIR images,
resultant lesion segmentation and overall lesion frequency and lesion distribution plots
is presented in Figure 6.2 to expose the strong similarities that may occur in terms of
WMH distribution in the brain of twin subjects.
As a supplementary illustration, the comparison within pairs of lesion frequency
(proportion of lesion occupying a regional volume) and lesion distribution (proportion
of the total lesion load in the considered region) is displayed in Figure 6.3 for all pairs
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Twin 1 Twin 2 Twin 1 Twin 2
Lesion frequency Lesion distribution
Figure 6.2: Example of similarities in WMH distribution in a twin pair. Images in axial (top
row) and coronal (middle row) view are presented for each twin with the corre-
sponding lesion segmentation. The bullseye representation of lesion frequency and
lesion distribution for each twin are displayed on the bottom row.
of twins. Regarding the ranking of the within pair correlations compared to random
pairing, Table 6.1 gathers the results for the local volumes, lesion frequency, lesion
distribution and local log-volumes as well as global volumes and log-volumes knowing
that a random pairing would give on average a ranking of 21.5 (number of pairs di-
vided by 2). The assessment of pairwise difference using Wilcoxon paired test showed
significant differences between local characteristics and global volumetric random re-
sults, the local characteristics leading to lower ranking (p-value <0.00001). The ranking
obtained through local features were significantly lower than those obtained with the
global volumetric measurements but in all cases the obtained ranking was lower than
what random ranking would provide.
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Pair Frequency Distribution Pair Frequency Distribution Pair Frequency Distribution
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43
Frequency Distribution
Figure 6.3: Comparison within twin pairs of lesion frequency and lesion distribution. For each
pair, the lesion frequency are given in the first two plots and followed by the lesion
distribution.
Local
Volumes
Local
Frequencies
Local
Distributions
Local
Log-Volumes
Global
Volume
Global
Log-volume
Mean 9.90 11.12 9.88 6.40 13.63 13.60
SD 9.65 11.37 9.62 7.78 10.66 10.71
Range [1 36.49] [1 41.48] [1 36.46] [1 38] [1.48 43] [1 43]
Median 5.7 6.2 5.8 3.0 10.5 10.5
IQR [2.5 15.97] [2.503 16.821] [2.49 15.98] [2 7] [5.52 18.48] [5 19]
Table 6.1: Statistics on the ranking of the correlations or volume difference when considering
twin pairs to random pairs of subjects.
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6.2.4 Discussion
In this initial application of the systematic lesion spatial description scheme, patterns of
similarity appeared within twin pairs as shown in Figures 6.2 and 6.3. Comparing ran-
dom pairing of twins to the true pairing showed that global volumetric measurements
of WMH were indeed related as reported by Carmelli et al. [233]. The proof of concept
experiment based on the correlation of local information on lesions allowed twin pair
specific information to be more readily available. This was shown by the lower ranking
systematically obtained when using local information compared to global measures. It
must however be underlined, that in this ranking experiment, neither age nor TIV was
taken into account. In the case of WMH spatial distribution, in which some regions
are more informative than others, considering all characteristics equally as done with
the Pearson correlation coefficient, may however not be the optimal solution. Greater
twin pairs concordance could certainly be obtained when using weighted correlation
relationships. To some extent the log-transformation of the volumes reflects the effects
of a reweighing and showed here the best results with respect to twin pairs association.
A further development would be to train a regression algorithm based on a subset of
the pairs in order to see if it is possible to identify the appropriate twin based on the
information from a single subject. It must additionally be underlined that the local char-
acteristics especially when reflecting properties of neighbouring regions may be highly
correlated.
6.3 WMH local information for visual scales decon-
struction
As mentioned in Section 6.2.3 for the twin population, a strong correlation was ob-
served between volumetric WMH and the Fazekas visual scale [217]. Since visual rat-
ing scales may incorporate lesion spatial distribution patterns in their depiction, the au-
tomatically derived patient-specific regional lesion burden descriptors introduced pre-
viously were then used in this context. The purpose was to improve the understanding
of the spatial similarity and discrepancy between visual grading scales and the expla-
nation for their high correlation. Here the scalar regional feature used was the local
lesion frequency. After a summary of the clinical context surrounding visual scales in
190 Chapter 6. WMH spatial distribution
Section 6.3.1, using the dataset presented in Section 5.3.6, experiments are detailed in
Section 6.3.2. In light of the results reported in Section 6.3.3, an online training tool
for radiologists was built in a joint effort with Ferran Prados Carrasco and is described
in Section 6.3.4.
6.3.1 Clinical context
Qualitative rating scales are used throughout the domains of science with the well
known Likert scale often used in psychology and social science. In the medical field,
the Likert scale is for instance used to evaluate the comfort of surgeons with new surgi-
cal tools. Many other qualitative scales exist and are often used to assess for instance a
subject’s situation with applications going from assessment of disability level, to pain
evaluation through depression status. In the imaging domain, those qualitative assess-
ments are used for diagnostic purposes such as oncologic staging, population stratifica-
tion or trial population enrichment. The neuroimaging world has seen the development
of many visual scales related to the evaluation of atrophy stage [234], or to the evalu-
ation of cerebrovascular damage with WMH [62], EPVS [235] and CMBs [236]. To
be accepted and used clinically, such scales do not only have to be clinically relevant
in terms of the features they assess but they must also be robust to inter- and intrarater
variability.
With respect to WMH, a vast proportion of studies associating clinical findings
with WMH burden have used visual rating scales. Historically, such scales were intro-
duced as a semiquantitative way to describe the lesion burden and distribution in the
brain without having to manually delineate the lesions, a task which is cumbersome and
time consuming, and subject to inter- and intrarater variability. A number of visual rat-
ing scales of various complexity has been developed over time [66,217,218,237–239].
Some are only applicable to magnetic resonance imaging (MRI) using either PD-
weighted images or T2-weighted images, while others are designed to be used either
with MRI or computed tomography (CT). The spatial information of WMH distribution
incorporated in the rating scales is highly variable, ranging from whole parenchymal
assessment (Manolio [240], simplified Fazekas [217]) to specific lobar lesion burden
(Scheltens [218]). While spatial stratification allows for different clinical and patho-
physiological explanatory pathways, the definition of the regional borders can be am-
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biguous and vary from one scale to another. The question of the distinction between
PVWMH and DWMH mentioned earlier is a striking example of such ambiguity. Fi-
nally, some scales have been purposefully defined for longitudinal assessment of the
lesion burden whereas others are only to be applied cross-sectionally [67].
With the recent advances in the automated extraction of WMH, lesion volume has
also been shown to be associated with clinical outcome, sometimes allowing for an even
stronger separation between clinical subgroups [62] or relation with risk factors [241]
than visual rating scales. The correlation between visual scales is considerable [65]
but the heterogeneity between visual grading systems has also been put forward as a
potential explanation for contradictory findings [64].
6.3.2 Data and experiments
6.3.2.1 Visual rating scales
The 82 FLAIR scans of the SABRE dataset described in Section 5.3.6 were rated by
four different raters with different levels of expertise. Each rater scored the scans
according to three popular visual rating scales, the Manolio scale [240], the Fazekas
scale [217] and the Scheltens scale [218], that range from a global impression to more
fine-grained regional scores [65]. The scales are summarised as follows:
Manolio scale [240] designed for a cardiovascular health study. The scale charaterises
the lesion burden globally and ranges from 0 (absence) to 9 (highest degree) by
matching to a template.
Fazekas scale [217] designed for ageing subjects in a dementia study, and the lesion
rating is dichotomised between periventricular and deep WMH, assessed on a
4 point scale from 0 (absence) to 3 (highest degree), and a composite score is
obtained by summing the subscales.
Scheltens scale [218] designed for ageing subjects probably affected by Alzheimer’s
disease. The lesion rating is defined differently according to global regions:
periventricular lesions (score range 0-6), deep white matter per lobe (total score
range 0-24), basal ganglia per nucleus (total score range 0-30) and infratentorial
regions (score range 0-24) themselves separated in subregions. Periventricular
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and deep regions are dichotomised based on the absolute distance (10 mm) to the
ventricular surface.
6.3.2.2 Statistical analysis
The scores given by the different raters were averaged to produce a mean score. The
average scores were correlated with the automated regional lesion burden to illustrate
the spatial interactions between scores on the different scales and the frequency of
lesions. In a second experiment, the individual visual scores for each one of the raters
was correlated with the automated regional descriptors. With the aim of studying the
degree of consistency/bias between each rater and the average, the degree of regional
interactions for each rater was compared to the degree of regional interactions of the
average ratings.
The global lesion burden and scale-specific aggregate regional burden estimates
were used as features to predict the rating scales. A multinomial ordinal regression
model was used for the regression in a stratified 2-fold cross-validation procedure with
50 repeats. Predictions were obtained with respect to the average of two, three or four
raters. The ability to predict the rating scales was tested using either the global relative
lesion burden or the scale-specific aggregate lesion loads.
Interrater variability was estimated as the average of the pairwise correlation be-
tween raters. Intrarater variability was estimated by repeat measurements of one single
rater on a subset of 20 subjects.
6.3.3 Results
The extracted total lesion burden for the 82 subjects in this study ranged from 0.38mL
to 25.28 mL (median 1.71 mL, IQR [0.81 mL 4.57 mL]). Figure 3 represents the median
lesion distribution across all subjects and the corresponding IQR. It illustrates the right-
left hemispherical symmetry as well as the prevalence of lesions in the perventricular
zones compared to deeper layers [237], the sparing of the infratentorial regions and
the tendency towards greater lesion burdens in the frontal regions [21] described in the
literature.
The correlations between quantitative volumes and visual rating scales (global
scores) across all raters are gathered in Table 6.2. All correlations were statistically
significant with p-values < 0.0005 and not significantly different from each other. In
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Figure 6.4: Median (left) and IQR (right) of the lesion burden frequency per local region rep-
resented in bullseyes plots.
line with the literature [58,66], there was a good agreement between the various scales.
In addition, visual scales and lesion volumes were strongly related with Kendall’s tau
coefficients of 0.59 0.58 and 0.61 for the Scheltens, the Manolio and the Fazekas scales.
The intra-rater intra-class correlation evaluated in a subset of 20 subjects were 0.73,
0.68 and 0.68 while the mean pairwise interrater ICC were 0.70, 0.80 and 0.64 for the
Scheltens, Manolio and Fazekas scales respectively.
Using a similar representation as the one used in Figure 6.1, the correlations be-
tween the average Scheltens sub-scales and the regional descriptors is illustrated in
Figure 6.5.
The observed correlations were found to be stronger for the subscales easier to map
regionally such as the frontal and posterior periventricular regions. The clear difference
in observed patterns when comparing the frontal lobe and the parietal lobe further sup-
ports the assumption that certain local features drive the visual rating process. Areas
with a low density of WMH (e.g. temporal lobe) were not found to be highly associated
with any of the regional lesion frequencies. Finally, a high degree of interaction was
Mean SD Min Max
Volume - Manolio 0.61 0.01 0.60 0.61
Volume - Fazekas 0.58 0.02 0.56 0.60
Volume - Scheltens 0.59 0.03 0.55 0.62
Manolio - Fazekas 0.72 0.02 0.71 0.75
Manolio - Scheltens 0.64 0.02 0.62 0.67
Fazekas - Scheltens 0.61 0.02 0.58 0.63
Table 6.2: Summary of Kendall’s tau correlation results between global scale scores.
194 Chapter 6. WMH spatial distribution
Figure 6.5: Correlation between the regional lesion loads and each Scheltens subscale. Plot
titles refer to the studied regions. Note the higher correlations between the periven-
tricular subscales and central lesion loads in the bullseyes and at the periphery of
the plot for lobar scores. The bigger plot on the left represents the correlations
between the global score and the local percentage of volume affected by lesions,
showing that the frontal lobe had the highest overall loading.
found across all regions when correlating with the Scheltens global scale.
The correlations between each global scale and the average of four raters, as well
as the difference in correlation observed between each rater and the average of the three
remaining raters is presented in Figure 6.6. When focusing on the differences between
a rater and the average, a pink (blue) color represents a stronger (weaker) interaction
between a given rater’s grades and the regional volume than the one found for the av-
erage score. Colloquially, one can interpret pink regions as over-influencing the rater’s
grading while blue regions are under-influencing the rater’s grading when compared to
the average rating. For example, in the Manolio scale grading, the influence of the three
first layers of the parietal and frontal regions on rater ]4’s scores was lower than that of
the average of the remaining raters for all scales, indicating that this rater should give
more weight to these areas when grading.
In Figure 6.6, the three global scores (left column) show relatively similar patterns
6.3. WMH local information for visual scales deconstruction 195
Scale Scheltens Manolio Fazekas
Global
Rater 1
Rater 2
Rater 3
Rater 4
Figure 6.6: Representation for each of the studied visual scales of the Kendall’s Tau correla-
tions between the local descriptors and the global average result (1st row) and of the
difference in correlation for each rater (row 2 to 5) with the correlations obtained
for the average made of the three remaining raters.
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Prediction with local features Prediction with global perc Inter rater variability
Scale Pred4 Pred3 Pred2 Pred4 Pred3 Pred2 IR in 3Cons IR in 2Cons IR Unique
Scheltens
FPV 0.77 0.75 (0.04) 0.71 (0.07) 0.58 0.57 (0.02) 0.55 (0.04) 0.65 (0.15) 0.56 (0.10) 0.48 (0.14)
LPV 0.51 0.47 (0.04) 0.43 (0.06) 0.49 0.46 (0.02) 0.42 (0.04) 0.56 (0.17) 0.45 (0.09) 0.37 (0.12)
PPV 0.79 0.75 (0.03) 0.69 (0.06) 0.76 0.72 (0.02) 0.65 (0.05) 0.55 (0.22) 0.46 (0.13) 0.37 (0.15)
FL 0.69 0.68 (0.02) 0.66 (0.03) 0.61 0.60 (0.02) 0.58 (0.03) 0.82 (0.07) 0.78 (0.04) 0.72 (0.05)
PL 0.68 0.67 (0.02) 0.64 (0.03) 0.69 0.68 (0.02) 0.65 (0.02) 0.80 (0.08) 0.75 (0.04) 0.69 (0.05)
OL 0.64 0.57 (0.09) 0.47 (0.13) 0.59 0.53 (0.10) 0.45 (0.16) 0.32 (0.29) 0.22 (0.15) 0.17 (0.16)
TL 0.46 0.43 (0.04) 0.39 (0.07) 0.39 0.37 (0.03) 0.34 (0.06) 0.6 (0.21) 0.49 (0.13) 0.40 (0.15)
0.81 0.80 (0.01) 0.79 (0.01) 0.80 0.80 (0.01) 0.78 (0.01) 0.88 (0.07) 0.85 (0.05) 0.80 (0.07)
BGIT 0.53 0.51 (0.01) 0.49 (0.04) 0.50 0.49 (0.01) 0.47 (0.04) 0.81 (0.11) 0.75 (0.09) 0.69 (0.12)
Tot 0.81 0.81 (0.00) 0.79 (0.01) 0.81 0.81 (0.00) 0.79 (0.01) 0.89 (0.06) 0.86 (0.04) 0.81 (0.06)
Manolio 0.86 0.85 (0.01) 0.84 (0.01) 0.84 0.83 (0.01) 0.82 (0.02) 0.88 (0.08) 0.86 (0.06) 0.82 (0.09)
Fazekas
PV 0.81 0.78 (0.05) 0.73 (0.07) 0.80 0.78 (0.05) 0.73 (0.07) 0.69 (0.16) 0.63 (0.11) 0.57 (0.17)
DWM 0.69 0.68 (0.02) 0.65 (0.02) 0.68 0.67 (0.01) 0.64 (0.02) 0.75 (0.20) 0.69 (0.15) 0.61 (0.19)
Tot 0.82 0.81 (0.03) 0.79 (0.03) 0.80 0.78 (0.04) 0.76 (0.04) 0.82 (0.12) 0.78 (0.09) 0.73 (0.12)
Table 6.3: Explanatory value of the automated local lesion loads.Bold font corresponds to re-
sults for which the prediction had a numerically higher or equal ICC to the training
average than the mean interrater variability with the average using the same num-
ber of raters. Underlined values reflect higher correlation of the prediction with the
training average than the mean pairwise ICC (last column). For the scales, the par-
tial total refers to the sum of the Scheltens subscales excluding basal ganglia and
infratentorial regions.
in the degree of regional loading with a predominant effect of periventricular zones.
Compared to both the Fazekas and the Manolio scales, the Scheltens scale appears
to be more homogenously distributed across all brain regions. In turn, the Manolio
representation presents dominantly high correlations in periventricular regions.
The ability to explain the local and global scales based on the average gradings is
gathered in Table 6.3. For all studied visual scales and subscales, the ICC between the
predicted and the actual values when training on an average of two, three or four raters
and using either the designed local features or the global values are calculated. Results
show that: first, when predicting subscales, the use of regional burden from the same
anatomical location as the sub-scale allows for better predictions than using global
features. Furthermore, the ability to predict the rating scale scores appears to increase
with an increase in the number of raters used to obtain the training average gradings.
The correlation between average scores and prediction, based on volumetric regional
predictors was higher than the interrater variability for most scales, except in regions
with lower prevalence of lesions (e.g. temporal lobe, basal ganglia and infratentorial
regions - Figure 6.5). The inter-rater correlation variance was also found to be higher
than for the automated prediction model.
For all studied visual scales and subscales, the correlations between the predicted
and the actual values were calculated when training on an average of two, three or four
raters and using either the designed local features or the global value. The notation
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Pred4 indicates for instance that the prediction was trained with the average of four
raters. When appropriate (two or three raters) the results are given under the form
mean (SD). The correlations are compared to the average interrater variability when
correlating each rater with an average of complementary raters. Cons3 indicates for
example the mean correlation between the left out rater and the average of the three
other raters.
6.3.4 Creation of an online training tool in WMH visual grading
scales
With the recent advance in knowledge dissemination technologies, a web-based train-
ing suite was created to help improving the precision and accuracy of raters that is now
available at http://www.cmictig.cs.ucl.ac.uk/vrt/. The website’s par-
ticipant is offered a serie of 20 FLAIR scans to grade after choosing the rating scale
he/she wants to be trained in as illustrated in Figure 6.7.
For each of the scans, the trainee can, with an online viewer, scroll across the
images and has to decide about a grade for each of the relevant subscales. After a train-
ing session is completed, color coded local potential biases are given according to the
bullseye representation along with a literary interpretation of the training thus enabling
a local adjustment of the evaluation in a subsequent training. Figure 6.8 presents a view
Figure 6.7: Print screen of the training system when about to choose the scale to train on.
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Figure 6.8: Print screen of the training system when about to rate the presented image for
the periventricular subscales in the Scheltens scale. A reminder of the subscales
description is always made available to the trainee.
of a page of grading for the Scheltens scale.
6.3.5 Discussion
The relevance of the regional-zonal analysis tool was here demonstrated in deconstruct-
ing visual rating scales and evaluating rater performance, for which an online training
tool in visual rating is now available. Further applications may include comparison of
populations, based for instance on ethnicity, vascular risk factors or clinical mode of
presentation.
The regional lesion frequency features used in this work were shown to charac-
terise both spatial similarities and differences between visual rating scales. The re-
gional lesion loads were found to predict well the respective anatomical scores of the
visual rating scales. The Manolio and the Fazekas scores showed similar spatial cor-
relation patterns with an emphasis on the periventricular regions, while the Scheltens
scores were shown to correlate in a more balanced fashion with across brain regions.
The proposed data-driven approach reveals the source of discrepancies between visual
rating scores, as underlined by [18,64], and can be used to inform the choice of grading
scale for a clinical study or to improve the classical rating protocols.
Secondly, this new tool can illustrate the spatial source of bias between a single
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rater and the consensus standard. It can show that during the rating process, some
readers paid more attention to a particular region than others. The regional maps reveal
the anatomical locations that bias the rating behaviour of a particular rater, which can
be used to provide objective feedback. The model can therefore potentially be used
as a tool for training radiologists in order to improve their rating performance and
calibrate the application of visual rating scales, reducing inter and intra-rater variability.
Note that the presented maps estimate the per-region rater bias under the assumption of
regional independence, and does not model the correlation between regions.
Thirdly, the regional loads were shown to be predictive of the local and global
average rating scales. In order to test the ability to reproduce a consensus grading,
both the automated algorithm and each human rater were compared to the average of
ratings. The automated prediction model performed similarly in terms of interrater
variability for most regions with a reduced variance, outperforming human raters for
several regions. Various factors can be put forward as limiting the model’s ability
to predict the average rating scores: first, an explicit choice was made regarding the
regions relevant to each scale; second, the lesion burden feature used in this work does
not account for the size and count criteria of the Scheltens scale, a limitation that could
be mitigated by including other types of local lesion features. The proposed predictive
model performed better than human raters in sub-scales with a large degree of rater
disagreement, possibly due to disagreements among raters with regards to the regional
definitions [18].
One of the main strengths of this study pertains to the number of raters involved in
the visual grading of white matter lesions in three different scales, allowing for an ex-
haustive comparison between raters and scales, and for an unbiased assessment of the
utility of regional features and their ability to predict the average ratings. The current
study also has some limitations. The proposed method relies heavily on the accuracy
of the automatic lesion segmentation and of the lobes parcellation, with segmentation
errors impacting directly the analysis outcome. Also, due to ceiling and flooring effects
in visual scale assessment, the assumption of normality underpinning the use of the cor-
relation coefficient as a marker of regional influence may not hold. Finally, the relevant
regions used for feature extraction were selected empirically based on the literature
descriptions, possibly affecting the prediction outcome.
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The quality of clinical neuroimaging has continuously improved in the past years,
due to the move to higher field strength (3T) and the use of more advanced sequences.
For instance, the designs of the three visual rating scales mentioned in this study were
based on 2D T2 or PD weighted images obtained on 1.5T or 0.35T MR systems whereas
clinical practice has evolved towards the use of FLAIR imaging and volumetric data
acquisition without slice gaps. With the known increase in sensitivity, specificity and
correlation with clinical outcome when using 3T images [242], changes in rating scales
are expected. At higher loads, the non-linear relationship between scores and volumes
highlighted by Van Straaten et al. [62], contributes to a ceiling effect of the rating
scales that may explain the high inter-rater correlation observed in this work compared
to the literature [66]. In those cases, using volumes rather than scales would be more
appropriate, making automated classification even more relevant.
In conclusion, this application shows how local automatically extracted lesion
loads can contribute to the understanding of visual rating scales, their prediction and
the evaluation of raters. A web based training suite has been made available, that will
expand the training potential of the local lesion assessment, helping the rater to perform
local adjustments in their evaluation. Accurate semi-quantitative or quantitative assess-
ments of WMH burden are likely to gain importance in the near future as WMH are
biomarkers which can be used for assessing disease progression, therapeutic interven-
tion (such as blood pressure lowering drugs) or risk of intervention (carotid stenting)
and the bullseye plots will help to visualise associations with risk factors or differences
between populations.
6.4 Discussion
This chapter focused on the derivation and application in various contexts of a system-
atic patient-specific regional representation of the lesion spatial distribution. In order
to account for atrophy and global ageing changes, the otherwise dominant absolute dis-
tance to the ventricles was abandoned in favour of a relative distance measure derived
from the application of Laplace equation. Regions were delineated based on the prop-
agation of lobar parcellation and discretisation of this distance map. They are therefore
dependent on the quality of the segmentation and on the choices regarding the dis-
cretisation. At the population level, this systematic spatial information on the lesion
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distribution appeared to be beneficial to correctly associate twin pairs as demonstrated
in Section 6.2.3. Furthermore, its relevance was demonstrated in the context of the
description and prediction of visual rating scales (Section 6.3.3). In fact, it allows the
representation of tridimensional information in a bidimensional systematic way. In the
presented cases, volumetric characterisations were mostly used but other traits, such as
intensity, cardinality or shape may also prove pertinent to be studied locally in the case
of WMH. The systematic location scheme for lesion spatial distribution was used in the
two presented applications in a perspective of synthesis of information. Other applica-
tions could include the spatial characterisation of individual lesions or the longitudinal
evolution of the spatial distribution. The latter requires however a robust longitudinal
segmentations of WMH, task that will be examined in the following chapter.
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Chapter 7
Extension to longitudinal studies
7.1 Contextualisation
From afar or close, the concept of longitudinal change is inherent to any investiga-
tion related to ageing or evolving pathologies and the problem of assessing changes is
at the core of such studies. In a research-focused perspective, assessment of changes
are key points in further understanding the pathways of a biological process. Fur-
thermore, when implementing clinical trials, measures of change are often used as
surrogate end-points to assess the effect of a tested drug. Thus, robust and accurate
longitudinal measures of imaging biomarkers are necessary. In the case of WMH, even
though most studies are cross-sectional, progression is observed with time and has been
largely correlated with detrimental clinical outcome [243] in processing speed [244],
executive and motor function [245]. Risk factors including variability in systolic blood
pressure [246] and current smoking [41] have also been shown to relate to the pro-
gression of WMH. Moreover, the baseline lesion load of WMH appears repeatedly as
a strong predictor of WMH progression [3, 247]. Dedicated visual rating scales have
been developed for the assessment of lesion changes but volumetric analysis applied
cross-sectionally has been observed to be more reliable than visual rating scales [248].
Although semi automated volumetric assessments may tend to overestimate the change
when the scans are observed side by side [249], differences across automated methods
in detected volume change may also be quite high [250].
In the ageing process, automatic measurements of change such as atrophy of the
whole brain, specific structures or tissues have been greatly discussed and guidelines
have been defined to warn against and avoid generating bias [251]. As underlined by
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Reuter et al. [252], bias in longitudinal measurements can be introduced in different
ways ranging from the acquisition, due to changes in protocols and scanners, to pro-
cessing when a specific time point in the serial images is handled differently compared
to the others. In most longitudinal frameworks the main principle is to make use of the
inherent within subject correlation of measurements in order to reduce the variability
due to noise. Not accounting for this correlation may prove inefficient and lead to in-
creased sample sizes as underlined by Elliott et al. [253]; including all time points is
stated as a point for an improvement in quantification by Vrenken et al. [102].
Specific volumetric longitudinal strategies devoted to lesion in the WM have for
now been developed in the case of MS. Existing strategies use for instance intensity
subtraction between pair of images [254, 255] but can be biased by errors in the reg-
istration. Similarly, studying the deformation field may not be enough to account for
appearing lesions [253] when registration errors occur. Methods relying on the analysis
of the difference between registered time points images, as Rey et al. do [256], may be
further hindered by other volumetric changes occurring between the time points such
as atrophy or oedema.
Furthermore, in studies with long-term follow-up, in which the drop-off rate can be
high, (e.g. in age-related studies), being able to handle different numbers of time points
without constraint is necessary. In the context of age-related WMH, the progressive
characteristic of the damage can be taken as an argument for looking progressively at
image pairs as performed by Bosc et al. [257]. However, noise and artefacts, prevalent
in ageing or demented population, may affect methods based on progressive inference
[258]. Conversely, other solutions based on image averaging and model building may
prove advantageous.
7.2 Methods
To account for all these reported challenges, the use of average images to guide the
processing of longitudinal data has been promoted by Reuter et al. [259]. Thus, the so-
lution developed here consists first in creating average data summarising the per-subject
information contained at all time points (Section 7.2.1), followed by the derivation of
an appropriate Gaussian mixture model (GMM) (Section 7.2.2) that will finally be used
to constrain the data model at each time point (Section 7.2.3). At that stage, lesion seg-
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mentation can be obtained in a post-processing step, similarly to what has been detailed
in Chapter 5. The main assumption of this work, presented at the BAMBI workshop
at MICCAI 2015 is that despite changes related to atrophy and lesion expansion, each
subject’s brain will retain most of its morphological characteristics through time.
In addition to the notations introduced in Chapter 4, in the following, the sub-
script τ denotes the time point and GW the groupwise average. With N the num-
ber of voxels and D the number of modalities, images intensities are vectorised into
Y (d) = {yd1, · · · ,ydn, · · ·ydN} with ydn the intensity at voxel n of modality d, so that
Y =

Y (1)
...
Y (D)
 .
7.2.1 Creation of an intra-subject average image
In order to build the average appearance model, two main components linking the in-
dividual images to the average space are needed: a spatial transformation and an in-
tensity transformation. An intensity matching between images is needed to account for
changes in contrast, MR scanning variations and artefacts. These transformations are
obtained through an iterative process, proved to limit bias towards a specific time point.
In order to avoid unrealistic spatial deformations, affine transformations roughly
aligning the images are first applied before considering non-rigid transformations to
obtain the final spatial transformations Tτ→GW. At each iteration, the intensities of
the images spatially transformed to the GW space are mapped to the intensities of the
current average image using a polynomial fit of degree 2 for each modality. In order to
avoid the mapping to be biased by the presence of lesions or artefacts, it is possible to
exclude the most obvious outliers to obtain the mapping coefficients. More formally,
the intensity matching and the resulting mapping coefficients hˆτ for one modality on
the bias field corrected log-transformed intensities Yˆτ can be expressed as
hˆτ = argmin
hτ
‖ A(Yˆτ(Tτ→GW)))hτ − YˆGW ‖2
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where A
(
Yˆτ(Tτ→GW)
)
is the polynomial matrix transformation of Yˆτ(Tτ→GW) such that
A(Yˆ ) =

1 yˆ1 yˆ21
...
...
...
1 yˆN yˆ2N
 .
The steps to create an average appearance model are:
Step 1 Register each of the individual time points to the current average image.
Step 2 Map the relevant intensities of each resampled image to the current image using
a polynomial fit of degree 2.
Step 3 Average all resampled and intensity transformed images to create the new cur-
rent average image.
Step 4 Go back to step 1.
With this set up the loop is performed five times: the first time estimating a rigid trans-
formation then two affine transformations before allowing for a non-rigid registration
at the last two iterations. It has proved empirically to be enough to reach a reasonable
convergence.
7.2.2 Model selection
After creating the average appearance model, patient-specific tissue priors and brain
mask are obtained using the GIF pipeline [198]. In this method, label-fusion is used
to propagate the tissue segmentation, and the anatomical tissue priors (A) are obtained
as the output of the fusion step. BaMoS (cf Chapter 4) is applied on the average im-
age with a marginal modification to the initialisation stage. After the initial EM con-
vergence that uses flat inlier/outlier priors, uniform distributions for the outlier tissue
classes and a unique Gaussian component for each inlier class, a typicality map, that
represents the ability of the inlier part of the model to represent each voxel, is derived
according to the method detailed by Van Leemput et al. [79]. The typicality value for a
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given voxel n follows the expression
tn =
J
∑
j=1
pn j
G
(
yn
∣∣θI j)
G
(
yn
∣∣θI j)+ 1√
(2pi)D |ΛI j |exp
(
−1
2
κ2
) ,
where pn j = pnI j + pnO j and κ = 3.
In this expression, the level of outlierness accounts for the variability in the shape
of covariance matrices, and therefore balances the sensitivity of the outlier detection
between tissue classes. This typicality map, smoothed with Gaussian filtering is used
instead of the flat priors to perform BaMoS model selection framework. Once the final
GMM is obtained, the atlases are replaced by the smoothed result of the tissue seg-
mentation. The full model (number of Gaussian components, parameters and atlases)
is used to constrain the segmentation at each time point.
7.2.3 Constraint over time point
Three main components are needed to perform the individual time point segmentation
based on the model derived for the average image. In addition to the model on the av-
erage, both the spatial and the intensity transformations relating each time point to the
average space are required. The statistical patient-specific atlases are transformed into
the individual time points while the bias-field corrected intensities of the time point im-
age are transformed towards the intensity space of the average image by the application
of the polynomial transformation Mhˆτ described by the coefficients hˆτ on the data Yˆτ .
The introduction of constraints over the time point model parameters, through priors
based on the average model, is made possible by the intensity transformation. With
these constraints, the time point model is simply obtained by a parameter optimisation
of the model on the average through an EM procedure without allowing the complexity
structure (number of components per tissue class) to evolve. The diagram representing
the constraints over the time point is displayed in Figure 7.1. The introduction of priors
over the parameters to constrain the model is obtained using a normal distribution for
the mean and an Inverse-Wishart distribution for the covariance in order to maintain a
possible decoupling for the parameters optimisation. As such the expectation step is
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Mhˆτ (Yˆτ)
Final EM
Lesion segmentation
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Figure 7.1: Diagram of the constraints operated on each time point based on the model on the
average. Groupwise elements are in red while time point specific entities are in
blue.
not modified but the M-step consists in maximising the following:
Q
(
ΞτKGW
∣∣∣Ξτ (t−1)KGW )= EZτ |Yˆτ ,Ξτ (t−1)KGW ,hˆτ log
[
f
(
Yˆτ ,Zτ
∣∣ΞτKGW, hˆτ) · f (ΞτKGW∣∣∣ΞGWKGW)] .
The distribution f
(
ΞKGW
∣∣∣ΞGWKGW) in which the script τ has been dropped for no-
tation convenience is expressed as
f
(
ΞKGW
∣∣∣ΞGWKGW)= ∏
l∈I,O
J
∏
j=1
Kl j
∏
k=1
G
(
µ jlk
∣∣∣µGWl jk ,ΛGWl jk )W −1(Λl jk ∣∣∣N˜ΛGWl jk ,N) ,
where G refers to a normal distribution and W −1 to an Inverse-Wishart distribution
with N˜ = N+D+1. The differentiation with respect to µ l jk then results in
∂Q
∂µ l jk
=
N
∑
n=1
pnl jk
∂
∂µ l jk
logG
(
Mhˆ(yˆn)
∣∣∣µ l jk ,Λl jk)+ ∂∂µ l jk logG
(
µ l jk
∣∣∣µGWl jk ,ΛGWl jk )
=
N
∑
n=1
pnl jk
(
Mhˆ(yˆn)−µ l jk
)
Λ−1l jk −
(
µ l jk −µ
GW
l jk
)
ΛGWl jk
−1
.
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Solving for µ l jk that annuls it then leads to
µ l jk =
(
N
∑
n=1
pnl jk Mhˆ(yˆn)Λ
−1
l jk
+µGWl jk Λ
GW
l jk
−1
)
·
(
N
∑
n=1
pnl jkΛ
−1
l jk
+ΛGWl jk
−1
)−1
.
Similarly the derivation with respect to Λl jk can be expressed as
∂Q
∂Λl jk
=
N
∑
n=1
pnl jk
∂
∂Λl jk
logG
(
Mhˆ(yˆn)
∣∣∣µ l jk ,Λl jk)
+
∂
∂Λl jk
logW −1
(
Λl jk
∣∣∣N˜ΛGWl jk ,N)
=
1
2
[
N
∑
n=1
pnl jk
(
−Λ−1l jk +Λ
−1
l jk
(
Mhˆ(yˆn)−µ l jk
)T (
Mhˆ(yˆn)−µ l jk
)
Λ−1l jk
)
+
(
−N˜Λ−1l jk +Λ
−1
l jk
N˜ΛGWl jk Λ
−1
l jk
)]
.
Finding the solution for Λl jk that nulls the differentiation obtained above consists of
resolving(
N˜+
N
∑
n=1
pnl jk
)
Λ−1l jk =
(
N
∑
n=1
pnl jkΛ
−1
l jk
(
Mhˆ(yˆn)−µ l jk
)T (
Mhˆ(yˆn)−µ l jk
)
Λ−1l jk
)
+ N˜Λ−1l jk Λ
GW
l jk
Λ−1l jk
N˜+
N
∑
n=1
pnl jk = Λ
−1
l jk
[
N
∑
n=1
pnl jk∆l jk + N˜Λ
GW
l jk
]
Λl jk =
∑Nn=1 pnl jk∆l jk + N˜Λ
GW
l jk
N˜+∑Nn=1 pnl jk
.
With ∆(t)l jk
the weighted covariance matrix, the parameters updated during the maximi-
sation step are modified into
µ (t)l jk
=
(
N
∑
n=1
p(t)nl jk
Mhˆ(yˆn)Λ
−1(t−1)
l jk
+µGWl jk Λ
GW
l jk
−1
)
·
(
N
∑
n=1
p(t)nl jk
Λ(t−1)l jk
−1
+ΛGWl jk
−1
)−1
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Figure 7.2: Scheme of the main aspects of the longitudinal framework.
Λ(t)l jk
=
N˜ΛGWl jk +
N
∑
n=1
p(t)nl jk
∆(t)l jk
N
∑
n=1
p(t)nl jk
+ N˜
.
The global scheme with the three main steps of the longitudinal framework (average
creation, model selection, time point constraint) is displayed in Figure 7.2.
7.3 Validation through simulation
7.3.1 Lesion simulator
7.3.1.1 Context
Due to the difficulty to obtain reliable, robust and reproducible ground truth from man-
ual segmentations, a potential alternative is the use of simulated data. In the majority
of the cases, an MRI simulator uses the pulse sequence parameters with the inclusion
of additional artefacts such as bias field and noise and produce completely synthetic
images based on tissue maps characteristics. Typically, the Brainweb project is such an
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example and is recommended as an initial step in the validation of lesion segmentation
algorithms [50]. As underlined by Lladó et al. [50] and Prastawa et al. [260], these
simulators do not allow for much variability and realism in the depiction of pathology.
In the case of Brainweb, only three lesion models of MS type lesions are available.
Using statistical texture, Prastawa et al. [260] have simulated contrast-enhanced MR
images of brain tumours. Closest to a longitudinal simulation, Melhem et al. [261] have
developed a simulator of healthy tissues and a lesion of varying size whose intensity
characteristics were derived from a single clinical scan. The simulation was designed to
evaluate the limit at which change in a lesion becomes noticeable for trained observers.
However, global longitudinal simulations are yet to be developed. In the lesion sim-
ulator developed here, clinical images are used as a basis both for healthy tissue and
typical lesion location. Similarly to the synthetic images created for validation pur-
poses in the studies of Jack et al. [103] and Gibson et al. [156], lesions are transferred
on the background clinical images. Since the transfer is based on probabilistic maps,
the applied lesion maps can then be adapted and evolution patterns simulated.
7.3.1.2 Cross-sectional simulation of images with lesions
In line with the synthetic image simulator detailed by Jack et al. [103], two sets of data
are used to simulate lesions: a receiving set, composed of subjects with minimal to no
WMH, and a donating set, composed of images with noticeable WMH lesion load and
their associated probabilistic lesion segmentation L. The process of simulating lesions
involves the spatial transformation of the lesions from the donating set to the receiving
set and the creation of appropriate lesion intensities.
After registration, smoothing and normalisation of the donating lesion map to the
receiving set, the probability maps are transformed into intensity maps by drawing
samples of Gaussian distributions with parameters derived from the data distribution of
the receiving set and using the probabilistic map to weight them.
To account for variation over time of scanner characteristics and subject position-
ing, random bias field and rigid transformations are applied to the images. The bias
field, modelled as a linear combination of polynomial basis functions (cf Section 3.2.1)
is obtained by randomly choosing the basis coefficients.
Given a probabilistic lesion map L, the Gaussianly sampled lesion intensities G,
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Figure 7.3: Different steps in the production of the simulated image with lesion from the initial
lesion free image to the final image. In this case, no rigid transformation is applied.
the log-transformed bias field BF , the rigid transformation R and the initial image I,
the final simulated image S can be expressed at voxel n by
Sn = R(exp(BFn)(LnGn+(1−Ln)In)) .
An example of the sequential intermediate steps of the production of the image
with inpainted lesion starting from an initial image with minimal lesion load is pre-
sented in Figure 7.3.
7.3.1.3 Longitudinal simulation
In order to ensure the realism of the lesion evolution and avoid extension of the lesions
onto unwanted tissues, the simulation process starts at the point of maximum lesion
load. Furthermore, if the ventricle segmentation is known, the periventricular nature of
lesions can be maintained.
To simulate smaller lesions, the initial propagated WMH load is modified by
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thresholding the probabilistic lesion segmentation at a certain value X , followed by
a normalisation step, i.e. Lnewn = (Ln−X)/X ∀Ln > X , with L being the original lesion
probability map. The value of X is chosen to produce an exact volumetric reduction in
WMH of D. As Lnew can contain non biologically plausible hard edges, it is then Gaus-
sianly smoothed. Due to the non-volume-preserving nature of the Gaussian smoothing
process, Lnew is finally re-mapped to have an exact reduction in WMH volume of D
trough a piecewise linear transformation.
Defining pb such that
]LS|LS > pb = ]L|L> 0.5−D,
the following system to define the two linear mapping is solved:
b1 = 0
a1 · pb+b1 = 0.5
 if LS < pb a2 · pb+b2 = 0.5a2+b2 = 1
 if LS > pb
In case the volume by which to decrease the lesion volume is higher than the remaining
lesion volume itself, no change is applied to the lesion map. This is done to ensure a
minimal amount of WMH as usually observed in ageing population. Considering an
evolution pattern with more than two time points, the changes occur iteratively, i.e. a
change in volume is applied on the last built lesion map. Although this would limit the
evolution to monotonic decreasing patterns, the lesion maps order can be reshuffled.
The lesion simulator flowchart is displayed in Figure 7.4. An example of the
outcome of the lesion simulator is presented in Figure 7.5 on which the same slices of
the FLAIR image (before rigid transformation and bias field application) is presented at
four time points of the lesion evolution with a non linear change of 15% of the volume
at each time point.
As seen in Chapter 5, the use of a manual gold standard for the validation of
automated algorithm is questionable and obtaining valuable manual segmentations is a
long and difficult process. Additional measures of segmentation robustness and validity
as those presented in Section 5.2.4 can be of interest but do not reflect the relevance of
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{G1, · · · ,Gt}{BF1, · · · ,BFt}{R1, · · · ,Rt}
Images
building
{S1, · · · ,St}
Figure 7.4: Representation of the lesion simulator flow chart. I refers to the initial images, L
to probabilistic lesion maps, V to the ventricle segmentation, G to the Gaussian
intensity sampling, BF to the randomly generated bias field, R to the rigid trans-
formations applied during the simulation and S to the simulated images. The red
elements correspond to unique images whereas blue entities correspond to sets of
multiple elements.
Time point 1 Time point 2 Time point 3 Time point 4
Figure 7.5: Results of the lesion simulator before application of the bias field and of the affine
transformation for four time points with a volume change of 15% per step on two
slices. For realism purposes and to simulate an overall increase in the lesion loads,
the order in which the images are simulated is reversed.
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the segmentation. In the case of longitudinal assessment, given the variability inherent
to manual segmentations, classical overlap assessments are not practical. The simulator
described above was used as an alternative to those issues so as to test the longitudinal
framework in different conditions of longitudinal evolution and compared to the cross-
sectional versions of BaMoS.
7.3.2 Experiments
7.3.2.1 Evaluation schemes
Since this simulator was designed to account for longitudinal changes, different evo-
lution patterns with varied maximum lesion loads and diverse number of time points
were tested.
The database used for WMH simulation comprised of 5 donating images and 17
receiving images. 4 patterns were simulated using the following:
Linear_500 : Linear reduction of 500 mm3 per step, spanning 6 time points.
Linear_750 : Linear reduction of 750 mm3 per step, spanning 4 time points.
NonLinear_5 : Non-linear reduction of 5% per step, spanning 6 time points.
NonLinear_15 : Non-linear reduction of 15% per step, spanning 4 time points.
Although the progressions are simulated by reducing the lesion load, for clinical
realism and illustration purposes, the time points were then reordered to simulate a
progressive increase in lesion load.
For each of these progression schemes, two additional plateauing patterns were
added to test for longitudinal bias:
Flat_High 1 time point with highest load was added to form a high plateau.
Flat_Low 2 time points with lowest load were added to form a low plateau.
Finally, to simulate treatment effect, composite patterns were created using the
linear patterns in order to simulate changes in the slope:
Treatment One increase step of 750 mm3 followed by two steps with an increase of
500 mm3 each.
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Figure 7.6: Left). Example of the four tested evolution patterns. The dashed horizontal lines
represent the plateauing experiments at either high (Flat_High) or low (Flat_Low)
load. Right) Example of the combination of two linear patterns to model a treat-
ment related change.
No treatment 3 steps with an increase of 750 mm3 per step.
Figure 7.6 left plots the four typical evolution paths with different minimum loads
and their associated plateauing versions while Figure 7.6 right presents the combination
of linear patterns to simulate the treatment effect case.
7.3.3 Segmentation assessment
The longitudinal framework (Long) was compared to the cross-sectional application of
BaMoS both in its original version (Cross) [262] and its sensitivity enhanced variant
(Cross+), i.e. when using the typicality map to estimate the outlier atlas. As the re-
ceiving images used in the simulation can contain trace amounts of lesions, the region
where all methods agreed to the presence of lesions for the time point with minimal
lesion load was excluded from the analysis, both in terms of volume and overlap.
Ground truth (GT) lesion segmentations are thus the simulated lesion probability
maps corrected for the baseline lesion segmentation intersection of all given methods.
Statistics of the ground truth volumes are presented in Table 7.1. Those corrected dif-
Linear 500 Linear 750 NonLinear 5 NonLinear 15
Mean 2645 2793 2871 2510
SD 2594 2619 2519 2307
Median 2379 2542 2881 2206
IQR [188 3941] [314 4176] [467 4040] [401 3745]
Table 7.1: Summary of the ground truth volumes (Lesion probability map - intersection of
baseline segmentations) across the different evolution patterns.
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DSC TPR AvDist OE/TotF OEFP/FP OEFN/FN FP/TotF
Linear 500 64.9 83.3 2.07 80.5 72.1 96.6 82.7[28.1 77.1] [65.9 90.6] [1.00 9.87] [48.3 90.4] [40.7 86.8] [88.1 100] [59.8 91.7]
Linear 750 66.3 80.2 2.00 80.2 70.3 94.0 78.9[35.2 77.2] [56.9 88.5] [0.86 6.06] [57.4 90.6] [45.7 87.0] [81.0 98.0] [56.4 87.9]
NonLinear 5 66.1 81.0 1.90 82.4 74.1 97.4 77.1[40.5 76.0] [64.7 88.4] [0.96 5.51] [67.3 90.4] [54.4 87.0] [91.9 99.6] [55.7 86.9]
NonLinear 15 64.4 78.6 2.02 79.1 70.4 95.2 75.2[41.4 76.5] [64.5 86.3] [0.98 6.28] [60.4 89.9] [51.0 85.1] [87.8 98.6] [57.7 85.3]
Table 7.2: Segmentation assessment table for the longitudinal framework according to the dif-
ferent strategies of evolution. Definitions of the assessment measures are given in
Section 5.2. AvDist is given in mm and all the other measures in %.
ferences were finally compared in terms of Dice score coefficient (DSC), true positive
rate (TPR) and average distance (AvDist) as defined by Styner et al. [159] and their
statistics calculated over subjects and time points. The origin of the errors was further
investigated differentiating false positive (FP) and false negatives (FN), outline (OE)
and detection error (DE) as introduced by Wack et al. [202] and detailed in Section 5.2.
Due to the non normality of the differences, when comparing across methods, paired
Wilcoxon tests were used while two sample tests for unmatched data were used when
comparing across evolution patterns.
7.3.4 Results
7.3.4.1 Evolution patterns and bias
The assessment across the evolution patterns are presented in Table 7.2. There was
no significant statistical difference relative to the differences in DSC for the pairwise
Wilcoxon tests performed but a trend towards better scores for patterns with lower
ranges of change was observed (NonLinear_5 and NonLinear_15). Confirming the
observations of relationships between lesion load and DSC mentioned in Section 5.2.2,
lower loads (Linear_500) showed a trend towards lower DSC.
Possible bias introduced by a flat WMH load at the lowest (Flat_Low) or at the
highest (Flat_High) end of the progression period was evaluated on the common time
points between the sets. The results for this experiment are presented in Table 7.3
emphasising the stability of the method when including plateauing time points.
7.3.4.2 Comparison between cross-sectional and longitudinal methods
In order to compare the proposed longitudinal version of BaMoS with the cross-
sectional methods, the assessment measures were calculated for the 1360 baseline cor-
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DSC TPR AvDist OE/TotF OEFP/FP OEFN/FN FP/TotF
Flat Low 65.4 81.2 2.06 81.0 72.0 96.4 77.3[37.1 76.8] [66.1 88.5] [0.94 6.67] [60.0 90.1] [50.2 86.3] [88.9 99.4] [58.8 88.3]
Flat High 65.9 80.9 1.99 81.0 72.4 96.4 78.2[37.2 77.1] [64.8 89.1] [0.96 6.51] [60.6 90.0] [50.1 86.7] [89.5 99.4] [60.1 88.9]
Slope 65.4 81.1 2.01 81.0 72.1 96.1 77.8[36.7 76.7] [64.2 88.8] [0.96 6.50] [59.6 90.3] [48.5 86.5] [88.1 99.3] [57.5 88.3]
Table 7.3: Segmentation assessment measures when evaluating the influence of plateauing
stages on the longitudinal framework. By contrast to Flat_High and Flat_Low, Slope
refers to a pattern without plateauing values. Results are given under the format me-
dian [IQR] and are obtained across all subjects and common time points. Definitions
of the assessment measures are given in Section 5.2.
rected difference lesion segmentations generated for each of the three compared meth-
ods. The corresponding results are summarised in Table 7.4. The pairwise statistical
significance for the differences across methods for the DSC, TPR and AvDist were ob-
tained with a paired Wilcoxon test. An increased performance in the order Cross <
Cross+ < Long was observed and all tests were significant with p-value <0.0001 ex-
cept for the average distance between the Long and Cross+ (p=0.13). The comparison
of the DSC across methods for the different progression patterns is presented in Fig-
ure 7.7 illustrating the larger variances in assessment measures for the cross-sectional
DSC TPR AvDist OE/TotF OEFP/FP OEFN/FN FP/TotF
Linear 500
Cross 18.1 15.5 11.38 55.5 38.2 65.2 9.5[2.0 47.2] [1.38 38.8] [3.0 22.4] [18.2 84.3] [12.1 65.4] [17.1 92.1] [2.1 31.6]
Cross+ 61.0 73.6 2.33 79.6 70.5 92.9 65.3[18.8 76.2] [34.3 86.0] [0.97 12.3] [43.7 90.3] [37.8 87.2] [68.3 99.0] [39.7 83.8]
Long 64.9 83.3 2.07 80.5 72.1 96.6 82.7[28.1 77.1] [65.9 90.6] [1.00 9.87] [48.3 90.4] [40.7 86.8] [88.1 100] [59.8 91.7]
Linear 750
Cross 26.9 19.6 6.44 61.2 42.2 66.1 8.8[2.9 54.0] [2.0 43.0] [2.51 21.31] [21.3 86.9] [18.6 76.6] [21.6 89.9] [2.2 24.8]
Cross+ 66.4 72.5 2.00 80.5 69.2 87.8 60.6[32.6 77.0] [45.2 82.9] [0.91 6.5] [56.8 89.6] [45.2 86.8] [63.1 96.0] [38.8 77.4]
Long 66.3 80.2 2.00 80.2 70.3 94.0 78.9[35.2 77.2] [56.9 88.5] [0.86 6.06] [57.4 90.6] [45.7 87.0] [81.0 98.0] [56.4 87.9]
NonLinear 5
Cross 14.2 9.1 11.19 55.1 31.3 59.5 6.1[0.8 43.2] [0.4 30.3] [3.63 22.68] [18.8 84.6] [11.1 59.7] [17.9 89.6] [1.5 16.2]
Cross+ 63.8 73.0 1.98 81.6 69.9 92.8 57.0[32.3 76.4] [39.0 82.9] [0.92 7.4] [57.8 90.3] [44.7 86.9] [76.3 97.7] [28.5 77.8]
Long 66.1 81.0 1.90 82.4 74.1 97.4 77.1[40.5 76.0] [64.7 88.4] [0.96 5.51] [67.3 90.4] [54.4 87.0] [91.9 99.6] [55.7 86.9]
NonLinear 15
Cross 21.0 14.3 8.64 59.0 41.2 61.8 7.8[4.5 46.2] [2.5 32.0] [3.30 18.86] [25.3 84.0] [16.7 69.0] [24.6 89.5] [2.2 20.0]
Cross+ 59.8 70.0 2.34 80.4 69.9 91.1 56.0[33.1 73.9] [40.1 81.2] [1.00 6.54] [58.2 89.4] [40.5 84.0] [78.5 96.7] [30.0 76.3]
Long 64.4 78.6 2.02 79.1 70.4 95.2 75.2[41.4 76.5] [64.5 86.3] [0.98 6.28] [60.4 89.9] [51.0 85.1] [87.8 98.6] [57.7 85.3]
Table 7.4: Segmentation assessment comparison for the three compared methods across all
subjects and time points for all non plateauing patterns, subjects and time points.
Results are given under the form median [IQR]. Definitions of the assessment mea-
sures are given in Section 5.2.
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Figure 7.7: Comparison of the DSC distributions between the three methods across the differ-
ent evolution patterns for the non-plateauing cases.
Cross Cross+ Long
Figure 7.8: Regression plots of the segmented volume against the reference volume both cor-
rected for the baseline segmentation intersection. Regression for the two cross-
sectional methods (Cross and Cross+) and the longitudinal (Long) one are pre-
sented.
methods compared to the proposed longitudinal version.
Additionally, the robustness was tested through a linear regression of the ground
truth volumes against the segmented volumes for all time points and subjects of the
non-plateauing evolution patterns considering all time points independently. Figure 7.8
displays the regression plots while Table 7.5 summarises the regression parameters.
Cross Cross+ Long
Slope 0.31 [0.25 0.38] 0.92 [0.82 1.02] 0.99 [0.91 1.07]
Const -5 [-115 106] 324 [142 507] 662 [480 845]
R2 0.41 0.79 0.86
Table 7.5: Coefficients of the regression between segmented volume and reference volume for
the three segmentation methods compared. The constant value is given in mm3.
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Figure 7.9: Mean DSC evolution in time with 95 % CI across the three evaluated methods for
all subjects and non plateauing evolution patterns. Early time points correspond to
smoother lesions and lower overall load.
Lastly, the longitudinal evolution of the DSC, corrected for the agreement volume at
baseline, was compared across methods using a linear mixed model. Significant differ-
ence was observed in the slopes with a quicker decrease in DSC for the cross-sectional
methods (p-value < 0.0001 and p-value =0.007 for Cross and Cross+ respectively).
The corresponding plots of the predicted mean DSC are presented in Figure 7.9. This
illustrates, above the effect of the lesion volume, the impact of the smoothness of the
lesions on the quality of the segmentation.
7.3.4.3 Simulation of treatment effect
For the 51 concerned cases, the slopes of WMH volume change were assessed using
linear mixed models to compare the fast evolution (linear change of 750 mm3 per step)
and the combined evolution (initial step of 750 mm3 change followed by two steps of
500 mm3 change) after the simulated treatment effect. The results of the estimation is
presented in Table 7.6 exposing notably the lower measurement variance observed for
the longitudinal framework compared to the cross-sectional methods.
7.3.5 Discussion
In this set up, the main strength of the simulator is also to some degree its main weak-
ness. The realism of the simulator comes from the fact that real clinical data is used
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Cross Cross+ Long
Treatment Mean 439 532 370CI [282 596] [383 681] [269 471]
No treatment Mean 786 782 627CI [597 975] [629 935] [525 729]
Statistics p-value 0.006 0.022 0.004
Table 7.6: Slope estimation after evolution bifurcation for the three methods. Mean and confi-
dence intervals (CI) are given for the two slopes.
both for the receiving and the donating set. However, the linear probabilistic intensity
weighting using both the receiving set signal and the sampled lesion intensities may
lead to some values incompatible with those expected according to the lesion ground
truth. On one side, if a voxel is slightly hyperintense in the receiving image, it may
appear truly hyperintense in the synthetic image even though the probabilistic weight
would on its own not allow for such a classification. In turn, if lesion intensities with
a relatively high probabilistic weight are to be combined with low intensities on the
receiving set, due for example to the presence of iron, the resulting synthetic intensity
may not satisfy the conditions necessary to be considered as lesion. Instead of drawing
samples from typical distributions only for the lesion intensities, a possible alternative
would be to also simulate healthy tissue distributions. In lieu of a probabilistic lin-
ear combination of intensities, another solution would be to derive the Mahalanobis
distance associated to a given lesion probability, calculate the corresponding inten-
sity based on existing inlier models and add centered Gaussian white noise afterwards.
Moreover, other methods of intensity interpolation could be implemented and their
impact studied. Lastly, it must be highlighted that the generalisability of the results
obtained through the simulator is highly dependent on the donating lesion maps and
receiving sets. Therefore, prior to simulation, a careful choice of the relevant dataset is
strongly recommended.
Here, the simulation is applied to existing clinical data so that the realism of the
simulated images is high. It must however be noted that the lesion simulator, although
tested with different lesion loads, is based on typical age-related lesion distribution pat-
terns as observed in the ADNI dataset that by design gathers subjects with limited car-
diovascular risk factors (Maximum Hachinski score of 4). Increasing the variability of
the lesion maps as well as the anatomical shape of change used for the simulator would
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be of further interest. Since volumetric brain tissue changes occur also in ageing, sim-
ulation of atrophy patterns combined with lesion increase would further improve the
realism of the simulator. With respect to the longitudinal framework, this simulator
allowed the evaluation of the impact of evolution patterns on the segmentation perfor-
mance as well as the impact of periods without change on the progression detection.
From the assessment of the longitudinal framework across evolution patterns, subjects
with smaller variations in WMH load led to slightly better overall segmentation results
although no statistical difference was observed.
Investigating longitudinal bias through volume plateauing, the stability in the re-
sults highlights the ability of the longitudinal framework to detect change even if peri-
ods of no-change are included. This stability is crucial in processes for which subtle and
irregular progressions are observed, such as multiple sclerosis. In terms of error, most
of the erroneous classifications appear at the border of the lesions and very few lesions
were completely undetected as illustrated by the high proportion of outline error. The
comparison between the longitudinal and the cross-sectional versions of BaMoS under-
lines the improved robustness of the proposed framework with higher performance and
lower variance in the results. Although a positive constant bias was observed with re-
spect to the expected volumes, the strong correlation observed between segmented and
reference volumes (R2=0.86) makes the detection of change trustworthy. The ability to
detect longitudinal rate of change was further exemplified in the simulations of treat-
ment effect. In this case, the difference observed between evolutions is similar to the
simulated ground truth difference. A decreased variance reflects higher measurement
robustness compared to both cross-sectional methods and would translate into a lower
required sample size in the context of a clinical trial.
7.4 Clinical application
The longitudinal framework was used to explore the evolution of WMH in the age-
ing population with respect to genetic status and especially APOE. While no direct
quantitative validation is possible in this case, comparison with findings reported in the
literature can highlight the relevance of the proposed method.
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7.4.1 APOE and WMH
The APOE gene, located on the 19th chromosome is present in the human population
under the three main isoforms APOE ε2, APOE ε3 and APOE ε4. Their expression
results in different forms of the apolipoprotein E (apoE), plasma cholesterol transport
protein highly implicated in the regulation of lipid transfer and lipolysis. The different
effects of the isoforms in terms of neurodegeneration do not seem to be related to
the differences occurring in terms of lipid metabolism. In terms of prevalence of the
different alleles, APOE ε3 is the more common before APOE ε4 and APOE ε2. If the
liver is the main producer of apoE in the rest of the body, in the brain, astrocytes and to
a lesser extent glia are the privileged production location [263].
The version ε4 is widely recognised as a major risk factor for the incidence of AD
and a decrease in the age of onset [264] and is thought to have a deleterious impact
on the cerebral vasculature [265]. If the presence of one allele ε4 increases the risk of
developing AD 3-fold, this value is up to 12-fold in case of homozygosity. Although it
affects the onset of the disease, impact on the disease progression is less certain. Re-
quired for the sustainment of neuronal plasticity, its activity in the repair of the nervous
system appears to be lower in the case of the apoE4 isoform [266] and apoE is sug-
gested to be implicated in myelin repair [16]. Neurotoxicity of cleaved forms of apoE
have also been mentioned.
With respect to the Aβ pathological pathway, apoE isoforms have been shown to
contribute differently to the fibrillisation of Aβ oligomers and to Aβ clearance with
increased fibrillisation and impaired clearance in the case of the isoform apoE4 and
contributes to an increased Aβ deposition both in the parenchyma and in the blood
vessels [265, 266].
If the synergetic circle linking WMH, Aβ and amyloid deposition is widely doc-
umented [264, 265, 267, 268], other biological hypotheses have been entertained to ex-
plain the relationships between APOE status and WMH apart from amyloid pathology
as reviewed by Tai et al. [269]. APOE ε4 allele has indeed been linked with the per-
meability of the BBB and with a decrease in the tight junctions of the blood vessels’
endothelium [270]. Presenting affected pericytes that contribute to the BBB effective-
ness, in AD, APOE ε4 carriers have been shown to display a higher BBB permeabil-
ity [263]. An increased permeability could in turn lead to neuroinflammatory processes,
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which may contribute to the development of WMH. Besides, the dose-dependent effect
of the number of ε4 alleles could be linked to the hypothesis of the protective effect of
allele ε3 on the BBB with respect to neuroinflammation [271]. Furthermore, APOE ε4
has been associated with a decrease in glucose uptake, thus leading to deprived regions
more vulnerable to ischaemia [272]. The homozygous ε44 presentation of the APOE
genotype has been associated with a reduction in capillary surface [273] in AD; this
reduction would directly affect the blood supply in white matter, thereby promoting
the development of WMH lesions. Further damage to the blood vessels associating
for instance APOE ε4 with microbleeds [274] and coronary heart disease [275] or
stroke [276] could be lastly related to the exacerbated deleterious effects of vascular
risk factors on WM in APOE ε4 carriers [277, 278].
Considering the direct or secondary impact of APOE on the brain vasculature, as-
sociations have been investigated between age-related WM damage and APOE genetic
status. Although meta-analyses tend to find a relation between APOE ε4 and WMH
burden [279], a few studies challenge this relationship [280, 281] and the question of
an early effect on the white matter microstructure is controversial [282, 283].
7.4.2 Data and experiments
Publicly available, with T1 and FLAIR images, acquired at multiple time points for
many subjects along with genetic samples, blood and CSF samples and neuropsycho-
logical evaluations, the ADNI (Alzheimer’s Disease Neuroimaging Initiative) database
arose as the database of choice to assess this longitudinal framework in a clinical set-
ting.
At their initial visit, following clinical and neuropsychological assessment, each
subject was given one of four diagnoses: Normal control (NC), early mild cognitive
impairment (EMCI), late mild cognitive impairment (LMCI) or probable AD. Subjects
with a Hachinski score for cerebrovascular disease higher than 4 were excluded from
the study thereby limiting the range of WMH load at baseline.
Subjects from the ADNI database were selected on criteria based both on scan rel-
evance and genetic status. Those with an APOE ε2 allele were excluded as it is thought
to have a protective effect against over-production of Aβ42 [284]). Only subjects for
whom at least four imaging time points with serial FLAIR scans were available were
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selected. In order to avoid introducing any preprocessing bias into the analysis, only
subjects with T1 scans preprocessed with N3 histogram sharpening, and corrected for
B1 bias field and gradient non linearity were used. Subjects were further excluded if
they had poor quality imaging.
The genotyping for APOE was performed at screening visit using DNA extracted
by Cogenic using a 3 mL aliquot of EDTA blood while the level of CSF Aβ is ob-
tained using the xMAP Luminex platform and the Innogenetics/Fujirebio AlzBio3
immunoassay kits. Further details on the diagnostic procedure, scanning and imag-
ing protocols as well as genotyping and Aβ measurement can be found at http:
//www.adni-info.org/scientists/ADNIStudyProcedures.aspx.
The longitudinal BaMoS framework was applied to the different sets of images
while the total intracranial volume (TIV) is automatically obtained from the average
image using the previously mentioned GIF pipeline [198].
7.4.3 Statistical analysis
All the statistical analyses were performed using Stata 12 v1. Due to the skewness of
the WMH volumes, they were log-transformed. Cross-sectional analysis of the log-
transformed WMH volumes at baseline was performed using linear regression models
including age, TIV and sex as covariates in all models. Four models were fitted: these
included diagnosis status (Model ASTD), genetic status (Model ASTG), diagnosis sta-
tus and genetic status (Model ASTGD), and genetic status and CSF Aβ concentration
(Model ASTGAβ ) as predictor variables. Joint F-tests were used to assess differences
between groups after adjustment for covariates. Fitted group specific means, standard-
ised to the mean levels of covariates in the sample as a whole (with 95% confidence
intervals), were also computed and back-transformed.
Longitudinal changes in WMH volume were assessed using linear mixed models,
with random intercepts and slopes, for the repeated measures. Linear mixed models,
provided that they are properly specified, appropriately allow for the non-independence
of repeated measures from the same subject [285]. The dependent variable in all models
was the log-transformed volume of WMH with time from initial measurement treated
as both a fixed and random effect (thereby allowing slopes to differ between subjects).
Other fixed effects were group terms (diagnosis and/or APOE status) and group-time
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interaction terms (thereby allowing mean rates of change to differ between groups)
and age, TIV and sex and their interactions with time. One model (Model ASTG)
investigated differences in slope between the APOE groups, a second (Model ASTD)
differences between the diagnostic groups and a third (Model ASTGD) differences
according to both of these factors simultaneously. A fourth model (Model ASTGAβ )
investigated APOE status and CSF Aβ concentration as predictors of rates of decline.
Joint Wald tests were used to compare rates of change between groups after adjustment
for covariates. Fitted group specific mean rates of change, standardised to the mean
levels of covariates in the sample as a whole (with 95% confidence intervals), were
computed and back-transformed for each model.
7.4.4 Results
7.4.4.1 Demographic results
The inclusion criteria led to the selection of 300 subjects that collectively underwent
1430 scans. The number of acquired time points varied from 4 to 7 (mean 4.77 SD
0.73) and the total length of time since initial assessment varied from 11 to 52 months
(mean 24.0, SD 9.4). The demographics of the included sample are presented in Table
7.7 by genetic status and diagnostic group. As expected, a decrease in CSF amyloid
level was observed with an increasing diagnosis severity and an increasing number of
APOE ε4 allele. Although age was comparable across APOE status, EMCI and LMCI
were younger than NC and AD.
7.4.4.2 Cross-sectional associations of WMH
The baseline data are summarised in Table 7.8. There was evidence (p = 0.030, Model
ASTD) that the volume of WMH differed between the diagnosis severity groups, the
difference being mostly driven by the low volumes observed in NC compared to the
three other groups. Although the mean in the AD group was slightly lower than that in
the EMCI and LMCI groups, these differences were not statistically significant and the
95% confidence interval for AD group mean was wide, reflecting the fact that this group
contains the fewest subjects. Similar results were seen when the differences between
the diagnostic groups were adjusted for APOE genetic status (p-value from joint test
of differences = 0.066, Model ASTGD). Considering the Aβ level as a continuous
marker also provided evidence of an association (p<0.0005) with (Model ASTGAβ ) or
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Diagnosis APOE status33 43 44 Global
Number
Total [Female Aβ ]
NC 56 [27 53] 18 [9 15] 3 [0 3] 77 [36 71]
EMCI 76 [37 73] 52 [21 50] 4 [0 3] 132 [58 126]
LMCI 27 [12 26] 24 [17 23] 11 [5 11] 62 [34 60]
AD 9 [3 9] 14 [5 14] 6 [1 6] 29 [9 29]
Global 164 [79 161] 108 [52 102] 24 [6 23] 300 [137 286]
Study duration
(months)
mean (SD)
NC 23.1 (7.4) 21.9 (4.9) 25.3 (0.6) 22.9 (6.8)
EMCI 26.1 (10.4) 27.4 (12.1) 30.8 (12.2) 26.7 (11.1)
LMCI 23.9 (5.6) 23.4 (8.1) 19.1 (6.0) 22.8 (6.9)
AD 14.6 (4.1) 15.8 (5.9) 20.5 (6.2) 16.4 (5.7)
Global 24.1 (8.9) 24.1 (10.4) 22.2 (7.9) 24.0 (9.4)
WMH (mL)
median [IQR]
NC 1.67 [0.76 3.54] 1.90 [1.33 5.72] 2.78 [2.15 17.46] 1.85 [0.78 4.33]
EMCI 1.91 [0.88 5.63] 2.75 [0.56 6.08] 0.92 [0.83 12.9] 2.08 [0.70 5.84]
LMCI 2.22 [1.15 4.45] 2.02 [0.60 5.02] 3.37 [1.78 9.10] 2.33 [1.08 5.66]
AD 8.31 [2.06 10.51] 3.37 [1.44 9.39] 0.98 [0.49 4.08] 3.52 [1.31 8.34]
Global 2.06 [0.88 5.42] 2.48 [0.68 6.08] 2.93 [0.96 5.64] 2.15 [0.88 5.74]
Age
mean (SD)
NC 74.2 (5.8) 73.0 (8.0) 78.1 (9.7) 74.1 (6.5)
EMCI 71.6 (7.2) 69.7 (7.2) 68.4 (5.1) 70.8 (7.2)
LMCI 71.4 (7.5) 71.4 (8.1) 70.6 (7.2) 71.3 (7.6)
AD 78.9 (6.0) 74.6 (7.3) 70.1 (7.2) 75.0 (7.3)
Global 72.9 (7.0) 71.3 (7.7) 71.1 (7.3) 72.1 (7.3)
TIV (mL)
mean (SD)
NC 1530 (158) 1543 (152) 1680 (458) 1539 (164)
EMCI 1564 (123) 1564 (165) 1720 (456) 156.9 (141)
LMCI 1553 (158) 1516 (201) 1492 (127) 152.8 (171)
AD 1568 (178) 1557 (173) 1537 (131) 1556 (162)
Global 1552 (143) 1549 (171) 1564 (141) 1552 (153)
Aβ (ng/L)
mean (SD)
NC 200.6 (44.4) 172.9 (41-8) 111.0 (42.3) 190.9 (47.0)
EMCI 197.7 (46.8) 170.4 (47.7) 121.1 (14.0) 185.1 (49.3)
LMCI 196.4 (44.9) 138.1 (32.5) 113.9 (31.4) 158.9 (50.8)
AD 156.4 (52.2) 143.2 (41.2) 101.6 (10.4) 138.7 (44.6)
Global 196.1 (46.3) 159.8 (45.0) 111.3 (26.4) 176.1 (51.6)
Acronyms expansion: TIV - Total Intracranial Volume ; NC - Normal Control ; EMCI - Early Mild Cognitive Impairment
; LMCI - Late Mild Cognitive Impairment ; AD - Alzheimer’s Disease ; Aβ - Aβ CSF level; WMH - White Matter
Hyperintensities ; IQR - InterQuartile Range; SD - standard deviation
Table 7.7: Demographic data of the studied sample by APOE and diagnostic status.
without adjustment for APOE. Across APOE status, an increase in WMH volume with
the number of ε4 alleles was observed, although this was not statistically significant
when APOE was considered with or without adjustment for diagnostic group or Aβ . In
all these models, the impact of age and TIV were significant (p<0.001) and the gender
difference was borderline significant for Model ASTG (p=0.094) such that females
tended to have more WMH.
The baseline data are summarised in Table 7.8.
7.4.4.3 Models of longitudinal WMH volume change
Table 7.9 summarises the results for the longitudinal assessment of the WMH rate of
change. Evolution rates are presented as adjusted mean values of percentage change in
volume per year.
There was strong evidence (p=0.009) that rates of change differed between the
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APOE Diagnosis
33 43 44 NC EMCI LMCI AD
Model Number (Aβ ) 164 (161) 108 (102) 24 (23) 77 (71) 132 (126) 62 (60) 29 (29)
ASTG
Volume 1.96 2.26 3.14
NACI [1.65 2.32] [1.83 2.79] [2.00 4.92]Overall p 0.13
Pairwise /
ASTD
Volume
NA
1.58 2.27 2.72 2.18
CI [1.23 2.03] [1.88 2.75] [2.07 3.59] [1.45 3.27]
Overall p 0.030
Pairwise NC vs EMCI * - NC vs LMCI **
ASTGD
Volume 2.01 2.20 2.96 1.62 2.32 2.61 2.05
CI [1.69 2.38] [1.78 2.72] [1.87 4.71] [1.26 2.08] [1.91 2.81] [1.97 3.46] [1.3 3.10]
Overall p 0.30 0.066
Pairwise / NC vs EMCI * - NC vs LMCI *
ASTGAβ
Volume 2.18 2.05 2.21
NACI [1.82 2.63] [1.64 2.56] [1.34 3.65]Overall p 0.90
Pairwise /
Table 7.8: Baseline models: effects of covariates on differences in WMH volumes across di-
agnostic groups and APOE genotypes when adjusting for age sex TIV. Results are
presented under their back-transformed format.
APOE groups with the largest mean rate in the APOE 44 group and the smallest in the
APOE 33 group. The mean rate in the APOE 44 group (15.5%/year) was significantly
higher than in each of the other two groups (8.7%/year in the 43 group and 5.7%/year
in the 33 group). The mean rates in these latter two groups did not differ significantly
from each other. Adjustment for either diagnostic group (Model ASTGD) or Aβ42
level (Model ASTGAβ ) attenuated the differences between the groups without alter-
ing the overall pattern. In the latter model the dependency of the rate of change on
the CSF Aβ42 level was statistically significant (p=0.003) and the observed trend lost
significance (p=0.39).
The variability observed within diagnostic did not allow for any significant pattern
APOE Diagnosis
33 43 44 NC EMCI LMCI AD
Model Number (Aβ ) 164 (161) 108 (102) 24 (23) 77 (71) 132 (126) 62 (60) 29 (29)
ASTG
% change 5.68 8.68 15.53
NACI [3.56 7.84] [5.95 11.48] [9.09 22.34]Overall p 0.009
Pairwise 33 vs 44 **
ASTD
% change
NA
6.99 6.83 9.38 8.51
CI [3.63 10.46] [4.48 9.23] [5.57 13.32] [1.44 16.06]
Overall p 0.71
Pairwise /
ASTGD
% change 5.69 8.71 15.34 7.60 7.18 8.70 6.25
CI [3.50 7.92] [5.94 11.55] [8.75 22.34] [4.22 11.09] [4.85 9.58] [4.94 12.29] [-0.76 13.75]
Overall p 0.015 0.90
Pairwise 33 vs 44 ** NC - EMCI * NC - LMCI *
ASTGAβ
% change 6.81 7.82 12.18
NACI [4.47 9.21] [4.96 10.76] [5.32 19.49]Overall p 0.39
Pairwise /
Table 7.9: Longitudinal models: effect of baseline predictors on differences in WMH volume
change when adjusting for age sex and TIV. Adjusted means of percentage of change
are presented along with the confidence intervals.
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APOE Baseline 2 years
33
44
Figure 7.10: Longitudinal segmentation for two LMCI subjects with status 33 (first row) and
44 (second row) with same lesion load at baseline (left). Note the faster rate of
accumulation for the homozygous APOE ε4 subject (right).
to arise across diagnostics. Again, the CI for AD was wide and its higher extremity
higher than for the other groups.
Figure 7.10 presents the evolution in WMH for two LMCI subjects with same load
at baseline one with status 33 and the other with status 44 at first scan and after 2 years.
7.4.5 Discussion
This longitudinal study shows a strong association between the APOE status and the
rate of WMH volume accumulation. An increased rate of change was observed for
the homozygous 44 compared to 33 and 43 carriers in a cohort with relatively low
vascular burden at baseline. The subjects in the study ranged from healthy controls
through people with mild cognitive impairment to Alzheimer’s Disease patients. These
findings were observed independently of diagnosis and the same trend although non
significant existed when correcting for CSF Aβ levels.
In the ADNI study, exclusion criteria were designed to limit the amount of vascu-
lar disease using a threshold of 4 on the Hachinski score. Therefore, results obtained
from that sample cannot be immediately generalised to a wider population. For in-
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stance, the percentage change of 15.5 % observed for the APOE 44 group might be
less likely to occur at higher initial loads. Compared to a general population, this co-
hort appears enriched in subjects carrying APOE ε4 alleles, which may have helped in
extracting relevant patterns and allowed the distinction between heterozygous 43 and
homozygous 44. The bias towards a vascular-risk free population may further explain
why no statistically significant differences at baseline were observed in this sample with
respect to APOE status. Additionally, the differences observed in terms of study length
for the LMCI and AD groups may have led to an underestimation of the observed pat-
tern differences. In the case of the AD population, an additional selection bias might
be added since subjects cumulating higher loads of WMH and AD pathology may drop
out quicker than those with little WMH; in AD, the selection criteria of four time points
may be more difficult to achieve. Despite these potential limitations, a slight trend for
increased volume and rates of change with diagnosis severity was still observed.
Initial volumes of WMH have been reported to be positively related to rates of
change in lesion load in both normal [128, 286] and demented populations. The possi-
bility of a non-linear accrual of WMH naturally raises the question of how best to model
accelerating biological processes in statistical analyses. Since volumes are bounded by
the brain size, logarithmic models are imperfect and results are difficult to compare
with observations published based on the raw data. However, in the log-transformed
framework, a relationship between initial raw measurement and absolute measure of
change is inherently allowed for since the log-transformed analysis models changes on
a relative scale.
There was evidence that different patterns of WMH evolution were related to
APOE status consistent with results reported by Godin et al. [287] for normal age-
ing. In this study, a much higher rate of increase in subjects homozygous for APOE
ε4 compared to heterozygous or non-carriers was reported. The finding of no statisti-
cally significant difference in rate of change between heterozygous 43 and non carriers
may be taken as a possible explanation for controversies regarding the link of APOE
ε4 with WMH evolution since in some studies the population was simply dichotomised
into carriers and non-carriers [288]. Yet, the different association strengths observed
with the covariates for the 43 and 33 carriers may reflect potential differences in the
pathological process between these two groups and would deserve further investiga-
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tion.
The association between amyloid pathology, APOE and WMH probably reflects
the link between Aβ , APOE ε4 and cerebral amyloid angiopathy (CAA) [39,264,269].
Since a similar trend was observed after adjustment for diagnosis group or Aβ level, the
additional effects of APOE on the vasculature, independently of amyloid, play certainly
a role in accounting for the much faster increase in WMH for subjects homozygous in
APOE ε4.
The possible joint effects and interaction of vascular risk factors such as hyper-
tension and APOE ε4 on the blood vessels is therefore in need of further investigation
with respect to the development of WMH. So far, cross-sectional studies have reported
controversial findings regarding the relationship between APOE ε4 and WMH. This
is further illustrated here by the absence of difference across genetic status at baseline
while significantly different rates of change are observed. This finding strongly sup-
ports the need to better understand the time course and development pattern of patho-
logical processes. Limitations of cross-sectional studies may be partially overcome by
the application of longitudinal models.
This study could, however, be expanded in a number of ways. Due to the com-
plexity of the possible biophysiological interactions between amyloid compounds and
apolipoprotein, any statistical conclusion should be treated cautiously. As such, CSF
level of Aβ -42 used as a surrogate disease marker for AD pathology [289] is also
known to be related to WMH [290]. Aβ -40 measures, more associated to vascular
deposition, could prove interesting to better understand the pathological process. Fur-
thermore, only global WMH loads were considered here, but regional assessment of the
lesion growth and differences in pattern across regions could improve the understanding
of APOE and AD pathology combined effects. Combining the systematic description
of lesion distribution detailed in Chapter 6 and the longitudinal method developed here
may highlight more specific patterns of evolution. Besides, allele ε2 carriers were ex-
cluded from this study. A possible link between the allele ε2 and WMH has however
been reported [291] but the very low prevalence of this allele in the population makes
any investigation difficult.
In conclusion, this clinical application of the longitudinal framework has shown
the influence of APOE ε4 on the rate of WMH accrual over and above diagnosis status.
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Carriage of a single ε4 allele gave a non- significant additional increase of 3% per year,
whereas homozygous carriers had a significant additional increase of 10% per year
compared with ε3 homozygotes. APOE ε4, especially when in the homozygous form,
is an important independent factor in the progression of WMH.
7.5 Discussion
In this framework, the average image on which a generative data model is then derived
enables the reduction of measurement noise and accounts for the within-subject correla-
tion. Accounting for such correlation instead of simply applying cross-sectional meth-
ods for quantitative assessment has indeed been shown to reduce the measurement vari-
ability [259]. Furthermore, the creation of an average image in a midspace overcomes
the problem of a bias towards a specific time-point as previously mentioned [251,252].
Lastly, the use of the generative model to constrain the segmentation at each time point
is in itself a guarantee that subtle changes can be accounted for while maintaining ro-
bustness.
Various points could nonetheless benefit from further investigation in order to bet-
ter evaluate the robustness and validate the procedure. For instance, the arbitrary choice
of the number of steps required to build the average image and the dependence on the
registration parameters would be of interest. Moreover, since a polynomial fit of degree
2 may not be too greatly affected by the presence of outliers, investigating the differ-
ences observed when excluding obvious outliers in the fit or not may put some light
into their impact on the average image creation.
Apart from the technical details of the framework, validation perspectives, espe-
cially taken with respect to clinical findings, must be considered with caution. As
observed in the case of BaMoS, small lesion loads are generally more difficult to han-
dle resulting in a higher uncertainty in the measurement. This tendency is strongly
reduced when considering a full set of longitudinal data. Such observation may have
a direct and important consequence when comparing longitudinal and cross-sectional
method for clinical studies. The artificially lower loads observed at early time points
of the evolution in the cross-sectional case can indeed result in a naturally higher slope
of evolution than with the longitudinal system. Due to this bias, differences between
groups could then reached different significance levels when using the longitudinal or
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the cross-sectional framework. This naturally leads to the question of the reproducibil-
ity of clinical observations, for which the dependence on the bias of the employed au-
tomatic techniques should be acknowledged. At times when early evolution and devel-
opment become the focus of state-of-the-art research, assessing confidently uncertainty
and bias in numerous conditions of processing is becoming essential. Moreover, type,
shape and direction of evolution may further affect the longitudinal assessment of lesion
evolution. In fact, with partial volume effects at the border of the lesions, direction of
lesion progression (isotropic or anisotropic) combined with the image resolution may
lead to different change detection although with the same volumetric variation. Simi-
larly to what has been reported in Section 5.2.2 with respect to the DSC, lesion size and
shape may influence the detection ability, highlighting further the greater uncertainty
inherent to lower lesion loads measurements. Shifts in WMH volume appear therefore
insufficient to describe the longitudinal evolution of the pathology. Complementary in-
formation regarding direction of expansion, apparition of new lesions presented in the
perspective of other modalities informative on WM tracts and vascularity would prove
extremely valuable to continue improving longitudinal algorithms and understanding
lesion evolution.
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Chapter 8
Summary and future work
8.1 Summary and limitations
Unexpected signal can occur in medical images due to pathological conditions or mech-
anistic acquisition defects. These observations must be taken into account not only
because they affect models and evaluation of normal aspects but also because they are
assumed to bear a biological meaning relevant to the understanding of pathological
conditions. The need for automated quantification of medical imaging observations
stems from the requirements of robustness and generalisability of measurements used
to better assess clinical hypotheses and establish pathophysiological pathways in large
cohorts. The high variability inherent to pathological presentation in the ageing popu-
lation strengthens the need for generic, robust and flexible solutions.
Chapter 4 introduced a generic data modelling framework that uses a hierarchi-
cal GMM to jointly model normal and unexpected observations. Instead of imposing
a predefined number of Gaussian components, the model complexity is automatically
derived based on a split and merge strategy making the model more representative of
biological tissues. Decoupling the modelling of the data from the pathological quantifi-
cation allows the proposed model to remain independent from the clinical application.
As described in Chapter 5, the model can then be used to segment WMH. Heuristic
rules, independent of the model, were designed to be applied as a post-processing step
to fit the clinical description and avoid the inclusion of false positives.
The internal evaluation performed in Section 5.4 showed the robustness of the le-
sion segmentation framework with respect to variations in preprocessing, modality or
acquisition protocol choices. Intrinsic to the lesion segmentation problem lies the ques-
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tion of the distinction between normality and abnormality and probabilistic represen-
tations are therefore required to account for the continuity in the damage. Noticeably,
it is in areas of greater uncertainty at the lesion border that most differences between
segmentation results were observed.
The external validation based on comparison to manual segmentations showed that
BaMoS was more robust compared to other available lesion segmentation algorithms.
As detailed in Section 5.2, multiple means of assessing a segmentation with respect
to a gold standard reference are needed in order to acquire a complete picture of the
performance of an algorithm and overcome the limitations of each single evaluation
measure. However, as stated in Section 5.2.4, due to the inconsistencies inherent to
manual delineations, such measurements cannot be used as the only evaluation source.
Thus, surrogate measurements, such as the consistency in the intensity characteristics
of the resultant segmentation need to be included in the assessment. It is then the com-
bination of all the measurements and the careful analysis of the source of discrepancies
that can contribute to the improvement of automated methods.
In Chapter 6, local lesion statistics were estimated using a subject specific geomet-
rical WM regional parcellation. A graphical representation of the regions was designed
to reflect these local statistics. The proposed regional analysis was used to estimate
the inherited component of vascular damage in twin pairs and to the prediction and
characterisation of rating scales. The results of these two studies demonstrated that the
proposed regional coordinate frame and associated local WMH statistics were able to
accurately describe WM disease patterns beyond global statistics. An online training
tool, aiming to standardise ratings and provide trainees a feedback on their local bias
towards lesions was derived from this representation.
In Chapter 7, the cross-sectional GMM framework was then extended to longitu-
dinal data. A longitudinal lesion simulator was created to validate this model, when
compared to the existing cross-sectional framework and results showed an increased
robustness and sensitivity when using the longitudinal framework. The proposed longi-
tudinal method was used to explore the relationships between APOE status and WMH
accumulation. Due to its high sensitivity and specificity, the proposed longitudinal
method showed highly significant differences in WMH accumulation between genetic
groups, with stronger associations than have been previously reported clinically.
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8.2 Future work
In the course of this work, many choices, opportunities and decisions with regards
to research avenues to close or to explore have been made. It is thus impossible to
properly appreciate how this research would have progressed if these decisions had
been different.
Given the pool of work developed during the last three years, different aspects
could be further investigated. With respect to the BaMoS model, additional a priori
information could be included to constrain the evolution and the range of possible mix-
ture models. Alternatively a different set of constraints may be applied to the covariance
matrices in order to account differently for the various modalities. The split and merge
strategy could also be replaced with a model sampling scheme, which would require
novel technical developments with regards to model sampling and model averaging.
The main application of BaMoS targeted the segmentation of WMH. Other post-
processing rules may however enable the quantification of other neurological mark-
ers such as enlarged perivascular spaces or lacunes. Priors over mixture model con-
figurations and parameters for specific applications/pathologies could help constrain
the space of solutions, resulting in more biologically meaningful mixture classes and
more relevant models. Also, if different priors were available for different pathologies,
Bayesian model comparison could then be used to select the best model and possibly
even classify the patient’s pathology. This could be further enhanced by an analysis
based on the model subclasses of the texture of the different lesions. Alternatively,
BaMoS may be applied to other conditions such as tumor segmentation and its inherent
ability to distinguish different types of outliers used to separate tumor tissue types.
Within the WMH application, other sources of data could be used to further ex-
plore the source of pathophysiological change by looking for instance at the location
with respect to white matter tracts and blood supply using diffusion imaging and arterial
spin labelling.
Given the general nature of the BaMoS model fit, a series of hand crafted hierar-
chical rules were used to select relevant elements after the model fit. Another approach
could be to use machine learning techniques to extract relevant classes/features for the
segmentation of specific pathologies. Such hybrid method of combining generative
model outcome with machine learning techniques has recently been shown to be quite
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successful in the context of tumor segmentation and stroke [292].
With the recent success of learning oriented methods and in particular deep-
learning, one may wonder if those techniques may solve completely the problems
of characterisation and segmentation of pathological data. The understanding of the
boundary between normality and abnormality is however not clear cut. Additional
knowledge and understanding may thus be reached by the combination of learning
processes and model building either using learning results to constrain and enhance
models or using the richness of information provided by models to better feed learning
processes.
Overall, solutions for the quantification of medical images go hand in hand with
the rise of new clinical questions and hypotheses, and the improvement of imaging
techniques. Collateral findings derived from quantification may enable new biological
hypotheses to be proposed. It is therefore crucial to go beyond the simple reproduction
of manual tasks and make use of enriched and robust information to improve patient
care.
Appendix
Acronyms and abbreviations
The following acronyms are ordered alphabetically and not by order of appearance.
AD Alzheimer’s disease.
ADF Anisotropic Diffusion Filter.
ADNI Alzheimer’s Disease Neuroimaging Initiative
AvDist Average distance
BBB Blood Brain Barrier.
BaMoS Bayesian Model Selection.
BaMoS-static Version of BaMoS, with no evolution of the model.
BaMoS-No-
Cov
Version of BaMoS, with no constraint over the covariance.
BaMoS-nc Version of BaMoS, not corrected for FP.
BF Bias field.
BG Basal Ganglia.
BGIT Basal Ganglia and Infratentorial region.
BiASM Bilayered Anatomically constrained Split and Merge expectation max-
imisation algorithm
BIC Bayesian Inference Criterion.
BM Refers to the BrainMaps methods for mask creation.
CC Connected component.
CG Centre of gravity.
CI Confidence interval.
CMB Cerebral microbleeds.
Cross Cross-sectional version of BaMoS with flat outlier priors.
Cross+ Cross-sectional version of BaMoS with adapted typicality map for out-
lier priors. SE stands for sensitivity enhanced.
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CSF Cerebrospinal fluid.
CSVD Cerebral Small vessel disease.
DE Detection error.
DSC Dice Similarity Coefficient.
DTI Diffusion Tensor Imaging.
DWI Diffusion Weighted Imaging.
ECM Expectation Conditional Maximisation.
EM Expectation-Maximisation.
EMCI Early Mild Cognitive Impairment.
EMS Expectation Maximisation Segmentation tool.
EMS-c Clinical version of EMS (with MRF as defined in Section 5.4)
EMS-d Default version of EMS (with adaptive MRF).
E-step Expectation step.
EPVS Enlarged perivascular spaces.
FCM Fuzzy-C Means
FFE Fast Field Echo.
FLAIR FLuid Attenuation Inversion Recovery.
FN False negative.
FNR False negative rate.
FP False positive.
FP/TotF Proportion of false positives among all errors.
FRONT Frontal lobe.
FPR False positive rate.
FWHM Full Width at Half Maximum.
GIF Geodesic Information Flow.
GM Grey matter.
GMM Gaussian mixture model.
GS Gold standard.
GT Ground Truth.
ICBM Refers to the priors derived from the ICBM consortium template.
ICM Iterative Conditional Mode.
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IIH Intensity inhomogeneity.
IQR Inter-quartile range.
KLD Kullback-Leibler Divergence.
LA Leukoaraiosis.
LMCI Late Mild Cognitive Impairment.
Long Longitudinal version of BaMoS with adapted typicality map for outlier
priors.
LST Lesion Segmentation Tool.
LST-WML Clinical version of LST (0.25) optimised for WMH.
LST-MS Default version of LST (0.3) optimised for MS.
MAP-EM Maximum a Posteriori Expectation-Maximisation.
MNI Montreal Neurological Institute.
MRF Markov Random Field.
MR(I) Magnetic Resonance (Imaging).
MS Multiple sclerosis.
M-step Maximisation step.
NABT Normal appearing brain tissue.
NB Non-Brain.
NC Normal Control.
OCC Occipital Lobe.
OER Outline error rate.
OEFP/FP Proportion of false positives belonging to the outline error.
OEFN/FN Proportion of false negatives belonging to the outline error.
OE/TotF Proportion of errors belonging to the outline error.
PAR Parietal lobe.
PD Proton density weighted.
SD Standard deviation.
SM Split and merge.
SVD Singular Value decomposition.
T1 T1-weighted.
T2 T2-weighted.
T2DB Type 2 Diabetes.
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TE Echo time.
TEMP Temporal lobe.
TI Inversion time.
TIV Total intracranial volume.
TLE Trimmed-likelihood estimator.
TLL Total lesion load.
TLLauto TLL obtained by an automated method.
TLLmanual Manually segmented TLL.
TN True negative.
TP True positive.
TPR True positive rate.
TR Repetition time.
TSE Turbo Spin Echo.
VD Volume difference.
WM White matter.
WMC White matter change.
WMH White matter hyperintensity.
WML White matter lesion.
Mathematical notations
In this work, a non bold lower case symbol corresponds generally to a scalar. A bold
lower case symbol refers to a vector while an upper case bold symbol corresponds
to a set of vectors. A letter in calligraphic writing generally corresponds to a known
function. Depending on the context, the notation f can either refer to a distribution
density function or to a probability function.
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Sub-, Superscripts and generalities
(t) Iteration t.
c Corrected for IIH.
τ Time point of longitudinal series.
GW Groupwise space in a longitudinal series
T Applied to a vector or a matrix, denotes the transposition operation.
(d) Taking the value d or Patho, T1, T2, denotes a specific channel.
| | Applied on a matrix, denotes the determinant of the matrix.
E Applied on a random variable, denotes the expectation of this variable.
e` The ` vector of the canonical basis.
̂ Denotes the optimised version of the parameters.
? Indicates a convolution operation.
Usual notations
δ (x) Dirac function
γ(n,x) Incomplete gamma function
Γ(n) Gamma function
λ Denotes a Lagrange multiplier
Indexing and counters
n and N Applied to the voxels of the image, with index n and total number N.
m and M Applied to the IIH polynomial basic functions, with index m and total number
M.
d and D Applied to the number of image modalities, with index d and total number
D.
l Used for the Level 1 of the model hierarchy and assume the value I or O.
j and J Used for the Level 2 of the hierarchy with index j, and J representing the
total number of anatomical classes.
k and
Kl j
Used for the Level 3 of the hierarchy with index k, and Kl j representing the
number of Gaussian distributions used to model class l j.
k and K Used only in Chapter 3, K represents the number of components in the con-
sidered GMM indexed by k.
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Sets and vectors
y Indexed by n and of size D, refers to the vector of normalized log-intensities.
Y Set of vectors yn, with n varying from 1 to N.
z Indexed by n, represents the unity vector of the canonical basis characterising
labelling configuration for voxel n.
Z Set of vectors z, represents the full labelling configuration for the images (hid-
den data).
Density distributions and parameters
µ Mean (vector) for a Gaussian distribution.
Λ Covariance matrix for a Gaussian distribution.
Ω Weighted covariance matrix in a GMM.
θ Set of Gaussian parameters {µ ,Λ}, generally indexed by l jk .
Θ Parameters of the Gaussian components of a mixture indexed by l j.
K Model under consideration, characterising the number of Gaussian compo-
nents Kl j per mixture l j. In chapter 3 refers to the model built from K Gaussian
components.
ΞK Denotes the complete set of parameters used for model K.
I and O Denotes the density distribution function for the inlier and outlier part of the
model respectively.
Φ Density distribution for a mixture at Level 2 of the hierarchy, indexed by l j.
L Notation adopted for the marginal log-likelihood.
G Notation adopted for a Gaussian density distribution.
U Notation adopted for a uniform distribution.
M Generic notation for a distribution at Level 3: can be either uniform (U )) or
Gaussian (G).
W −1 Generic notation for the Inverse Wishart distribution
Bias Field correction
BF Refers to the bias field correction function
χ Indexed by m, corresponds to a IIH polynomial basis function.
χ Refers to the matrix built from the value taken by the M basis functions at the
N considered locations.
v Indexed by n, corresponds to the spatial location of voxel n.
τnd Introduced in the bias field correction process to account for the weight at-
tributed to the observation at location n for channel d.
ϒ Indexed by d, corresponds to the diagonal matrix built with the N τnd values
corresponding to channel d.
y¯nd Introduced in the bias field correction process.
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r Indexed by d, corresponds to the vector of size N of residuals defined at each
location for channel d as ynd− y¯nd .
cmd Refers to the bias field linear coefficient applied to function ξm for channel d.
cm Denotes the vector of bias field linear coefficients of size D applied to basis
function ξm.
cd Denotes the vector of bias field linear coefficients of size M relative to channel
d.
C Denotes the set of vectors of bias field coefficients cm.
Mixing weights and atlases
8.2.0.1 Generic GMM - Chapter 3
w Indexed by l jk , denotes the mixing weight of the component l jk in mixture l j.
w Indexed by l j, represents the vector of mixing weights wl jk used to model
mixture l j.
W Denotes the set of all vectors wl j in the model.
a (b) When simply indexed by l j (l), corresponds to the global mixing weight of
class l j (l) at Level 2 (Level 1). When also indexed by n, corresponds to a
voxelwise a priori probability.
a (b) In the context of statistical atlases, corresponds to the vector built from anl j
(bnl), indexed by n. Otherwise, corresponds to the vector of global mixing
weights.
A (B) Set of vectors {a1, · · · ,aN} ({b1, · · · ,bN}) representing the statistical atlases.
˜ When used as a diacritic mark, denotes the relaxed version of the coeffi-
cient/atlas.
ω In chapter 3, indexed by k, corresponds to the mixing weight of the Gaussian
component k. Indexed by nk relates to the spatially varying mixing weights
defined in probabilistic atlases. From chapter 4 onward, when indexed by nl jk ,
is defined as ωnl jk = bnlan jwl jk .
Ω In Chapter 3, corresponds to the statistical atlases used for the simple GMM.
From Chapter 4 onward, depending on the context, denotes either the set
{b,a,W} of global mixing weights or the set {B,A,W} using the statistical
atlases for Level 1 and Level 2.
Atlas adaptation and parameters
D Denotes the Dirichlet distribution.
B Denotes the Beta distribution.
ε Defines the strength of the prior relaxation process. A lower value repre-
sents a stronger relaxation. From chapter 4, in the three-layered hierarchical
framework, is indexed by the level of the hierarchy (1 or 2).
κ Directly related to ε . The highest κ , the strongest the relaxation.
ϖnk ,ϖ n In chapter 3 denote the Dirichlet prior parameters at voxel n for the compo-
nent k of the GMM and the corresponding vector of gathered values
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αn j,α n From chapter 4 onward, similar to ϖnk ,ϖ n but applied to the J anatomical
tissues defined at Level 2 of the three-layered hierarchical model.
βn j,β n Same as αn j and α n but at Level 1 of the hierarchy.
pnl Responsibility marginalized over the second level.
pn j Responsibility marginalized over the first level.
Gσ Gaussian kernel with standard deviation σ .
MRF notations
Nn Denotes the set of Von Neumann neighbours of voxel n, i.e. the 6 nearest
neighbours (east, west, north, south, top and bottom).
pn Denotes the vector of responsibilities for all l jk components.
PNn Denotes the set of responsibilities vector pm where m ∈ Nn.
UMRF Energy function related to the current labelling configuration.
φnl jk Abbreviation of f
(
yn
∣∣∣zn = el jk ,ΞK).
ψnl jk Abbreviation of exp
(
−UMRF
(
el jk
∣∣∣P(t)Nn,H)).
H MRF inter-class energy matrix.
Constraint over the covariance matrix
e Denotes the global noise model on the image.
∆l jk Weighted covariance matrix for the Gaussian component l jk at Level 3.
Ψ Prior over the model covariances.
Sl jk Scaling diagonal matrix used to compensate for the log-transformation of theintensities in the prior over the covariances.
Model evolution
þ(k)d Corresponds to the d
th highest eigenvalue of the covariance matrix Λk
q(k)d , Qk Vector of the orthogonal decomposition of the covariance matrix Λk corre-
sponding to the eigenvalue þ(k)d and associated orthogonal matrix.
KLDS Calculated on k (l jk in the hierarchical scheme) denotes the Kullback-Leibler
divergence for a component to split.
KLDM Evaluated on the double k1,k2, denotes the Kullback-Leibler divergence for
the comparison of two components to merge.
υ Decimation factor accounting for the proportion of truly independent voxels.
BIC(K) Bayesian Information Criterion on model K.
P(K) Penalisation function over the model K used in BIC
corrr Value of correlation between adjacent voxels in the r-direction.
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Lesion definition
Patho Modalities that can be used as indicator of pathology in the case of WMH, that
is FLAIR, T2 and PD.
L Set of components potentially considered as lesions.
T L Set of components considered as lesions.
S Set of possible lesion-related components that need further refinement.
RL Final set of lesion-related components refining S.
Correction for false positives
ST Tissue binary mask after final classification. T takes its values in GM, WM,
CSF, NB...
Spatial distribution
ST Tissue binary mask after final classification. T takes its values in GM, WM,
CSF, NB...
Longitudinal extension
hτ Intensity mapping polynomial coefficients.
A(Yˆ) Polynomial matrix of Yˆ.
Tτ→GW Spatial transformation from time point space τ to groupwise (GW) space.
t Indexed by n it refers to the typicality map.
Mhτ Intensity mapping transformation with parameters hτ
N˜ Number of degree of freedom of the Inverse Wishart distribution
Longitudinal simulator
LS Simulated lesion map.
L Lesion map.
I Original image.
S Simulated image.
BF Bias field.
G Gaussianly distributed lesion intensities.
R Rigid transformation.
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